Health Statistics Review of Asbestos-Related Diseases in Three Massachusetts Communities with Potential Human Exposure to Vermiculite Ore by Massachusetts. Bureau of Environmental Health. Community Assessment Program. & United States. Agency for Toxic Substances and Disease Registry.
  
 
 
Massachusetts 
Department  
Of 
Public Health 
 
Bureau of Environmental 
Health,  
Community Assessment 
Program 
 
 
 
 
Health Statistics Review of Asbestos-
Related Diseases in Three 
Massachusetts Communities with 
Potential Human Exposure to 
Vermiculite Ore 
 
 
July 2008 
 i
TABLE OF CONTENTS 
 
I. EXECUTIVE SUMMARY ..............................................................................1 
II. INTRODUCTION.............................................................................................8 
III. BACKGROUND ...............................................................................................9 
IV. METHODS ......................................................................................................10 
A. DATA SOURCES.................................................................................................................. 11 
1. Incidence Data .............................................................................................................. 11 
2. Mortality Data .............................................................................................................. 13 
B. GEOGRAPHIC DISTRIBUTION.............................................................................................. 15 
C. STATISTICAL ANALYSES .................................................................................................... 17 
1. Calculation of a Standardized Incidence Ratio (SIR)................................................... 17 
2. Interpretation of a Standardized Incidence Ratio (SIR) ............................................... 17 
3. Calculation of a Standardized Mortality Ratio (SMR) ................................................. 18 
4. Interpretation of a Standardized Mortality Ratio (SMR).............................................. 19 
5. Calculation of a Standardized Rate Ratio (SRR).......................................................... 20 
6. Calculation of the 95% Confidence Interval ................................................................ 21 
D. REVIEW OF RISK FACTOR INFORMATION ........................................................................... 22 
V. RESULTS.........................................................................................................24 
A. BILLERICA ......................................................................................................................... 24 
1. Asbestos-Related Cancer Incidence in the Town of Billerica (Table 1)....................... 25 
2. Asbestos-Related Cancer Incidence in Billerica Census Tracts (Tables 1A and 1B)... 26 
3. Review of Cancer Incidence Risk Factor Information.................................................. 27 
4. Asbestos-Related Mortality in the Town of Billerica (Table 2) .................................... 29 
5. Asbestos-Related Mortality in the Billerica Census Tracts (Table 2A-2C).................. 30 
6. Review of Mortality Risk Factor Information............................................................... 32 
7. Geographic Distribution............................................................................................... 34 
8. Summary ....................................................................................................................... 35 
B. CAMBRIDGE ....................................................................................................................... 36 
1. Asbestos-Related Cancer Incidence in the City of Cambridge (Table 3) ..................... 37 
2. Asbestos-Related Cancer Incidence in Cambridge Census Tracts (Table 3A – 3H).... 38 
3. Review of Cancer Incidence Risk Factor Information.................................................. 39 
4. Asbestos-Related Mortality in the City of Cambridge (Table 4) .................................. 41 
5. Asbestos-Related Mortality in Cambridge Census Tracts (Tables 4A – 4O) ............... 41 
6. Review of Mortality Risk Factor Information............................................................... 44 
7. Geographic Distribution............................................................................................... 46 
8. Summary ....................................................................................................................... 47 
C. EASTHAMPTON .................................................................................................................. 49 
1. Asbestos-Related Cancer Incidence in the Town of Easthampton (Table 5)................ 49 
2. Asbestos-Related Cancer Incidence in Easthampton Census Tracts (Table 5A) ......... 50 
3. Review of Cancer Incidence Risk Factor Information.................................................. 50 
 ii
4. Asbestos-Related Mortality in the Town of Easthampton (Table 6) ............................. 51 
5. Asbestos-Related Mortality in the Easthampton Census Tracts (Table 6A)................. 52 
6. Review of Mortality Risk Factor Information............................................................... 53 
7. Geographic Distribution............................................................................................... 53 
8. Summary ....................................................................................................................... 54 
VI. LIMITATIONS ...............................................................................................55 
VII. CONCLUSIONS ......................................................................................57 
VIII. RECOMMENDATIONS.........................................................................61 
REFERENCES.......................................................................................................62 
TABLES..................................................................................................................64 
FIGURES..............................................................................................................101 
APPENDIX A .......................................................................................................105 
APPENDIX B .......................................................................................................107 
APPENDIX C .......................................................................................................109 
APPENDIX D .......................................................................................................145 
APPENDIX E .......................................................................................................161 
 
 iii
TABLES 
 
Table 1. Asbestos-Related Cancer Incidence – Billerica 
Table 1A. Asbestos-Related Cancer Incidence – Billerica Census Tracts 3161-3164 
Table 1B. Asbestos-Related Cancer Incidence – Billerica Census Tracts 3165 
Table 2. Asbestos-Related Cancer Mortality – Billerica 
Table 2A. Asbestos-Related Cancer Mortality – Billerica Census Tracts 3161-3162 
Table 2B. Asbestos-Related Cancer Mortality – Billerica Census Tracts 3163-3164 
Table 2C. Asbestos-Related Cancer Mortality – Billerica Census Tracts 3165 
Table 3. Asbestos-Related Cancer Incidence – Cambridge 
Table 3A. Asbestos-Related Cancer Incidence – Cambridge Census Tracts 3521-3524 
Table 3B. Asbestos-Related Cancer Incidence – Cambridge Census Tracts 3525-3528 
Table 3C. Asbestos-Related Cancer Incidence – Cambridge Census Tracts 3529-3532 
Table 3D. Asbestos-Related Cancer Incidence – Cambridge Census Tracts 3533-3536 
Table 3E. Asbestos-Related Cancer Incidence – Cambridge Census Tracts 3537-3540 
Table 3F. Asbestos-Related Cancer Incidence – Cambridge Census Tracts 3541-3544 
Table 3G. Asbestos-Related Cancer Incidence – Cambridge Census Tracts 3545-3548 
Table 3H. Asbestos-Related Cancer Incidence – Cambridge Census Tracts 3549-3550 
Table 4. Asbestos-Related Cancer Mortality – Cambridge 
Table 4A. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3521-3522 
Table 4B. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3523-3524 
Table 4C. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3525-3526 
Table 4D. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3527-3528 
Table 4E. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3529-3530 
Table 4F. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3531-3532 
Table 4G. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3533-3534 
Table 4H. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3535-3536 
Table 4I. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3537-3538 
Table 4J. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3539-3540 
Table 4K. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3541-3542 
Table 4L. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3543-3544 
Table 4M. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3545-3546 
Table 4N. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3547-3548 
Table 4O. Asbestos-Related Cancer Mortality – Cambridge Census Tracts 3549-3550 
Table 5. Asbestos-Related Cancer Incidence – Easthampton 
Table 5A. Asbestos-Related Cancer Incidence – Easthampton Census Tracts 8223-8224 
Table 6. Asbestos-Related Cancer Mortality – Easthampton 
Table 6A. Asbestos-Related Cancer Mortality – Easthampton Census Tracts 8223-8224 
 
 
FIGURES 
 
Figure 1. Billerica Census Tract Map 
Figure 2. Cambridge Census Tract Map 
Figure 3. Easthampton Census Tract Map 
 
 iv
 
APPENDICES 
 
Appendix A:  Asbestos-Related Health Outcomes:  Incidence Data 
Appendix B:  Asbestos-Related Health Outcomes:  Mortality Data 
Appendix C:  Standardized Rate Ratios 
Appendix D:  Cancer Incidence and Mortality Data Review – Hingham 
Appendix E:  Cancer Incidence and Mortality Data Review - Westminster
 1
I. EXECUTIVE SUMMARY 
Under a cooperative agreement with the federal Agency for Toxic Substances and Disease 
Registry (ATSDR), the Massachusetts Department of Public Health’s (MDPH) Bureau of 
Environmental Health (BEH) reviewed the incidence and mortality of asbestos-related diseases 
in five communities.  ATSDR issued cooperative agreements to select state public health 
agencies to conduct health statistics reviews related to potential human exposure to contaminated 
vermiculite ore (an asbestos-containing mineral) at sites across the United States.  These sites 
were identified by the U.S. Environmental Protection Agency (USEPA) as having possibly 
received vermiculite from a mine in Libby, Montana.  Specifically, the purpose of these health 
statistics reviews was to determine whether elevated numbers of asbestos-related diseases and 
deaths occurred in select Massachusetts communities that may have received asbestos-
contaminated vermiculite ore.   
 
Libby, Montana, is the site of a vermiculite mine which began operation in the early 1920s and 
continued operations until 1990 when it closed.  The vermiculite from the Libby mine is a 
naturally-occurring fibrous mineral contaminated with a particularly toxic form of asbestos 
called tremolite.  For decades, contaminated ore from the Libby mine was shipped to processing 
facilities throughout the United States to be used in the manufacture of building construction 
materials, steel, plastics, fertilizers and chemicals.  While in operation, the USEPA estimates that 
the Libby mine may have produced 80% of the world’s supply of vermiculite.   
 
In 2000, ATSDR analyzed mortality statistics for Libby for the 20-year period from 1979 to 
1998 to generate an understanding of mortality potentially associated with historical asbestos 
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exposures in Libby.  For the 20-year period reviewed, mortality in Libby resulting from 
asbestosis was approximately 40 to 60 times higher than expected.  Mesothelioma mortality was 
also elevated.  Both asbestosis and mesothelioma are strongly associated with exposure to 
asbestos.  It was the findings from ATSDR’s report that prompted the federal agency to work 
cooperatively with select states to review health statistics on diseases and deaths potentially 
related to exposure to asbestos-contaminated vermiculite ore.  
 
Initially, the USEPA identified five communities in Massachusetts with industries that possibly 
could have received vermiculite ore from Libby, Montana.  These communities included:  
Billerica, Cambridge, Easthampton, Hingham, and Westminster.  After an extensive records 
review, the USEPA concluded that there was no evidence of an industrial facility in Hingham or 
Westminster that accepted or processed vermiculite ore. 
 
Populations living near vermiculite-processing facilities may have encountered higher-than-
average levels of asbestos exposure.  These exposures may have occurred among individuals 
living in the vicinity of these facilities or among individuals working at the facilities.  The 
majority of releases would have occurred during the mining, milling, or exfoliation of 
vermiculite.  Exfoliation, the major processing step at vermiculite-processing facilities, involves 
heating the vermiculite to eliminate water and puff the vermiculite; this process results in the 
release of asbestos from the vermiculite. The most significant route of human exposure to 
asbestos is the inhalation of asbestos fibers.  Asbestos exposure is known to increase the risk of a 
number of diseases including asbestosis, mesothelioma, lung cancer, and other respiratory 
diseases. 
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Of the five communities identified initially by the USEPA as possibly having received 
vermiculite ore from the Libby, Montana mine, one community, Easthampton, was found upon 
further investigation to have an exfoliation facility within its boundaries. Two other 
communities, Billerica and Cambridge, had industrial facilities in their communities that either 
manufactured (the Zonolite Company in Billerica) or conducted research on (the W.R. Grace 
Company in Cambridge) asbestos-containing products.   
 
With a few exceptions, the incidence of and mortality from asbestos-related sentinel cancers and 
causes of death occurred about as expected in the five communities of Billerica, Cambridge, 
Easthampton, Hingham, and Westminster.  Cancer incidence data were reviewed for the 10-year 
period of 1986 through 1995 while mortality data were reviewed for the 20-year period of 1979 
through 1998.  A review of the geographic distribution of place of residence at diagnosis or death 
for the five communities did not reveal any unusual spatial patterns either on a townwide basis or 
in the vicinity of the industrial facilities of interest.   
 
In Hingham and Westminster, where there is no evidence of the industrial use of vermiculite, 
with a few exceptions, the incidence of and mortality from asbestos-related cancers and diseases 
was about as expected.  In Westminster, one additional case of cancer of the peritoneum, 
retroperitoneum, and pleura (two diagnoses observed versus one diagnosis expected) as well as 
one additional death from asbestosis (one death observed versus 0.1 deaths expected) occurred 
during the time period evaluated.  In Hingham, townwide mortality was statistically significantly 
elevated for peritoneum cancers (including mesothelioma) with 11 deaths reported when 
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approximately two deaths were expected. Seven of the 11 deaths were reportedly due to 
mesothelioma; the death certificates of two of the seven individuals indicated possible 
occupational exposure to asbestos. Shipbuilding in southeastern Massachusetts was one of the 
primary industries during the period around World War II.  Asbestos was used in shipbuilding to 
insulate boilers, steam pipes, and hot water pipes.  
 
In Easthampton, the location of the Zonolite exfoliation facility, the incidence of asbestos-related 
sentinel cancers was lower than expected based on national rates.  Mortality rates for sentinel 
causes of death were about as expected in Easthampton.  No deaths were reported from cancers 
of the peritoneum, retroperitoneum, and pleura (including mesothelioma) and one death from 
asbestosis was reported while less than one death would be expected in this population.  Thus, 
the occurrence of asbestos-related cancers and diseases in Easthampton was about as expected. 
 
In Billerica, where the Zonolite Company manufactured products using vermiculite over an 
eleven-year period, the incidence and/or mortality for some sentinel health outcomes were 
statistically significantly different than expected for the town as a whole.  While the incidence of 
mesothelioma was as expected, the mortality rate for males was higher than expected in 
Billerica, with six deaths from cancers of the peritoneum, retroperitoneum, and pleura (five 
specifically from mesothelioma) reported whereas approximately 1.2 deaths were expected.  
Although smoking history was not available on the death certificates of these individuals, two of 
the six death certificates listed occupations where asbestos exposures were possible.  In addition, 
both the incidence of and mortality from lung and bronchus cancers were statistically 
significantly elevated in Billerica townwide and in three of its five census tracts.  A review of 
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available risk factor information revealed that between 80 and 90 percent of the individuals 
diagnosed with lung and bronchus cancer were current or former smokers; this increased to 
between 96 and 100% for those individuals with a known smoking history.  Also, between 10 
and 12 percent of those diagnosed with lung and bronchus cancer or those who died of this 
cancer reported occupations where exposure to asbestos was possible.  A review of the 
geographic distribution of place of residence at diagnosis or death for these sentinel health 
outcomes did not reveal any unusual patterns that could not be attributed to areas of higher 
population density.  No unusual geographic patterns were noted in the vicinity of the former 
Zonolite facility. 
 
In Cambridge, where the W.R. Grace facility conducted research and development on products 
that contained asbestos, the townwide incidence and/or mortality rates were about as expected 
for the following sentinel health outcomes:  mesothelioma; cancers of the peritoneum, 
retroperitoneum, and pleura; lung and bronchus cancer; and deaths from asbestosis.  In some 
instances the number of observed deaths exceeded the number expected but the differences were 
not statistically significant.  
 
Although the incidence of lung and bronchus cancer citywide occurred significantly less often 
than expected, two census tracts had significantly more diagnoses of lung and bronchus cancer 
than expected and four census tracts had significantly more deaths from lung and bronchus 
cancer than expected.  An examination of risk factor information for these census tracts revealed 
that smoking may have played a role in the development of these cancers, with between 77 and 
89% of the cases being current or former smokers.  Among those individuals with known 
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smoking status in these two CTs, 100% of them were current or former smokers.  Although 
smoking history is not available on death certificates, occupational information for 3 of the 4 
census tracts with higher than expected mortality rates indicated that between 7 and 10% of the 
individuals could have been exposed to asbestos on their jobs. 
 
In the census tract where the W.R. Grace facility was located, both the incidence and mortality 
for the sentinel health outcomes was about as expected.  No diagnoses or deaths were reported in 
this CT (or its adjacent CT) for mesothelioma, asbestosis, or cancers of the peritoneum, 
retroperitoneum, or pleura.  No statistically significant differences in the incidence or mortality 
rates for lung and bronchus cancer were found in either of these CTs.   
 
In conclusion, through the Massachusetts Cancer Registry, the Bureau of Environmental Health 
will continue to monitor the incidence of asbestos-related diseases in Easthampton.  Although the 
incidence and mortality rates of asbestos-related diseases in Easthampton were about as expected 
or lower than expected, based on statewide rates, due to the former presence of an exfoliation 
facility in Easthampton that processed vermiculite from 1963 until 1992 and the long latency 
period of asbestos-related diseases, MDPH will continue to monitor the incidence of asbestos-
related cancers in Easthampton.   
 
This report covered a broad range of health outcomes, such as the incidence of digestive organ 
cancers and mortality from chronic obstructive pulmonary disease.  While the focus of the 
analysis was on those cancer types or causes of death strongly associated with asbestos exposure, 
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MDPH has provided all of the data generated as part of its cooperative agreement with ATSDR 
in the hope that the data will be informative to local health departments and their communities.
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II. INTRODUCTION 
Under a cooperative agreement with the federal Agency for Toxic Substances and Disease 
Registry (ATSDR), the Massachusetts Department of Public Health’s (MDPH) Bureau of 
Environmental Health (BEH) reviewed the incidence and mortality of asbestos-related diseases 
in five Massachusetts communities.  ATSDR issued cooperative agreements to selected state 
public health agencies to conduct health statistics reviews related to potential human exposure to 
contaminated vermiculite ore (an asbestos-containing mineral) at sites across the United States.  
These sites were identified by the U.S. Environmental Protection Agency (USEPA) as having 
possibly received vermiculite from a mine in Libby, Montana.  Specifically, the purpose of these 
health statistics reviews was to determine whether elevated numbers of asbestos-related diseases 
and deaths occurred in select Massachusetts communities that may have received asbestos-
contaminated vermiculite ore.   
 
Initially, the USEPA identified five communities in Massachusetts with industries that possibly 
could have received vermiculite ore from Libby, Montana.  These communities included:  
Billerica, Cambridge, Easthampton, Hingham, and Westminster.  After an extensive records 
review, the USEPA concluded that there was no evidence of an industrial facility in Hingham 
that accepted or processed vermiculite ore (W. Toland, USEPA, personal communication, 2005).  
The USEPA record review included Hingham business registration records and building permits 
dating back to the 1930s; Massachusetts Secretary of State, Corporate Registration Division 
records; and personal visits to the Hingham Fire and Police Departments as well as the Hingham 
Public Library and Senior Citizens Center.  The USEPA also investigated whether a facility in 
Westminster, the Advance Coating Company, ever received vermiculite ore and concluded that 
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there was no evidence of this facility ever receiving or processing vermiculite ore (D. McIntyre, 
USEPA, personal communication, 2005).  Because this health statistics review began before it 
was concluded that vermiculite ore had not been shipped to either Hingham or Westminster, we 
had conducted health statistics reviews for both communities and have included them in 
Appendices D and E. 
III. BACKGROUND 
Libby, Montana, is the site of a vermiculite mine which began operation in the early 1920s and 
continued operations until 1990 when it closed.  The Zonolite Company operated the mine from 
the 1920s until 1963, when the W.R. Grace Company bought the mine.  The vermiculite from the 
Libby mine is a naturally-occurring fibrous mineral contaminated with a particularly toxic form 
of asbestos called tremolite.  The vermiculite ore was estimated to contain between 0 and 25% 
tremolite asbestos by weight (ATSDR 2001).  For decades, contaminated ore from the Libby 
mine was shipped to processing facilities throughout the United States to be used in the 
manufacture of building construction materials, steel, plastics, fertilizers and chemicals (ATSDR 
2001).  While in operation, the USEPA estimates that the Libby mine may have produced 80% 
of the world’s supply of vermiculite.   
 
In 2000, ATSDR analyzed mortality statistics for Libby for the 20-year period from 1979 to 
1998 (ATSDR 2000a).  Its review of death certificate data was conducted to generate an 
understanding of mortality potentially associated with historical asbestos exposures in Libby.  
For the 20-year period reviewed, mortality in Libby resulting from asbestosis was approximately 
40 to 60 times higher than expected.  Mesothelioma mortality was also elevated.  Both asbestosis 
and mesothelioma are strongly associated with exposure to asbestos.  It was the findings from 
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ATSDR’s report that prompted the federal agency to work cooperatively with select states to 
review health statistics on diseases and deaths potentially related to exposure to asbestos-
contaminated vermiculite ore.  
 
Populations living near vermiculite-processing facilities may have encountered higher-than-
average levels of asbestos exposure.  These exposures may have occurred among individuals 
living in the vicinity of these facilities or among individuals working at the facilities.  The 
majority of releases would have occurred during the mining, milling, or exfoliation of 
vermiculite.  Exfoliation, the major processing step at vermiculite-processing facilities, involves 
heating the vermiculite to eliminate water and puff the vermiculite; this process results in the 
release of asbestos from the vermiculite (ATSDR 2001).  The most significant route of human 
exposure to asbestos is the inhalation of asbestos fibers.  Asbestos exposure is known to increase 
the risk of a number of diseases including asbestosis, mesothelioma, lung cancer, and other 
respiratory diseases. 
IV. METHODS 
The health statistics reviews of the five Massachusetts communities were conducted according to 
a standard protocol established by the ATSDR (ATSDR 2001).  Three different statistics were 
calculated for each community:  standardized incidence ratios (SIRs), standardized mortality 
ratios (SMRs), and standardized rate ratios (SRRs).  These statistics will be defined later in the 
section entitled Statistical Analyses.  In the body of this report, we present the SIRs and SMRs 
for three of the five communities.  All SRRs are reported in Appendices C and D.  ATSDR 
included the calculation of SRRs in its protocol to allow for comparisons amongst communities 
across the country.  As stated in its protocol, comparisons between two communities are only 
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valid if there are no differences in the age-sex distributions of the two community populations.  
Because each SRR is weighted by the population distribution of a particular reference 
population, comparisons between communities are valid; see Appendix C for an explanation of 
how an SRR is calculated.  Most relevant for this report, however, are the SIRs and SMRs that 
allow comparison of a community’s experience to that of a larger, more stable population (in this 
case, the U.S. population).  Although MDPH typically calculates SIRs and SMRs using the 
statewide cancer or mortality experience for comparison, it was necessary for this health 
statistics review to follow the methodology prescribed in the ATSDR protocol.  Both approaches 
are valid; the key factor is to use a large, stable population for comparison. 
A. Data Sources 
 
Asbestos-related cancer incidence and mortality data were obtained from the MDPH Bureau of 
Health Statistics, Research, and Evaluation (BHSRE).  The BHSRE contains both the Registry of 
Vital Records and Statistics and the Massachusetts Cancer Registry (MCR).   
 
1. Incidence Data 
 
Cancer incidence data (i.e., reports of new cancer diagnoses) for individuals diagnosed with an 
asbestos-related cancer type were obtained from the MCR for the towns of Billerica, Cambridge, 
Easthampton, Hingham, and Westminster.  Asbestos-related cancer types were stipulated by the 
ATSDR in its protocol and include malignant neoplasms of the following sites:  digestive organs; 
respiratory system and intrathoracic organs (hereinafter referred to as respiratory system 
cancers); lung and bronchus; peritoneum, retroperitoneum, and pleura (hereinafter referred to as 
peritoneum cancers); and mesothelioma.  Coding for these cancer types follows the International 
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Classification of Diseases for Oncology (ICD-O2) system (WHO 1990).  (The incidence coding 
definitions specified in the protocol are shown in Appendix A.)  Mesothelioma, cancer of the 
lining of the lung and other organs, is defined by morphology or cell type and not by the site of 
occurrence.  Therefore, if a mesothelioma occurred in the peritoneum or pleura, for example, it 
will be counted in that cancer type as well as a mesothelioma.  The observed cases in this 
evaluation consisted of individuals diagnosed with one of the above cancer types during the time 
period of January 1, 1986 through December 31, 1995, the period of study stipulated in the 
ATSDR protocol.  Cases were selected for inclusion based on the residential address reported to 
the hospital or reporting medical facility at the time of diagnosis.   
 
For this report, we focus primarily in the Results section on incidence data for those cancer types 
suggested as having a strong association with asbestos exposure.  These sentinel cancer types 
include:  lung and bronchus, peritoneum cancers, and mesothelioma.  ATSDR, in its protocol, 
included other cancer types which it characterizes as having a weaker association with asbestos 
exposure; these include digestive organ cancers and respiratory system cancers other than those 
involving the lung and bronchus.  The category of respiratory system cancers is broad and 
includes the following parts of the respiratory system: lung and bronchus; peritoneum, 
retroperitoneum, and pleura (including mesothelioma); larynx, trachea, thymus, heart and 
mediastinum, and other ill-defined sites within the respiratory system.  Because the associations 
between asbestos and lung and bronchus cancer and mesothelioma are the strongest, and because 
other risk factors (such as tobacco) are more strongly associated with cancers in other parts of the 
respiratory system, we focus in this report on lung and bronchus cancer and peritoneum cancers. 
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The MCR data files may occasionally contain duplicate reports of cases. The data in this report 
have been controlled for duplicate cases by excluding them from the analyses. Duplicate cases 
are additional reports of the same primary site cancer case.  The decision that a case was a 
duplicate report and should be excluded from the analyses was made by the MCR after 
consulting with the hospital or reporting facilities and obtaining additional information regarding 
the histology and/or pathology of the case.  Individuals who were diagnosed with multiple 
primary site cancers were included as separate cases in the analyses in this report.  A multiple 
primary cancer case is defined by the MCR as a new cancer in a different location in the body, or 
a new cancer of the same histology (cell type) as an earlier cancer, if diagnosed in the same 
primary site (original location in the body) more than two months after the initial diagnosis. 
 
2. Mortality Data 
 
Asbestos-related mortality was defined as any death in the five communities where the 
underlying cause was one of the following asbestos-related diseases specified by the ATSDR in 
its protocol: 
• Malignant neoplasm of digestive organs 
• Malignant neoplasm of respiratory system and intrathoracic organs (hereinafter referred 
to as respiratory system cancers) 
• Malignant neoplasm of lung and bronchus 
• Malignant neoplasm of peritoneum, retroperitoneum, and pleura (includes 
mesothelioma); hereinafter referred to as peritoneum cancers (including mesothelioma) 
• Malignant neoplasm without specification of site (hereinafter referred to as site-
unspecified neoplasms) 
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• Diseases of pulmonary circulation 
• Chronic obstructive pulmonary disease (COPD) 
• Pneumoconioses and other lung diseases due to external agents (hereinafter referred to as 
pneumoconioses) 
• Asbestosis 
• Other diseases of the respiratory system 
Coding for these causes of death follows the International Classification of Diseases, Injuries, 
and Causes of Death (ICD-9) system, Ninth Revision (WHO 1978).  Malignant neoplasms 
without specification of site were included in the death certificate search because ATSDR 
discovered, in its review of mortality data for Libby, Montana, that some mesothelioma deaths 
had been miscoded as unspecified malignant neoplasms.  MDPH reviewed death certificates with 
the ICD-9 code for unspecified malignant neoplasms and, if the death certificate listed 
mesothelioma on it, then it was re-coded to the correct ICD-9 code for mesothelioma.  
Individuals who died of one of the above causes between January 1, 1979 and December 31, 
1998 and whose death certificate showed a residence in one of the five communities were 
included in this analysis.  The 20-year time period was specified in the ATSDR protocol. 
 
As with the incidence data, the primary focus in this report is on those causes of death with a 
strong association with asbestos exposure.  These sentinel causes of death include:  lung and 
bronchus cancers, peritoneum cancers (including mesothelioma deaths), and asbestosis.  ASTDR 
included other causes of death in its protocol because either they represent a weaker association 
with asbestos exposure or they are conditions that could be aggravated by asbestos exposure and 
lead to premature mortality (such as COPD). 
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B. Geographic Distribution 
 
Residential address at the time of diagnosis or time of death for each individual reported with a 
sentinel cancer or cause of death was mapped using a computerized geographic information 
system (GIS) (ESRI 1998). This allowed for the assignment of census tract location for each case 
which permitted an evaluation of the spatial distribution of individual cases at a smaller 
geographic level (i.e. census tracts) than the community as a whole.  
 
Because accurate age group and gender specific population data are required to calculate cancer 
incidence and mortality rates, the census tract (CT) is the smallest geographic area for which 
these rates can be accurately calculated. Specifically, a CT is a smaller statistical subdivision of a 
county as defined by the U.S. Bureau of the Census. Census tracts usually contain between 2,500 
and 8,000 persons and are designed to be homogeneous with respect to population characteristics 
(USDOC 1990).  
 
Because the incidence and mortality data, collectively, span the years 1979 through 1998, it was 
necessary to consider census tract designations that existed within the five communities in both 
the 1980 and 1990 census years. According to the 1980 U.S. Census (USDOC 1980), the town of 
Billerica compromised five census tracts, the city of Cambridge compromised thirty census 
tracts, the town of Easthampton compromised two census tracts, the town of Hingham 
compromised three census tracts, and the town of Westminster comprised one census tract. 
Between the 1980 and 1990 censuses, the Bureau of the Census further subdivided one census 
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tract in Easthampton (CT 8224) and one census tract in Hingham (CT 5012). The split in these 
census tracts produced three census tracts in Easthampton (CT 8223, CT 8224.01, and CT 
8224.02) and four census tracts in Hingham (CT 5012.01, CT 5012.02, CT 5011.01, CT 
5011.02). In order to evaluate cancer incidence by census tract over time, population data for the 
split census tracts were combined for 1990 in Hingham and Easthampton to remain consistent 
with the 1980 population data and CT designations.  Therefore, for the purpose of this 
evaluation, cancer and mortality rates were calculated according to the 1980 census tract 
designations for five census tracts in Billerica (CT 3161-CT 3165), thirty Cambridge census 
tracts (CT 3521–CT 3550), two in Easthampton (CT 8223 and CT 8224), three Hingham census 
tracts (CT 5011.01, CT 5011.02 and CT 5012), and one Westminster census tract (CT 7081). 
 
The geographic distribution was determined using a qualitative evaluation of the point pattern of 
cases within the towns and their individual census tracts. In instances where the address 
information was incomplete (i.e., did not include specific streets or street numbers), efforts were 
made to research those cases using telephone books and town residential lists issued within two 
years of an individual’s diagnosis or death.  This evaluation specifically focused on the 
geographic pattern of sentinel health outcomes in the neighborhoods surrounding the facilities 
that potentially received asbestos-contaminated vermiculite.  For confidentiality reasons, maps of 
the location of individual cases are not provided in this report. 
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C. Statistical Analyses 
 
1. Calculation of a Standardized Incidence Ratio (SIR) 
 
To determine whether elevated numbers of asbestos-related cancer cases occurred in the five 
Massachusetts communities, cancer incidence data were tabulated by age group and gender to 
compare the observed number of cancer cases to the number that would be expected based on the 
U.S. cancer rate1.  Standardized incidence ratios (SIRs) were calculated for the time period 1986-
1995 for each of the asbestos-related ICD-O2 codes for each city as a whole and for each census 
tract within each community. 
 
To calculate SIRs, population data from the 1990 U.S. Census (USDOC 1992) were used to 
obtain the population of a community by age group and gender.  The 1990 census population 
serves as an approximate mid-year point for the study time period of 1986-1995. 
 
2. Interpretation of a Standardized Incidence Ratio (SIR) 
 
An SIR is an estimate of the occurrence of cancer in a population relative to what might be 
expected if the population had the same cancer experience as a larger comparison population 
designated as “normal” or average. Using the U. S. population as a comparison provides a stable 
population base for the calculation of incidence rates. 
 
                                                 
1 As stated earlier, the MDPH, in calculating SIRs, typically estimates an expected number of cases by applying the 
statewide cancer rate to the population of interest.  However, because this Health Statistics Review is part of a 
national review, the federal ATSDR stipulated that all participating states use national cancer rates to estimate the 
expected number of cases in a community. 
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Specifically, the SIR is the ratio of the observed number of cases in an area to the expected 
number, where the expected number is based on the U.S. cancer incidence rates provided by the 
Surveillance, Epidemiology, and End Results (SEER 2000).  The population structure of each 
community is adjusted to the U.S. incidence rate to calculate the number of expected cancer 
cases.  Comparisons of SIRs between communities or census tracts are not possible because each 
community has different population characteristics. 
 
An SIR of exactly one indicates that the number of asbestos-related cancer cases observed in the 
community or census tract being evaluated is equal to the number of cases expected in the 
comparison or “normal” population.  An SIR greater than one indicates that more cancer cases 
occurred than were expected, and an SIR less than one indicates that fewer cancer cases occurred 
than were expected.  Accordingly, an SIR of 1.5 is interpreted as 50% more cancer cases than the 
expected number; an SIR of 0.9 indicates 10% fewer cancer cases than expected2. 
 
3. Calculation of a Standardized Mortality Ratio (SMR) 
 
To determine whether elevated numbers of asbestos-related deaths occurred in the five 
communities or their census tracts, mortality data were tabulated in a similar way to the cancer 
incidence data, to compare the observed number of deaths to the number that would be expected 
based on nationwide death rates for asbestos-related causes of death.  Standardized mortality 
ratios (SMRs) were calculated for the 20-year period 1979-1998 for each of the asbestos-related 
                                                 
2Typically, MDPH reports an SIR as the ratio of the observed number of cases to the expected number multiplied by 
100.  Therefore, an SIR of 100 would indicate that the number of cancer cases observed is equal to the number 
expected.  However, to conform to the ATSDR protocol for this Health Statistics Review, an SIR is simply defined 
as the ratio of the observed to the expected.  MDPH typically uses a multiplier of 100 for the ease of interpretation.  
Both methods of calculating an SIR produce comparable results. 
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ICD-9 codes, for each community as a whole and their census tracts.  Population data from the 
1990 Census (USDOC 1992) were used to calculate the SMRs.  The ATSDR determined that the 
1990 Census data provide the most representative estimates of the size and age structure for the 
time period of interest (ATSDR 2001).  In addition, the 1990 census population serves as an 
approximate mid-year point for the study period. 
 
4. Interpretation of a Standardized Mortality Ratio (SMR) 
 
An SMR is interpreted in a similar way to an SIR.  An SMR is an estimate of the occurrence of 
mortality in a population relative to what might be expected if the population had the same 
mortality experience as a comparison population designated as “normal” or average.  The SMR 
is the ratio of the observed number of deaths in an area to the expected number of deaths based 
on mortality rates in the U.S. population (ATSDR 2001).  For this review, the expected numbers 
of deaths were provided by the National Center of Health Statistics (ATSDR 2001).  As with 
SIRs, comparisons of SMRs between communities are not possible because each community has 
different population characteristics. 
 
As with an SIR, an SMR of exactly one indicates that an area’s mortality experience is equal to 
that expected based on U.S. mortality rates.  An SMR greater than one indicates that more deaths 
occurred than were expected, and an SMR less than one indicates that fewer deaths occurred than 
were expected. 
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5. Calculation of a Standardized Rate Ratio (SRR) 
 
A third statistic called a standardized rate ratio (SRR) was also computed in this Health Statistics 
Review.  An SRR is the ratio of the number of expected deaths (or cancer cases) in the reference 
population, based on the cancer or mortality rates in the community, to the number of observed 
deaths (or cancer cases) in the reference population.  An SRR greater than one indicates that a 
community’s mortality (or incidence) is higher than that of the reference population while an 
SRR less than one indicates that a community’s mortality (or incidence) is lower than that of the 
reference population. 
 
As stated earlier, comparisons of SIRs or SMRs between communities or census tracts are not 
possible because of differences in the age and gender distributions of the communities.  
Comparing the cancer or mortality experience of communities can be achieved, however, by 
using a common population distribution (a reference population) to calculate an SRR.   
 
The SRRs calculated in this Health Statistics Review are reported in Appendix C.  While one of 
the objectives of ATSDR’s national review was to compare the SRRs between the communities 
that received Libby vermiculite (i.e. a national ranking), the MDPH focus was on community-
specific SIRs and SMRs for asbestos-related diseases, to determine if asbestos-related cancers or 
deaths occurred at rates greater than would be expected in a given community. 
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6. Calculation of the 95% Confidence Interval 
 
To help interpret or measure the stability of a standardized rate such as an SIR or SMR, the 
statistical significance of each SIR (or SMR) was assessed by calculating a 95% confidence 
interval (95% CI) to determine if the observed number of cases or deaths is “significantly 
different” from the expected number or if the difference may be due solely to chance (Rothman 
and Boice 1982). Specifically, a 95% CI is the range of estimated SIR (or SMR) values that have 
a 95% probability of including the true SIR (or SMR) for the population. If the 95% CI range 
does not include the value one, then the study population is significantly different from the 
comparison or “normal population”. “Significantly different” means there is less than a 5% 
chance that the observed difference (either increase or decrease) is the result of random 
fluctuation in the number of observed cancer cases or deaths. 
 
For example, if a confidence interval does not include one and the interval is above one (e.g., 
1.5-1.8), there is a statistically significant increase in number of cancer cases or deaths. 
Similarly, if the confidence interval does not include one and the interval is below one (e.g., 0.4-
0.8), the number of cases or deaths is statistically significantly lower than expected. If the 
confidence interval range includes one, the true SIR may be one. In this case, it cannot be 
determined with certainty that the difference between the observed and expected number of cases 
or deaths reflects a real increase or decrease or is the result of chance. It is important to note that 
statistical significance does not necessarily imply public health significance. Determination of 
statistical significance is just one tool used to interpret standardized rates. 
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In addition to the range of the estimates contained in the confidence interval, the width of the 
confidence interval also reflects the stability of the SIR (or SMR) estimate.  For example, a 
narrow confidence interval (e.g., 1.2-1.4) allows a fair level of certainty that the calculated SIR is 
close to the true SIR for the population. A wide interval (e.g., 0.8-4.5) leaves considerable doubt 
about the true SIR, which could be much lower than or much higher than the calculated SIR. 
This would indicate an unstable statistic.  Due to the instability of incidence and mortality rates 
based on small numbers of cases or deaths, statistical significance was not assessed when fewer 
than five cases or deaths were observed. 
 
D. Review of Risk Factor Information  
 
For our evaluation of asbestos-related cancer incidence, MDPH reviewed smoking history and 
occupation reported to the MCR at the time of cancer diagnosis.  For our evaluation of asbestos-
related mortality, occupation recorded at the time of death was reviewed; however, it was not 
possible to evaluate the contribution of smoking as smoking status is not recorded on death 
certificates.  This risk factor information was assessed to determine whether these factors may 
have contributed to the observed rates of asbestos-related disease incidence or mortality in any of 
the five study communities. 
 
Occupational exposures to certain chemicals have been associated with the development of 
certain cancers and health outcomes.  Industrial workers often have more intense and prolonged 
exposures to chemicals than does the general population, particularly in the past when standards 
and regulations for workers’ protection were not established or enforced.  Exposure to asbestos 
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fibers is an important and well-documented risk factor for asbestosis, mesothelioma, and lung 
cancer (ATSDR 2001).  Some evidence exists of associations, although weaker than for the 
above-mentioned outcomes, between asbestos exposure and digestive/gastrointestinal cancers as 
well as other respiratory diseases.  Individuals who have been exposed to asbestos and smoke 
tobacco products have an increased risk of lung cancer 60 to 90 times greater than the general 
population (ACS 2001).  Both smokers and nonsmokers exposed to asbestos also have a greater 
risk of developing a type of cancer that starts in the pleura (the layer of cells that line the outer 
surface of the lung).  Insulation workers, asbestos factory workers, shipyard workers, asbestos 
miners and millers, and construction workers have all been identified as being at high risk of 
developing mesothelioma due to asbestos exposure.  Family members of workers exposed to 
asbestos are also suspected to be at an increased risk of developing mesothelioma when they 
breathe in asbestos fibers from the clothing of exposed workers (ATSDR 2001).   
 
Usual occupation and usual industry as reported at the time of diagnosis or death was reviewed 
to determine whether occupational exposures could have contributed to the incidence of 
asbestos-related cancers or deaths evaluated in this report.  It should be noted, however, that the 
occupational information reported to the MCR and the Registry of Vital Records, when 
available, is limited to job titles and does not include information that could further define 
exposure potential for individual cases.  In addition, occupational information is often 
incomplete in that a number of individuals will have a reported occupation as “unknown” or 
“retired.”   
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For this review, job title was placed into one of four categories:  asbestos exposure reported at 
the time of diagnosis or at the date of death; possible asbestos exposure; other occupations; and, 
finally, housewives, at home-workers, and never-worked were placed in a fourth category.  Job 
titles such as construction worker, fireman, mechanic, plumber, railroad worker, and shipyard 
worker were grouped into occupations with possible asbestos exposure because, historically, 
these occupations have had some risk of asbestos exposures. In addition, occupations such as 
electricians, electrical engineers, engineers, foremen, laborers, machinists, machine operators, 
steel and metal workers, and technicians which are thought to have less risk of asbestos exposure 
were grouped as other occupations.  Other occupations also included retired, unknown, disabled 
or unemployed at the time of diagnosis or at death. 
 
Information about personal risk factors such as family history and diet and other factors that may 
also influence the development of certain cancers is not collected by the MCR or the Registry of 
Vital Records, and therefore, it was not possible to evaluate these factors in this review. 
V. RESULTS 
A. Billerica 
 
The former industrial facility in Billerica that was identified by the USEPA as having received 
vermiculite from the Libby, Montana mine was known as the Zonolite Company, which 
occupied a 3-acre parcel of land located in the Iron Horse Industrial Park at 900 High Street in 
North Billerica, in CT 3165 (Figure 1).  The USEPA reported that available historical records 
indicate that, between 1953 and 1963, the Zonolite Company leased a facility in North Billerica 
from the Boston and Maine Railroad (B&M) to manufacture home insulation, concrete, and fill 
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material using the mineral vermiculite (USEPA 2001).  The W. R. Grace Company purchased 
the Zonolite plant in 1963 and closed it in 1964.  The plant was believed to have processed 
vermiculite ore from the Libby mine.   
 
Iron Horse Park is a federal Superfund site that occupies approximately 553 acres of land in 
North Billerica.  Designated in 1984 as a Superfund site, it has undergone extensive evaluation 
and cleanup by the USEPA, work that is ongoing.  Industrial activities by B&M as well as other 
companies that leased or bought parcels of land on the site from B&M, including the Johns-
Manville Products Corporation (a manufacturer of asbestos-containing products), resulted in 
widespread contamination of the property, including asbestos contamination. 
 
1. Asbestos-Related Cancer Incidence in the Town of Billerica (Table 1) 
 
During 1986-1995, two of the three sentinel cancer types evaluated in Billerica on a townwide 
basis occurred as expected or slightly below the expected rates:  peritoneum cancers (3 diagnoses 
observed vs. 4.4 diagnoses expected) and mesothelioma (3 diagnoses observed vs. 2.6 diagnoses 
expected).  (Because the three mesotheliomas occurred in the pleura, they are the same 
individuals as the three cases of peritoneum cancers.)  During this 10-year period, however, 
townwide incidence of cancers of the lung and bronchus occurred statistically significantly more 
often than expected based on national rates (231 diagnoses observed vs. 166.7 diagnoses 
expected; SIR = 1.4, 95% CI = 1.2 – 1.6).  Lung and bronchus cancer was statistically 
significantly elevated among females (111 diagnoses observed vs. 65.6 diagnoses expected; SIR 
= 1.7, 95% CI = 1.4 – 2.0) and nearly achieved statistical significance among males (120 
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diagnoses observed vs. 100.3 expected; SIR = 1.2, 95% CI = 1.0 – 1.4).  These data are presented 
in Table 1. 
 
As seen in Table 1, the incidence of cancers of the digestive organs was slightly higher than 
expected, but the elevation was not statistically significant.   
 
2. Asbestos-Related Cancer Incidence in Billerica Census Tracts (Tables 
1A and 1B) 
 
Incidence rates of sentinel cancer types were near expected rates in two of Billerica’s five census 
tracts:  CT 3163 and CT 3165 (the location of the Zonolite Company).  In CT 3165, no diagnoses 
of peritoneum cancers or mesothelioma were reported.  In CT 3165, 44 diagnoses of lung and 
bronchus cancers were reported where 31.7 diagnoses were expected.  The elevation nearly 
achieved statistical significance and was due to non-statistically significant elevations among 
males (24 diagnoses observed vs. 17.8 diagnoses expected) and females (20 diagnoses observed 
vs. 13.1 diagnoses expected).  In CT 3163, the number of observed diagnoses of lung and 
bronchus cancer exceeded the expected number (34 observed vs. 26.0 expected); the difference 
was not statistically significant.  One individual diagnosed with mesothelioma (of the pleura) 
resided in CT 3163.  During 1986-1995, cancers of the lung and bronchus occurred more 
frequently than expected in all five CTs, an elevation that was statistically significant in CTs 
3161 and 3164.  Among males and females combined, 25 more cases occurred than expected in 
CT 3161 (78 observed vs. 52.7 expected; SIR = 1.5, 95% CI = 1.2 – 1.9).  Among females in CT 
3164, approximately seven more cases occurred than expected (15 observed vs. 8.0 expected; 
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SIR = 1.9, 95% CI = 1.1 – 3.1).  Two of the three mesothelioma cases in Billerica resided in CT 
3162.  These data are presented in Tables 1A and 1B.  
 
The incidence of digestive organ cancers was about as expected in all five of Billerica’s CTs. 
 
3. Review of Cancer Incidence Risk Factor Information  
 
a) Tobacco History 
 
A review of tobacco use among individuals in Billerica diagnosed with cancers of the lung and 
bronchus revealed that 88% (202 of 231) were current or former smokers, 10% (24 of 231) had 
unknown smoking status at the time of diagnosis, and 2% (5 of 231) reported being non-
smokers.  Thus, 98% of those individuals with a known smoking history and who were 
diagnosed with lung and bronchus cancer reported being current or former smokers.  Within the 
two CTs with statistically significant elevations in lung and bronchus cancer, the percentage of 
individuals who were reported to be current or former smokers ranged from 80 to 90 percent; this 
increased to between 96 and 100% for those individuals with a known smoking history.  
Therefore, for lung and bronchus cancer, which was statistically significantly elevated in 
Billerica, it appears that smoking may have played some role in the development of these 
cancers. 
 
b) Occupational History Review 
 
A review of occupational information reported to the MCR for the 449 individuals in Billerica 
diagnosed with one of the asbestos-related cancers during 1986 – 1995 showed that three 
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individuals reported occupational exposure to asbestos at the time of their diagnosis.  In addition, 
10% (44 of 449) reported an occupation that could possibly be associated with an increased risk 
of asbestos exposure. 
 
During 1986-1995, the incidence of lung and bronchus cancer occurred statistically significantly 
more often than expected in Billerica, particularly among females.  Ten percent (22 of 231) of 
those diagnosed with lung and bronchus cancer reported job titles associated with possible 
exposure to asbestos.  In addition, two individuals reported asbestos exposure in their 
occupational history.  
 
The incidence of lung and bronchus cancer also occurred statistically significantly more often 
than expected in CT 3161 and among females in CT 3164.  One individual in CT 3161 reported a 
positive occupational asbestos exposure.  In addition, five of the 78 individuals diagnosed with 
lung and bronchus cancer in this CT reported occupations with possible exposure to asbestos, the 
remaining 92% of cases reported either job titles not typically related to asbestos exposure or 
limited information regarding their occupational history.  In CT 3164, none of the females 
reported occupations associated with possible asbestos exposure; 3 of the 15 females reported no 
or limited occupational information. 
 
For lung and bronchus cancers in Billerica, it appears that between 8 and 10% of the individuals 
diagnosed during the 10-year period of 1986 through 1995 reported occupations, at the time of 
their diagnosis, associated with an increased risk of asbestos exposure.  It should be noted, 
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however, that specific job duty information that could further define exposure potential for these 
individuals was not available through the MCR. 
 
4. Asbestos-Related Mortality in the Town of Billerica (Table 2) 
 
Over the 20-year time period 1979-1998, townwide mortality occurred statistically significantly 
more often than expected based on national rates for the following sentinel causes of death:  lung 
and bronchus cancers and peritoneum cancers including mesothelioma.  The mortality rate for 
asbestosis was about as expected with one death reported where approximately 0.4 deaths were 
expected. 
 
During this time period, a statistically significant increase (SMR = 1.2. 95% CI = 1.1 -1.4) in 
mortality from cancers of the lung and bronchus occurred (331 deaths observed vs. 271.4 deaths 
expected).  The elevation occurred mainly among females (135 observed vs. 93.5 expected; SMR 
= 1.4, 95% CI = 1.2 – 1.7), although among males, the elevation nearly achieved statistical 
significance.  During 1979-1998, deaths due to peritoneum cancers (including mesothelioma) 
occurred townwide more often than expected (7 observed vs. 2.1 expected; SMR = 3.4, 95% CI 
= 1.4 – 6.9).  This elevation occurred mainly among males (6 observed vs. 1.2 expected; SMR = 
5.0, 95% CI = 1.8 – 10.9).  Five of the seven deaths were from mesothelioma.  These data are 
presented in Table 2. 
 
During 1979-1998, the mortality rates for six of the ten causes of death evaluated in Billerica on 
a townwide basis occurred approximately as expected:  digestive organ cancers, unspecified 
neoplasms, diseases of pulmonary circulation, pneumoconioses, asbestosis, and other diseases of 
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the respiratory system.  Although in some instances the number of observed deaths exceeded the 
expected number, based on national rates, no statistically significant differences between the 
numbers of observed and expected deaths were found for these six causes of death.  Mortality 
due to cancers of the respiratory system was significantly elevated townwide, however, the 
majority of these cancers were of the lung and bronchus (331 of 345 or 96%) and were discussed 
as sentinel outcomes.  Deaths due to COPD occurred statistically significantly more often than 
expected in Billerica during this time period (185 observed vs. 150.2 expected; SMR = 1.2, 95% 
CI = 1.1 – 1.4).   
 
5. Asbestos-Related Mortality in the Billerica Census Tracts (Table 2A-
2C) 
 
With a few exceptions, mortality rates for sentinel causes of death were near expected rates in 
three of the five CTs of Billerica:  CT 3161, CT 3162, and CT 3163.  In CT 3161, although the 
number of observed deaths was greater than expected for the three sentinel causes of death, the 
differences were not statistically significant for lung and bronchus cancer (104 observed vs. 86.0 
expected); the numbers of observed deaths for the other sentinel causes of death were less than 
five and thus statistical significance was not evaluated.  In CT 3161, two mesothelioma deaths 
and one asbestosis death were reported.  In CT 3162, two mesothelioma deaths occurred while 
no asbestosis deaths were reported in this census tract; for lung and bronchus cancer, 71 deaths 
occurred where approximately 56.0 were expected, this difference was not statistically 
significant.  In CT 3163, no deaths from either asbestosis or peritoneum cancers (including 
mesothelioma) occurred; the number of deaths from lung and bronchus cancers was slightly 
greater than expected (45 deaths observed vs. 41.9 deaths expected). 
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In CTs 3164 and 3165 (the location of the Zonolite Company), mortality due to lung and 
bronchus cancer was statistically significantly elevated for females.  In CT 3165, 31 deaths were 
reported where approximately 19.1 were expected (SMR = 1.6, 95% CI = 1.1 – 2.3).  One death 
from pleural cancer occurred in CT 3165 while no asbestosis deaths occurred.  In CT 3164, 20 
deaths from lung and bronchus cancers were reported where approximately 11.2 were expected 
(SMR = 1.8, 95% CI = 1.1 – 2.8).  No asbestosis deaths occurred in CT 3164 while one death 
from mesothelioma occurred. 
 
Mortality from most other causes of death was not significantly elevated in Billerica’s five CTs, 
with a few exceptions.  CT 3161 experienced a statistically significantly elevated mortality rate 
in males for other diseases of the respiratory system (12 observed vs. 4.5 expected; SMR = 2.7, 
95% CI = 1.4 – 4.7).  In CT 3165, deaths from cancers of the digestive organs occurred in males 
more often than expected (28 observed vs. 16.6 expected; SMR = 1.7, 95% CI = 1.1 – 2.4).  
Deaths due to COPD occurred statistically significantly more frequently than expected in CTs 
3162 and 3163.  In CT 3162, 30 deaths were reported from COPD in males while approximately 
17.7 were expected (SMR = 1.7, 95% CI = 1.2 – 2.4).  In CT 3163, 17 deaths were reported in 
females from COPD while approximately 8.9 were expected (SMR = 1.9, 95% CI = 1.1 – 3.1). 
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6. Review of Mortality Risk Factor Information  
 
a) Occupational History Review 
 
A review of occupational information on the death certificates of the 843 individuals of Billerica 
who died of one of the asbestos-related diseases during the 20-year time period (1979 – 1998) 
revealed two individuals with occupational exposures to asbestos.  In addition, 13% (106 of 843) 
of these individuals had information on their death certificates that indicated possible 
occupational exposure to asbestos.   
 
A review of occupational information on the death certificates of individuals in Billerica who 
died due to cancers of the lung and bronchus, a sentinel cancer that was significantly elevated 
during 1979-1998, revealed that one individual reported a job title indicating asbestos exposure.  
Townwide, 12% (40 of 331) of those who died of lung and bronchus cancers had job titles on 
their death certificates with possible asbestos exposure.  In CTs 3164 and 3165, where the 
mortality rates for cancers of the lung and bronchus were significantly elevated, occupational 
information on death certificates revealed that 6% (6 of 108) of individuals had job titles 
associated with possible exposure to asbestos. 
 
Between 1979-1998, the townwide mortality rate for peritoneum cancers (including 
mesothelioma) was statistically significantly higher than expected in Billerica, mainly among 
males.  A review of occupational information on the seven individuals with these types of 
cancers indicated that one reported a job title indicating asbestos exposure while another 
individual’s death certificate had a job title indicating possible asbestos exposure.  The remaining 
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five individuals had job titles not thought to be associated with occupational exposure to 
asbestos. 
 
During 1979-1998, the mortality rate for cancers of the digestive system occurred statistically 
significantly more often than expected in CT 3165 among males. Twenty-five percent of the 
males (7 of 28) had occupations where exposure to asbestos might have been possible.  The 
remaining 75% had other occupations not typically associated with asbestos exposure.   
 
Mortality from COPD was statistically significantly elevated in Billerica as well as in two 
particular CTs (3162 and 3163).  Townwide, 14% (25 of 185) of those who died of COPD had 
occupations that could have been associated with an increased risk of exposure to asbestos.  In 
CTs 3162 and 3163, 16% (8 of 49) and 15% (5 of 33) of those who died of COPD had 
occupations involving possible exposure to asbestos, respectively. 
 
For most of the statistically significantly elevated mortality rates in Billerica, it appears that 
between 6 and 29% of the individuals who died during the 20-year period of 1979 through 1998 
had occupations reported on their death certificates that have been associated with an increased 
risk of asbestos exposure.  It should be restated, however, that specific job duty information that 
could further define exposure potential for these individuals was not available through the death 
certificates. 
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7. Geographic Distribution 
 
In addition to determining incidence and mortality rates for asbestos-related diseases, a 
qualitative evaluation of the point pattern of sentinel cancer diagnoses and deaths in Billerica 
was conducted.  Place of residence at the time of diagnosis or death was mapped to assess any 
possible geographic concentration of individuals in relation to each other or in relation to the 
Zonolite facility.   
 
In general, review of the geographic distribution of sentinel health outcomes for the years 1985-
1996 did not reveal any apparent spatial patterns at the neighborhood (or census tract) level that 
could not be attributed to such factors as areas of higher population density.  The three 
individuals diagnosed with mesothelioma (as well as cancer of the pleura) resided in the two CTs 
in the southern section of Billerica (CT 3162 and 3163).  (The Zonolite facility was in CT 3165 
in northern Billerica.)  The cases were fairly evenly distributed across the two census tracts and 
did not reside in any one neighborhood.  Similarly, no unusual pattern was noted in the 
distribution of place of residence for those individuals diagnosed with lung and bronchus cancer. 
 
A review of the geographic distribution of residence at the time of death from sentinel causes of 
death did not reveal any unusual patterns.  One death from asbestosis occurred in Billerica during 
the 20-year period evaluated.  The residence at time of death was in CT 3161.  Five deaths from 
mesothelioma and two deaths from peritoneum cancers occurred during this time period; 
mapping of the seven residences at death revealed that they were spread fairly evenly across 
Billerica.  The geographic distribution of residence at death for those individuals who died of 
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lung and bronchus cancer appeared to be consistent with the areas of higher population density 
throughout the town. 
 
8. Summary 
 
• For Billerica, the incidence and/or mortality rates for three of the sentinel health 
outcomes associated with exposure to asbestos were about as expected based on national 
rates.  These included:  the incidence of mesothelioma and cancers of the peritoneum, 
retroperitoneum, and pleura; and, deaths from asbestosis.   
• During the 20-year period of 1979-1998, deaths in Billerica due to cancers of the 
peritoneum, retroperitoneum, and pleura (including mesothelioma) occurred more often 
than expected, particularly among men.  Seven deaths were reported where 
approximately two were expected; this elevation was statistically significant.  Five of the 
seven deaths were from mesothelioma and two deaths were from cancers of the pleura 
and peritoneum, respectively.  The geographic distribution of the seven residences of the 
individuals who died from these causes was not unusual, with their places of residence 
covering four of the five census tracts.  One individual resided in the CT where the 
Zonolite facility was located.  It is possible that occupational exposure to asbestos could 
have contributed to two of the seven deaths. 
• Incidence and mortality rates for cancer of the lung and bronchus were statistically 
significantly elevated townwide in Billerica as well as in CTs 3161 and 3164.  In CT 
3165, the mortality rate for lung and bronchus cancer in females was significantly 
elevated.  A review of risk factor information (occupational and smoking history) for 
individuals diagnosed with lung and bronchus cancer revealed that both risk factors likely 
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played some role in the incidence of this cancer in Billerica.  While asbestos exposure 
and smoking are both independently associated with an increased risk of lung cancer, if 
an individual is exposed to both, their risk is increased by 60 to 90 fold.  Townwide and 
within the two census tracts where lung cancer incidence was elevated, between 80 and 
90% of the individuals diagnosed were reported to be current or former smokers and 
those percentages increased to between 96 and 100% among those with a known smoking 
history.  Approximately 10% of the Billerica residents diagnosed with lung cancer 
between 1986 and 1995 and 12% of those who died of lung cancer between 1979 and 
1998 were reported to work in occupations involving possible exposure to asbestos.  
• In general, review of the geographic distribution of sentinel cancers and deaths did not 
reveal any apparent spatial patterns at the neighborhood (or census tract) level that could 
not be attributed to such factors as areas of higher population density. 
 
B. Cambridge 
The property in Cambridge that was identified by the USEPA as having possibly received 
vermiculite ore from the Libby, Montana, mine is at 62 Whittemore Avenue (CT 3550), where 
the W.R. Grace Company owned a facility.  In response to an Environmental Working Group 
(EWG) Action report (EWG 2005) which indicated that the Cambridge facility received 112 
shipments of vermiculite ore, totaling 10,279 tons, the MDEP communicated with the Licensed 
Site Professional (LSP) for the Cambridge W.R. Grace site and received the following 
information (J. Miano, MDEP, personal communication, January 2006): 
• No evidence exists that the W.R. Grace facility at this location was an exfoliation facility. 
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• It is possible that the W.R. Grace facility received vermiculite ore from the Libby, 
Montana mine.  However, because the facility was not equipped to process large amounts 
of vermiculite ore, it is likely that any amount received was relatively small in volume. 
• Although there is no evidence of the disposal of vermiculite ore on the property, MDEP 
reports that asbestos has been found in surface and subsurface soil on the property.  
Although it is known that many buildings containing asbestos-containing materials were 
demolished on the property, it is not clear that this was the only source of asbestos in soil.  
It is known that W.R. Grace did bench-scale research and development at this facility on 
their products, many of which contained asbestos (such as brake pads, adhesives, 
caulking compounds, and fireproofing sprays). 
• MDEP reported that the asbestos in soil was determined to pose No Significant Risk 
under the current use conditions of the property, and that there will be a deed notice 
containing an Activity Use Limitation (AUL) to control development and soil disturbance 
activities to mitigate potential exposures for future property use. 
 
1. Asbestos-Related Cancer Incidence in the City of Cambridge (Table 3) 
 
In the city of Cambridge, the three sentinel cancer types occurred citywide at rates either 
approximately equal to or less than expected during the period 1986-1995:  peritoneum cancers 
(7 diagnoses observed vs. 13.5 diagnoses expected), mesothelioma (3 diagnoses observed vs. 8.3 
expected), and lung and bronchus cancer (434 diagnoses observed vs. 507.7 diagnoses expected).  
(The three mesotheliomas occurred in the peritoneum, retroperitoneum or pleura and therefore 
are counted in that cancer type as well.)  The incidence of lung and bronchus cancers citywide 
occurred statistically significantly less often than expected based on national rates. 
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As seen in Table 3, the incidence of cancers of the digestive organs was about as expected, with 
588 diagnoses observed compared to approximately 585 expected. 
 
2. Asbestos-Related Cancer Incidence in Cambridge Census Tracts (Table 3A 
– 3H) 
 
Incidence rates of sentinel asbestos-related cancers were near expected rates in 28 of the 30 CTs 
in Cambridge.  In some CTs the number of observed diagnoses was greater than the number 
expected for some cancer types, but the differences were not statistically significant.  Four of the 
28 CTs had statistically significantly lower rates of lung and bronchus cancers than would be 
expected:  CT 3527, 3535, 3540, and 3542.  Two CTs, 3529 and 3530, however, had statistically 
significantly more diagnoses of lung and bronchus cancers than expected.  Among females in CT 
3529, 13 diagnoses were observed while approximately 6 were expected (SIR = 2.1, 95% CI = 
1.1 – 3.6).  Among males in CT 3530, 28 diagnoses were observed while approximately 13 were 
expected (SIR = 2.2, 95% CI = 1.4 – 3.1).   
 
In CT 3550, the location of the W.R. Grace Company, no diagnoses of peritoneum cancers or 
mesothelioma were reported.  The incidence of lung and bronchus cancers was lower than 
expected in this CT (18 diagnoses observed vs. 26.2 diagnoses expected).  In CT 3549, which 
borders the W.R. Grace facility, there were no peritoneum cancers or mesotheliomas reported; 
the incidence of lung and bronchus cancers was about as expected (28 diagnoses observed vs. 
27.4 expected).   
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The incidence of digestive organ cancers was about as expected in all but two of Cambridge’s 30 
CTs.  Among males in CT 3546, approximately 10 more cases occurred than expected (24 
observed vs. 14.4 expected; SIR = 1.7, 95% CI = 1.1 – 2.5).  Similarly, among males in CT 
3549, approximately 10 more cases occurred than expected (25 observed vs. 15.1 expected, SIR 
= 1.7, 95% CI = 1.1 – 2.5).   
 
3. Review of Cancer Incidence Risk Factor Information 
 
a) Tobacco History 
 
A review of tobacco use among individuals in Cambridge diagnosed with cancers of the lung and 
bronchus revealed that 87% (379 of 434) were current or former smokers, 7% (29 of 434) had 
unknown smoking status at the time of diagnosis, and 6% (26 of 434) reported being non-
smokers.  Thus, 93% of individuals with a known smoking history and who were diagnosed with 
lung and bronchus cancer reported being current or former smokers.  Among males in CT 3530 
and females in CT 3529, where the rates of lung and bronchus cancer were statistically 
significantly elevated and approximately twice the rates expected, the percentages of current or 
former smokers were 89% (25 of 28) and 77% (10 of 13), respectively.  Among those individuals 
with known smoking status in these two CTs, 100% of them were current or former smokers.  
Therefore, it appears that smoking was likely to have played some role in the development of 
lung and bronchus cancers in Cambridge. 
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b) Occupational History Review 
 
A review of occupational information reported to the MCR for the 1,074 individuals in 
Cambridge diagnosed with one of the asbestos-related cancers during 1986-1995 revealed that 
nine individuals reported at the time of their diagnosis occupational exposure to asbestos. In 
addition, 3% (33 of 1074) reported an occupation that could possibly be associated with an 
increased risk of asbestos exposure. The remaining 96% of the individuals had job titles not 
thought to be associated with asbestos exposure. 
 
During 1986-1995, lung and bronchus cancer occurred statistically significantly more often than 
expected in CT 3529 (among females) and CT 3530 (among males).  Among females in CT 
3529, the occupation of 23% (3 of 13) was reported as unknown or retired, 54% (7 of 13) were 
reported to work in occupations not associated with exposure to asbestos, and 23% (3 of 13) 
were either housewives or never worked.  Among males in CT 3530, the occupation of 39% (11 
of 28) was reported as unknown or retired, 14% (4 of 28) reported job titles associated with 
possible exposure to asbestos, and 47% (13 of 28) were reported to work in occupations not 
associated with exposure to asbestos.  
 
During 1986-1995, the incidence of cancers of the digestive organs occurred statistically 
significantly more often than expected among males in CTs 3546 and 3549.  In CT 3546, one 
individual reported an occupation with an increased risk of exposure to asbestos and, of the 
remaining 23 individuals with digestive organ cancer, 15 reported job titles not typically related 
to asbestos exposure while 8 were retired or their occupation was unknown.  In CT 3549, three 
individuals reported occupations with possible exposure to asbestos and, of the remaining 22 
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individuals, 13 reported job titles not associated with asbestos exposure and 9 were either retired 
or their occupation was unknown. 
 
4. Asbestos-Related Mortality in the City of Cambridge (Table 4) 
 
Over the 20-year time period 1979-1998, townwide mortality occurred about as expected for 
lung and bronchus cancers (865 deaths observed vs. 840 deaths expected; SMR = 1.0, 95% CI = 
1.0-1.1).  For peritoneum cancers (including mesothelioma), 11 deaths were observed while 
approximately 7 were expected (SMR = 1.6, 95% CI = 0.8 – 2.9).  The mortality rate for 
asbestosis was about as expected with one death observed while approximately 2 deaths were 
expected. 
 
Mortality from cancer of the digestive organs occurred statistically significantly more often than 
expected in Cambridge (696 deaths observed vs. 552.4 expected; SMR = 1.3, 95% CI = 1.2 – 
1.4).  This was due to statistically significant increases in deaths reported among both males and 
females in the city.  COPD mortality was statistically significantly lower than expected with 473 
deaths observed versus approximately 568 deaths expected (SMR = 0.8, 95% CI = 0.8 – 0.9). 
 
5. Asbestos-Related Mortality in Cambridge Census Tracts (Tables 4A – 4O) 
 
Mortality rates for sentinel causes of death were near expected rates in 24 of Cambridge’s 30 
census tracts3.  Some census tracts experienced more observed deaths than expected but the 
differences were not statistically significant.  In 4 of the 24 census tracts (3536, 3540, 3541, and 
3542), the mortality rate for lung and bronchus cancers was statistically significantly lower than 
                                                 
3 These include:  3521, 3523, 3524, 3526, 3527, 3529, 3531 – 3543, 3545, 3546, 3547, 3549, and 3550. 
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expected.  In two census tracts (3522 and 3528), the mortality rate for lung and bronchus cancers 
was of borderline statistical significance.  In CT 3522, 45 deaths were observed while 
approximately 33 deaths were expected (SMR = 1.4, 95% CI = 1.0 – 1.8).  Similarly, in CT 
3528, 31 deaths were observed while approximately 21 were expected (SMR = 1.5, 95% CI = 
1.0 – 2.1).  In CT 3550, where the W.R. Grace facility was located, 50 deaths from lung and 
bronchus cancer were observed while approximately 45 deaths were expected; the elevation was 
not statistically significant.   
 
Statistically significant elevations in lung and bronchus cancer mortality occurred in four census 
tracts:  3525, 3530, 3544, and 3548.  In CT 3525, 35 deaths were observed while approximately 
21 were expected (SMR = 1.6, 95% CI = 1.1 – 2.3); this elevation occurred mainly among males.  
In CT 3530, 62 deaths were observed while approximately 36 were expected (SMR = 1.7, 95% 
CI = 1.3 – 2.2); this elevation occurred mainly among males.  In CT 3544, mortality from lung 
and bronchus cancer was significantly elevated in females only, with 14 deaths observed while 
approximately 7 were expected (SMR = 2.1, 95% CI = 1.2 – 3.6).  In CT 3548, 30 deaths were 
observed while approximately 20 deaths were expected (SMR = 1.5, 95% CI = 1.0 – 2.2); this 
elevation occurred mainly among males. 
 
In 22 of Cambridge’s 30 census tracts, no deaths from either asbestosis or peritoneum cancers 
(including mesothelioma) occurred during the 20-year period of 1979-1998.  One asbestosis 
death occurred in CT 3547.  Eleven deaths were reported townwide during this period from 
peritoneum cancers (including mesothelioma) while approximately 7 deaths were expected; this 
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difference is not statistically significant (SMR = 1.6; 95% CI = 0.8 – 2.9).  The 11 deaths 
occurred in 7 census tracts:   
 
Census Tract Observed Expected Cancer Subtype 
3521 1 0.2 retroperitoneum 
3529 3 0.2 2 mesotheliomas and 1 retroperitoneum 
3533 1 0.2 retroperitoneum 
3538 1 0.3 retroperitoneum 
3544 1 0.1 mesothelioma 
3546 2 0.4 2 mesotheliomas 
3548 2 0.2 2 mesotheliomas 
 
In CT 3550, the location of the W.R. Grace Company, no deaths were reported from asbestosis 
or peritoneum cancers (including mesothelioma) during the 20-year period.  Lung and bronchus 
cancer deaths occurred more often than expected (50 observed vs. 44.6 expected) but the 
elevation was not statistically significant.  Similarly, in CT 3549, which borders the W.R. Grace 
Company, no deaths were reported from asbestosis or peritoneum cancers (including 
mesothelioma) during the 20-year period.  The number of lung and bronchus cancer deaths 
observed was greater than the number expected (54 observed vs. 44.9 expected) but the elevation 
was not statistically significant. 
 
Mortality from most other causes of death was not significantly elevated in Cambridge’s 30 CTs, 
with some exceptions.  Mortality from cancers of the digestive organs was statistically 
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significantly elevated in 10 of 30 census tracts4 and was significantly lower than expected in two 
CTs:  3542 and 3550 (the CT where the W.R. Grace facility was located).  Mortality from COPD 
was significantly lower than expected in 4 of the 30 CTs:  3541, 3542, 3543, and 3545.  One CT, 
3522, had a statistically significant elevation in COPD among females (18 observed vs. 10.1 
expected; SMR = 1.8, 95% CI = 1.1 – 2.8).  Similarly, one census tract (3521) had a statistically 
significant elevation in mortality from diseases of pulmonary circulation (6 observed vs. 2.1 
expected; SMR = 2.9, 95% CI = 1.1 – 6.2). 
 
6. Review of Mortality Risk Factor Information  
 
a) Occupational History Review 
 
A review of occupational information on the death certificates of the 2,523 individuals of 
Cambridge who died of one of the asbestos-related diseases during the 20-year time period 
revealed three individuals with occupational exposures to asbestos.  In addition, 8% (194 of 2, 
523) of these individuals had death certificates that indicated possible occupational exposure to 
asbestos based on their recorded usual occupation and industry.  Of these individuals, the 
majority (51%) had construction work listed as their occupation at time of death. The remaining 
49% had job titles such as firemen, mechanics, plumbers, and railroad and shipyard workers.   
 
Although not statistically significant, more deaths from peritoneum cancers (including 
mesothelioma) occurred townwide than expected (11 observed vs. 6.7 expected).  Of the 7 
individuals who died of mesothelioma, two individuals worked in occupations where exposure to 
                                                 
4 These include:  3521, 3524, 3525, 3528, 3529, 3530, 3533, 3544, 3546, and 3549. 
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asbestos was possible.  Of the 4 individuals who died of other peritoneum cancers, one 
individual worked in an occupation where asbestos exposure was possible. 
 
Mortality from lung and bronchus cancer, a sentinel cancer, was statistically significantly 
elevated in four CTs:  3525, 3530, 3544, and 3548.  Except for CT 3544, where no death 
certificates indicated job titles with possible asbestos exposures, between 7 and 10% of the 
individuals in the other three CTs who died of lung and bronchus cancer could have been 
exposed to asbestos, based on the occupation recorded on their death certificate. 
 
Mortality from cancers of the digestive organs was statistically significantly elevated townwide 
and in 10 of Cambridge’s 30 CTs.  Of the 696 individuals who died from cancers of digestive 
organs townwide, 6% (39 of 696) were reported to work in occupations where exposure to 
asbestos was possible.  Except for CTs 3529 and 3544, where no death certificates indicated job 
titles with possible asbestos exposures, between 4 and 17% of the individuals in the other eight 
CTs who died of digestive organ cancer could have been exposed to asbestos. 
 
Mortality from COPD and diseases of pulmonary circulation was also statistically significantly 
elevated in CT 3522.  However, the death certificates did not identify any individuals who were 
likely to have been exposed to asbestos in their workplace.  In CT 3521, where mortality from 
diseases of pulmonary circulation was elevated, one of six individuals who died from this cause 
could have been exposed to asbestos in the workplace. 
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For most of the statistically significantly elevated mortality rates in Cambridge, mainly in 
particular CTs, it appears that between 4 and 17% of the individuals who died during the 20-year 
period of 1979 through 1998 had occupations reported on their death certificates that have been 
associated with an increased risk of asbestos exposure.  It should be noted, however, that specific 
job duty information that could further define exposure potential for these individuals was not 
available through the death certificates. 
 
7. Geographic Distribution 
 
In addition to determining incidence and mortality rates for asbestos-related diseases, a 
qualitative evaluation of the point pattern of sentinel cancer diagnoses and deaths in Cambridge 
was conducted.  Place of residence at the time of diagnosis or death was mapped to assess any 
possible geographic concentration of individuals in relation to each other or the W.R. Grace 
facility. 
 
In general, review of the geographic distribution of residence at time of death for those who died 
of lung and bronchus cancer did not reveal any spatial patterns at the neighborhood level that 
could not be attributed to high population density. 
 
Seven individuals were diagnosed with cancers of the peritoneum, retroperitoneum, and pleura in 
Cambridge during the 1986 – 1995 time period.  Three of these individuals had mesothelioma.  
The place of residence at time of diagnosis for these seven individuals spanned six census tracts 
(3521, 3527, 3534, 3542, 3546, and 3548), with none in the census tract where the W.R. Grace 
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Company was located.  The three individuals with mesothelioma resided in three CTs:  3527, 
3546, and 3548. 
 
A review of the geographic distribution of residence at time of death for the 11 individuals who 
died of cancers of the peritoneum, retroperitoneum, and pleura, seven of whom died of 
mesothelioma, showed that these 11 individuals resided in seven CTs (3521, 3529, 3533, 3538, 
3544, 3546, and 3548).  Of the seven individuals who died of mesothelioma, their places of 
residence at death were mapped to four CTs:  3529, 3544, 3546, and 3548.  None of these deaths 
occurred in individuals residing in CT 3550, where the W.R. Grace facility was located. 
 
8. Summary 
 
• For the sentinel health outcomes associated with exposure to asbestos, the incidence 
and/or mortality rates in Cambridge were about as expected.  These included:  
mesothelioma; cancers of the peritoneum, retroperitoneum, and pleura; lung and 
bronchus cancer; and deaths from asbestosis. 
• The incidence of lung and bronchus cancer citywide occurred statistically significantly 
less often than expected based on national rates. 
• In 28 of the 30 census tracts in Cambridge, incidence rates of sentinel cancers were near 
expected rates.  Two census tracts, 3529 and 3530, however, had significantly more 
diagnoses of lung and bronchus cancer than expected.  In both census tracts, smoking 
may have played a role in the development of these cancers, with between 77 and 89% of 
the cases being current or former smokers.  These percentages increased to 100% for 
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those individuals with a known smoking status.  In addition, in CT 3530, 14% of the 
cases reported job titles associated with possible exposure to asbestos.   
• In 26 of the 30 census tracts in Cambridge, mortality rates for sentinel causes of death 
were near expected rates.  In 4 of the 30 CTs (3525, 3530, 3544, and 3548), however, 
statistically significantly more deaths occurred from lung and bronchus cancer than were 
expected.  Between 7 and 10% of the individuals in the 3 CTs other than CT 3544 could 
have been exposed to asbestos, based on the occupation recorded on their death 
certificate.  (Smoking history is not reported on death certificates.) 
• In general, review of the geographic distribution of sentinel cancers and deaths did not 
reveal any apparent spatial patterns at the neighborhood level that could not be attributed 
to such factors as areas of higher population density.  The place of residence (either at 
diagnosis or time of death) for those individuals with asbestosis, mesothelioma, or cancer 
of the peritoneum, retroperitoneum or pleura spanned eleven census tracts, with no 
apparent concentrations in any of the CTs.  
• In CT 3550, the location of the W.R. Grace facility, the incidence and mortality for the 
sentinel health outcomes was about as expected.  No diagnoses or deaths were reported in 
this CT (or the adjacent CT of 3549) for the following outcomes:  mesothelioma, 
asbestosis, or cancers of the peritoneum, retroperitoneum, or pleura.  In addition, no 
statistically significant differences in the incidence or mortality rates of lung and 
bronchus cancer were found in the two CTs. 
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C. Easthampton 
 
The former Zonolite Facility in Easthampton was an exfoliation plant that was operated by W.R. 
Grace & Company.  It received asbestos-contaminated vermiculite from Libby, Montana from 
1963 to 1984 that was used to produce Zonolite attic insulation and Monokote fireproofing 
material.  The facility continued production using vermiculite from sources other than the Libby 
mine until 1992.  The site, which is located in a mixed residential/commercial area, is one of 28 
Phase I sites being evaluated under ATSDR’s National Asbestos Exposure Review.  The former 
facility is located in CT 8224. 
 
Under a cooperative agreement with ATSDR, the MDPH /BEH conducted a public health 
consultation on the former Zonolite facility in Easthampton.  MDPH/BEH analyzed 
environmental sampling data and historical information on the facility to assess past, present, and 
future opportunities for asbestos exposure of facility workers and the surrounding community.  
 
1. Asbestos-Related Cancer Incidence in the Town of Easthampton 
(Table 5) 
 
During 1986-1995, the three sentinel cancer types evaluated in Easthampton on a townwide basis 
occurred below expected rates:  peritoneum cancers (no diagnoses observed vs. 2.7 diagnoses 
expected), mesothelioma (1 diagnosis observed vs. 1.7 diagnoses expected), and lung and 
bronchus cancer (91 diagnoses observed vs. 107.4 diagnoses expected).  (See Table 5 for a 
summary of results). 
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As seen in Table 5, the townwide incidence of cancers of the digestive organs was about as 
expected or below expected rates. 
 
2. Asbestos-Related Cancer Incidence in Easthampton Census Tracts 
(Table 5A) 
 
The incidence of sentinel cancers in Easthampton’s two census tracts, CT 8223 and CT 8224, 
was about as expected or lower than expected during the 10 years examined.  In CT 8224, one 
diagnosis of mesothelioma was observed and one diagnosis was expected. 
 
Cancers of the digestive system occurred slightly more often than expected among males in both 
Easthampton census tracts; neither elevation was statistically significant.  These results are 
presented in Table 5A. 
 
3. Review of Cancer Incidence Risk Factor Information  
 
a) Tobacco Use 
 
A review of tobacco use among individuals diagnosed with lung and bronchus cancer indicated 
that 81% (74 of 91) were current or former smokers, 6% (5 of 91) were non-smokers, and 13% 
(12 of 91) had unknown smoking status at the time of diagnosis. Among those individuals with a 
known smoking history, 94% (74 of 79) were current or former smokers.  Smoking history was 
unknown for the one individual in Easthampton diagnosed with mesothelioma during 1986-1995. 
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b) Occupational History Review 
 
A review of occupational information reported to the MCR for the 209 individuals in 
Easthampton diagnosed with one of the asbestos-related cancers during 1986-1995 showed that 
one individual reported occupational exposure to asbestos at the time of their diagnosis.  In 
addition, 8% (17 of 209) reported an occupation that could possibly be associated with an 
increased risk of asbestos exposure.  It should be noted, however, that specific job duty 
information that could further define exposure potential for these individuals was not available 
through the MCR.  The remaining 91% (191 of 209) of the individuals had job titles not 
associated with an increased risk of exposure to asbestos. 
 
4. Asbestos-Related Mortality in the Town of Easthampton (Table 6) 
 
Over the 20-year time period 1979-1998, townwide mortality for the sentinel causes of death was 
about as would be expected.  No diagnoses of peritoneum cancers (including mesotheliomas) 
were reported and one case of asbestosis was reported while less than one case was expected.  
The incidence of lung and bronchus cancer was also about as expected (179 observed deaths vs. 
176.4 deaths expected). 
 
During 1979-1998, the mortality rates for the following additional causes of death were at or 
near expected rates:  digestive organ cancers, site-unspecified neoplasms, diseases of pulmonary 
circulation, COPD, and pneumoconiosis.  For other diseases of the respiratory system, however, 
the mortality rate for males was statistically significantly elevated townwide (25 observed vs. 
10.5 expected; SMR = 2.4, 95% CI = 1.6 – 3.5).  A review of the death certificates for these 25 
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males did not reveal any specific asbestos-related diseases such as mesothelioma or asbestosis.  
Causes of death or contributing conditions included pulmonary fibrosis, chronic lung disease, or 
various acute conditions (such as pneumonias).  The conditions listed on the death certificates 
were non-specific, some of which are associated with multiple causes while the majority are 
thought to be idiopathic (of unknown cause). 
 
5. Asbestos-Related Mortality in the Easthampton Census Tracts (Table 
6A) 
 
Mortality rates for sentinel causes of death were near expected rates in Easthampton’s two 
census tracts.  No deaths due to peritoneum cancers were reported in either CT.  In CT 8224 (the 
location of the former Zonolite facility), no deaths from asbestosis were reported; in CT 8223, 
one death from asbestosis was reported while less than one death was expected.  The mortality 
rate for lung and bronchus cancer was about as expected in both CTs, with no statistically 
significant differences compared to national rates. 
 
During 1979-1998, the mortality rate for digestive organ cancers in CT 8223 was elevated, 
mainly from a statistically significant elevation of digestive cancer deaths among males (42 
observed vs. 25.1 expected; SMR = 1.7, 95% CI = 1.2 – 2.3).  Deaths due to other diseases of the 
respiratory system also occurred statistically significantly more often than expected among males 
in CT 8223 (11 observed vs. 4.5 expected, SMR = 2.4, 95% CI = 1.2 – 4.4) and CT 8224 (14 
observed vs. 5.9 expected; SMR = 2.4, 95% CI = 1.3 – 4.0).   
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6. Review of Mortality Risk Factor Information   
 
a) Occupational History Review 
 
A review of occupational information on the death certificates of the 501 individuals of 
Easthampton who died of one of the asbestos-related diseases during the 20-year time period of 
1979-1998 revealed one individual with an occupational exposure to asbestos.  In addition, 8% 
(40 of 501) of these individuals had death certificates that indicated possible occupational 
exposure to asbestos based on their recorded usual occupation and industry.  
 
Mortality from other diseases of the respiratory system was statistically significantly elevated in 
Easthampton as well as in its two CTs.  Townwide, 16% (5 of 31) of those who died from other 
diseases of the respiratory system had occupations that could have been associated with an 
increased risk of asbestos exposure.  In CT 8223, where mortality from digestive organ cancers 
was statistically significantly elevated, 10% (6 of 60) who died from this cause had occupations 
involving possible exposure to asbestos.  It should be noted, however, that specific job 
information that could further define exposure potential for these individuals was not available 
through the death certificates. 
 
7. Geographic Distribution 
 
In addition to determining incidence and mortality rates for asbestos-related diseases, a 
qualitative evaluation of the point pattern of sentinel cancer diagnoses and deaths in 
Easthampton was conducted.  Place of residence at the time of diagnosis or death was mapped to 
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assess any possible geographic concentration of individuals in relation to each other or in relation 
to the Zonolite facility.   
 
In general, review of the geographic distribution of sentinel health outcomes did not reveal any 
apparent spatial patterns at the neighborhood level that could not be attributed to such factors as 
areas of higher population density.  The residences at diagnosis or at death were evenly 
distributed across Easthampton and across both CTs, consistent with the population density 
distribution of the town. 
 
8. Summary 
 
• For Easthampton and its two census tracts, the incidence rates for the three sentinel 
cancer types were about as expected or lower than expected, based on national rates.  
These included:  mesothelioma; cancers of the peritoneum, retroperitoneum, and pleura; 
and lung and bronchus cancer.   
• Over the 20-year time period (1979-1998), with one exception, mortality rates for 
sentinel causes of death were near or below expected rates across Easthampton and 
within its two census tracts.  In CT 8223, one death from asbestosis was reported while 
less than one death was expected.  No deaths from cancers of the peritoneum, 
retroperitoneum, or pleura were reported in either census tract.  The mortality rate for 
lung and bronchus cancer was about as expected in both CTs, with no statistically 
significant differences compared to national rates. 
• The mortality rate for other diseases of the respiratory system was statistically 
significantly elevated in Easthampton males.  A review of the death certificates for these 
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males did not reveal any specific asbestos-related diseases such as mesothelioma or 
asbestosis; rather non-specific conditions, with multiple causes, such as chronic lung 
disease or pulmonary fibrosis were listed. 
 
VI. LIMITATIONS 
The purpose of this health statistics review was to assess whether Massachusetts communities 
with facilities that received vermiculite from the Libby, Montana mine had higher than expected 
rates of asbestos-related cancers or deaths.  This type of assessment has several limitations. 
 
Mesothelioma is a key sentinel cancer for the surveillance of asbestos-related diseases because it 
is almost exclusively associated with asbestos exposure.  However, its incidence and mortality 
can be expected to be underestimated in Massachusetts as well as across the country.  The 
difficulty in diagnosing mesothelioma contributes to its under-diagnosis, which can, in turn, 
affect both incidence and mortality rates (Pinheiro et al. 2004).  In addition, research has shown 
that the use of an electronic death certificate file, using ICD -9 coded cause of death data to 
identify individuals who died of mesothelioma, historically resulted in the underascertainment of 
mesothelioma cases.  Before 1999, mortality data on mesothelioma were limited due to the lack 
of a specific ICD-9 code for mesothelioma.  Mesothelioma deaths were often coded as a 
neoplasm of an unspecified site (ICD 199.1).  To improve ascertainment for this analysis, death 
certificates were obtained and reviewed for every cause of death coded as ICD 199.1.  In 1999, 
an ICD-10 code specifically for mesothelioma began to be used.  Even with the implementation 
of the ICD-10 coding system, however, mesothelioma is expected to be under-diagnosed and 
miscoded, for perhaps 20% of the deaths from mesothelioma (Pinheiro et al. 2004).  Because the 
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rate of under-diagnosis of mesothelioma in Massachusetts would be expected to be comparable 
to the country as a whole, the comparisons made in this report between mesothelioma incidence 
and mortality in the five Massachusetts communities versus that of the United States as a whole 
should still be valid. 
 
Other limitations associated with the use of death certificate and cancer incidence data include 
possible confounding from occupational or environmental exposures to asbestos from sources 
other than the vermiculite sites; an inability to account for population migration; and, uncertainty 
associated with disease latency periods.  For asbestos-related diseases and most types of cancer, 
the latency period or period of development can range from 10 to 30 years and, in some cases, 
may be more than 40 or 50 years.  
 
This was an analysis of descriptive health outcome data to determine whether the pattern or 
occurrence of selected cancer types or causes of death were unusual.  Information from 
descriptive analyses cannot determine the precise causal relationships or the synergistic roles that 
may have played a part in the development of individual cancers or diseases in these 
communities.  The synergistic relationship between smoking and asbestos exposure is illustrated 
with an increased risk of lung cancer in smokers who are exposed to asbestos of 60 to 90 fold. 
 
Some of the health outcomes in this report have very strong associations with asbestos exposure.  
For example, mesothelioma is almost exclusively associated with asbestos exposure.  For lung 
and bronchus cancer, however, there are multiple risk factors, the strongest being cigarette 
smoking.  Other important risk factors include secondhand smoke; occupational or 
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environmental exposures to asbestos, arsenic, radon, and some organic chemicals such as 
benzene; air pollution; and radiation exposure (ACS 2005).  Although smoking history was 
reported to the MCR for the majority of individuals, smoking history is not recorded on death 
certificates.  In addition, detailed occupational information on specific job duties, that would 
allow an evaluation of the potential for asbestos exposure, was not available for this report. 
 
VII. CONCLUSIONS 
 
Of the five communities identified initially by the USEPA as possibly having received 
vermiculite ore from the Libby, Montana mine, one community, Easthampton, was found upon 
further investigation to have an exfoliation facility within its boundaries.  Industrial activities at 
exfoliation facilities represent the greatest potential for the release of asbestos fibers into the 
workplace as well as the environment.  Two other communities, Billerica and Cambridge, had 
industrial facilities in their communities that either manufactured (the Zonolite Company in 
Billerica) or conducted research on (the W.R. Grace Company in Cambridge) asbestos-
containing products.  After an extensive records review, the USEPA concluded that there was no 
evidence of an industrial facility in Hingham that accepted or processed vermiculite ore.  The 
USEPA also concluded that there was no evidence that the Advance Coating Company in 
Westminster ever accepted or processed vermiculite ore. 
 
With a few exceptions, the incidence of and mortality from asbestos-related sentinel cancers and 
causes of death occurred about as expected in the five communities of Billerica, Cambridge, 
Easthampton, Hingham, and Westminster.  A review of the geographic distribution of place of 
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residence at diagnosis or death for the five communities did not reveal any unusual spatial 
patterns either on a townwide basis or in the vicinity of the industrial facilities of interest. 
 
In Hingham and Westminster, where there is no evidence of the industrial use of vermiculite, 
with a few exceptions, the incidence of and mortality from asbestos-related cancers and diseases 
was about as expected.  In Westminster, one additional case of cancer of the peritoneum, 
retroperitoneum, and pleura (two diagnoses observed versus one diagnosis expected) as well as 
one additional death from asbestosis (one death observed versus 0.1 deaths expected) occurred 
during the time period evaluated.  In Hingham, townwide mortality was statistically significantly 
elevated for peritoneum cancers (including mesothelioma) with 11 deaths reported when 
approximately two deaths were expected.  Seven of the 11 deaths were reportedly due to 
mesothelioma; the death certificates of two of the seven individuals indicated possible 
occupational exposure to asbestos.  Shipbuilding in southeastern Massachusetts was one of the 
primary industries during the period around World War II.  Asbestos was used in shipbuilding to 
insulate boilers, steam pipes, and hot water pipes.  
 
In Easthampton, the location of the Zonolite exfoliation facility, the incidence of asbestos-related 
sentinel cancers was lower than expected based on national rates.  Mortality rates for sentinel 
causes of death were about as expected in Easthampton.  No deaths were reported from cancers 
of the peritoneum, retroperitoneum, and pleura (including mesothelioma) and one death from 
asbestosis was reported while less than one death would be expected in this population.  Thus, 
the occurrence of asbestos-related cancers and diseases in Easthampton was about as expected. 
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In Billerica, where the Zonolite Company manufactured products using vermiculite over an 
eleven-year period, the incidence and/or mortality for some sentinel health outcomes were 
statistically significantly different than expected for the town as a whole.  While the incidence of 
mesothelioma was as expected, the mortality rate for males was higher than expected in 
Billerica, with six deaths from cancers of the peritoneum, retroperitoneum, and pleura (five 
specifically from mesothelioma) reported whereas approximately 1.2 deaths were expected.  
Although smoking history was not available on the death certificates of these individuals, two of 
the six death certificates listed occupations where asbestos exposures were possible.  In addition, 
both the incidence of and mortality from lung and bronchus cancers were statistically 
significantly elevated in Billerica townwide and in three of its five census tracts.  A review of 
available risk factor information revealed that between 80 and 90 percent of the individuals 
diagnosed with lung and bronchus cancer were current or former smokers; this increased to 
between 96 and 100% for those individuals with a known smoking history.  Also, between 10 
and 12 percent of those diagnosed with lung and bronchus cancer or those who died of this 
cancer reported occupations where exposure to asbestos was possible.  A review of the 
geographic distribution of place of residence at diagnosis or death for these sentinel health 
outcomes did not reveal any unusual patterns that could not be attributed to areas of higher 
population density.  No unusual geographic patterns were noted in the vicinity of the former 
Zonolite facility. 
 
In Cambridge, where the W.R. Grace facility conducted research and development on products 
that contained asbestos, the townwide incidence and/or mortality rates were about as expected 
for the following sentinel health outcomes:  mesothelioma; cancers of the peritoneum, 
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retroperitoneum, and pleura; lung and bronchus cancer; and deaths from asbestosis.  In some 
instances the number of observed deaths exceeded the number expected but the differences were 
not statistically significant.  
 
Although the incidence of lung and bronchus cancer citywide occurred significantly less often 
than expected, two census tracts had significantly more diagnoses of lung and bronchus cancer 
than expected and four census tracts had significantly more deaths from lung and bronchus 
cancer than expected.  An examination of risk factor information for these census tracts revealed 
that smoking may have played a role in the development of these cancers, with between 77 and 
89% of the cases being current or former smokers.  Among those individuals with known 
smoking status in these two CTs, 100% of them were current or former smokers.  Although 
smoking history is not available on death certificates, occupational information for 3 of the 4 
census tracts with higher than expected mortality rates indicated that between 7 and 10% of the 
individuals could have been exposed to asbestos on their jobs. 
 
In the census tract where the W.R. Grace facility was located, both the incidence and mortality 
for the sentinel health outcomes was about as expected.  No diagnoses or deaths were reported in 
this CT (or its adjacent CT) for mesothelioma, asbestosis, or cancers of the peritoneum, 
retroperitoneum, or pleura.  No statistically significant differences in the incidence or mortality 
rates for lung and bronchus cancer were found in either of these CTs.   
 
In general, review of the geographic distribution of sentinel cancers and deaths in Cambridge did 
not reveal any apparent spatial patterns at the neighborhood level that could not be attributed to 
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such factors as areas of higher population density.  The place of residence (either at diagnosis or 
time of death) for those individuals with either asbestosis, mesothelioma, or cancers of the 
peritoneum, retroperitoneum, or pleura spanned 11 census tracts with no apparent concentrations 
in any of the census tracts. 
 
 
This report covered a broad range of health outcomes, such as the incidence of digestive organ 
cancers and mortality from chronic obstructive pulmonary disease.  While the focus of the 
analysis was on those cancer types or causes of death strongly associated with asbestos exposure, 
MDPH has provided all of the data generated as part of its cooperative agreement with ATSDR 
in the hope that the data will be informative to local health departments and their communities. 
 
VIII. RECOMMENDATIONS 
 
Through the Massachusetts Cancer Registry, the Bureau of Environmental Health will continue 
to monitor the incidence of asbestos-related diseases in Easthampton. Although the incidence 
and mortality rates of asbestos-related diseases in Easthampton were about as expected or lower 
than expected, based on statewide rates, due to the former presence of an exfoliation facility in 
Easthampton that processed vermiculite from 1963 until 1992 and the long latency period of 
asbestos-related diseases, MDPH will continue to monitor the incidence of asbestos-related 
cancers in Easthampton.   
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TABLES 
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All
Census Tracts Obs Exp SIR Obs Exp SIR Obs Exp SIR
Digestive 187 176.1 1.1 0.9 -- 1.2 114 94.5 1.2 1.0 -- 1.5 73 81.2 0.9 0.7 -- 1.1
Respiratory 262 183.3 1.4 * 1.3 -- 1.6 143 113.4 1.3 * 1.1 -- 1.5 119 69.1 1.7 * 1.4 -- 2.1
Lung & Bronchus 231 166.7 1.4 * 1.2 -- 1.6 120 100.3 1.2 1.0 -- 1.4 111 65.6 1.7 * 1.4 -- 2.0
Peritoneum 3 4.4 NC NC -- NC 2 2.7 NC NC -- NC 1 1.7 NC NC -- NC
Mesothelioma 3 2.6 NC NC -- NC 2 1.9 NC NC -- NC 1 0.6 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health
95% CI 95% CI 95% CI
TABLE 1
Asbestos-Related Cancer Incidence
Billerica, MA
1986-1995
Total Males Females
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
CT 3161
Digestive 58 56.1 1.0 0.8 -- 1.3 31 28.3 1.1 0.8 -- 1.6 27 27.2 1.0 0.7 -- 1.4
Respiratory 87 58.0 1.5 * 1.2 -- 1.9 42 34.5 1.2 0.9 -- 1.7 45 22.3 2.0 * 1.5 -- 2.7
Lung & Bronchus 78 52.7 1.5 * 1.2 -- 1.9 35 30.5 1.2 0.8 -- 1.6 43 21.2 2.0 * 1.5 -- 2.7
Peritoneum 0 1.4 NC NC -- NC 0 0.8 NC NC -- NC 0 0.5 NC NC -- NC
Mesothelioma 0 0.8 NC NC -- NC 0 0.6 NC NC -- NC 0 0.2 NC NC -- NC
CT 3162
Digestive 41 35.7 1.2 0.8 -- 1.6 23 20.3 1.1 0.7 -- 1.7 18 15.6 1.2 0.7 -- 1.8
Respiratory 55 38.0 1.5 * 1.1 -- 1.9 35 24.4 1.4 1.0 -- 2.0 20 13.9 1.4 0.9 -- 2.2
Lung & Bronchus 44 34.5 1.3 0.9 -- 1.7 28 21.6 1.3 0.9 -- 1.9 16 13.2 1.2 0.7 -- 2.0
Peritoneum 2 0.9 NC NC -- NC 1 0.6 NC NC -- NC 1 0.3 NC NC -- NC
Mesothelioma 2 0.5 NC NC -- NC 1 0.4 NC NC -- NC 1 0.1 NC NC -- NC
CT 3163
Digestive 29 26.2 1.1 0.7 -- 1.6 23 14.8 1.6 1.0 -- 2.3 6 11.5 0.5 0.2 -- 1.1
Respiratory 37 28.6 1.3 0.9 -- 1.8 20 18.1 1.1 0.7 -- 1.7 17 10.6 1.6 0.9 -- 2.6
Lung & Bronchus 34 26.0 1.3 0.9 -- 1.8 18 16.0 1.1 0.7 -- 1.8 16 10.0 1.6 0.9 -- 2.6
Peritoneum 1 0.7 NC NC -- NC 1 0.4 NC NC -- NC 0 0.3 NC NC -- NC
Mesothelioma 1 0.4 NC NC -- NC 1 0.3 NC NC -- NC 0 0.1 NC NC -- NC
CT 3164
Digestive 22 22.2 1.0 0.6 -- 1.5 13 13.8 0.9 0.5 -- 1.6 9 9.0 1.0 0.5 -- 1.9
Respiratory 30 24.1 1.3 0.8 -- 1.8 14 16.4 0.9 0.5 -- 1.4 16 8.5 1.9 * 1.1 -- 3.1
Lung & Bronchus 26 21.8 1.2 0.8 -- 1.8 11 14.5 0.8 0.4 -- 1.4 15 8.0 1.9 * 1.1 -- 3.1
Peritoneum 0 0.6 NC NC -- NC 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 0 0.3 NC NC -- NC 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health
95% CI 95% CI 95% CI
TABLE 1A 
Asbestos-Related Cancer Incidence
Billerica, MA
1986-1995
Total Males Females
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
CT 3165
Digestive 32 35.9 0.9 0.6 -- 1.3 22 17.4 1.3 0.8 -- 1.9 10 18.0 0.6 0.3 -- 1.0
Respiratory 47 34.7 1.4 1.0 -- 1.8 27 20.0 1.4 0.9 -- 2.0 20 13.8 1.5 0.9 -- 2.2
Lung & Bronchus 44 31.7 1.4 1.0 -- 1.9 24 17.8 1.4 0.9 -- 2.0 20 13.1 1.5 0.9 -- 2.4
Peritoneum 0 0.8 NC NC -- NC 0 0.5 NC NC -- NC 0 0.3 NC NC -- NC
Mesothelioma 0 0.5 NC NC -- NC 0 0.4 NC NC -- NC 0 0.1 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health
TABLE 1B 
Asbestos-Related Cancer Incidence
Billerica, MA
1986-1995
Total Males Females
95% CI 95% CI 95% CI
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All
Census Tracts Obs Exp SMR Obs Exp SMR Obs Exp SMR
Digestive 186 159.8 1.2 1.0 -- 1.3 103 87.2 1.2 1.0 -- 1.4 83 72.4 1.2 0.9 -- 1.4
Respiratory 345 281.4 1.2 * 1.1 -- 1.4 207 185.1 1.1 1.0 -- 1.3 138 95.7 1.4 * 1.2 -- 1.7
Lung & Bronchus 331 271.4 1.2 * 1.1 -- 1.4 196 177.3 1.1 1.0 -- 1.3 135 93.5 1.4 * 1.2 1.7
Peritoneum 7 2.1 3.4 * 1.4 -- 6.9 6 1.2 5.0 * 1.8 -- 10.9 1 0.9 NC NC -- NC
Without specification 63 62.8 1.0 0.8 -- 1.3 31 32.6 1.0 0.7 -- 1.4 32 30.1 1.1 0.7 -- 1.5
Pulmonary 17 24.8 0.7 0.4 -- 1.1 6 11.3 0.5 0.2 -- 1.2 11 13.4 0.8 0.4 -- 1.5
COPD 185 150.2 1.2 * 1.1 -- 1.4 105 82.4 1.3 1.0 -- 1.5 80 64.9 1.2 1.0 -- 1.5
Pneumoconioses 2 2.2 NC NC -- NC 2 2.1 NC NC -- NC 0 0.1 NC NC -- NC
Asbestosis 1 0.4 NC NC -- NC 1 0.4 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 39 30.2 1.3 0.9 -- 1.8 24 15.6 1.5 1.0 -- 2.3 15 14.3 1.1 0.6 -- 1.7
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 2
Asbestos-Related Mortality
Billerica, MA
1979-1998
Total Males Females
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3161
Digestive 49 51.3 1.0 0.7 -- 1.3 27 25.8 1.1 0.7 -- 1.5 22 24.7 0.9 0.6 -- 1.4
Respiratory 106 89.2 1.2 1.0 -- 1.4 64 56.1 1.1 0.9 -- 1.5 42 31.2 1.4 1.0 -- 1.8
Lung & Bronchus 104 86.0 1.2 1.0 -- 1.5 62 53.7 1.2 0.9 -- 1.5 42 30.4 1.4 1.0 -- 1.9
Peritoneum 3 0.7 NC NC -- NC 3 0.4 NC NC -- NC 0 0.3 NC NC -- NC
Without specification 19 20.1 0.9 0.6 -- 1.5 5 9.7 0.5 0.2 -- 1.2 14 10.1 1.4 0.8 -- 2.3
Pulmonary 5 7.9 0.6 0.2 -- 1.5 3 3.3 NC NC -- NC 2 4.5 NC NC -- NC
COPD 46 48.1 1.0 0.7 -- 1.3 24 23.3 1.0 0.7 -- 1.5 22 22.0 1.0 0.6 -- 1.5
Pneumoconioses 2 0.7 NC NC -- NC 2 0.6 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 1 0.1 NC NC -- NC 1 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 15 9.6 1.6 0.9 -- 2.6 12 4.5 2.7 * 1.4 -- 4.7 3 4.9 NC NC -- NC
CT 3162
Digestive 37 31.7 1.2 0.8 -- 1.6 18 18.6 1.0 0.6 -- 1.5 19 13.4 1.4 0.9 -- 2.2
Respiratory 73 58.0 1.3 1.0 -- 1.6 49 39.9 1.2 0.9 -- 1.6 24 19.1 1.3 0.8 -- 1.9
Lung & Bronchus 71 56.0 1.3 1.0 -- 1.6 48 38.2 1.3 0.9 -- 1.7 23 18.7 1.2 0.8 -- 1.9
Peritoneum 2 0.4 NC NC -- NC 2 0.3 NC NC -- NC 0 0.2 NC NC -- NC
Without specification 14 12.6 1.1 0.6 -- 1.9 11 7.0 1.6 0.8 -- 2.8 3 5.7 NC NC -- NC
Pulmonary 6 4.9 1.2 0.4 -- 2.7 2 2.4 NC NC -- NC 4 2.5 NC NC -- NC
COPD 49 29.6 1.7 * 1.2 -- 2.2 30 17.7 1.7 * 1.2 -- 2.4 19 12.1 1.6 0.9 -- 2.5
Pneumoconioses 0 0.4 NC NC -- NC 0 0.4 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 4 5.9 NC NC -- NC 2 3.3 NC NC -- NC 2 2.6 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 2A
Asbestos-Related Mortality
Billerica, MA
1979-1998
Total Males Females
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3163
Digestive 27 23.2 1.2 0.8 -- 1.7 15 13.5 1.1 0.6 -- 1.8 12 9.8 1.2 0.6 -- 2.1
Respiratory 45 43.4 1.0 0.8 -- 1.4 27 29.3 0.9 0.6 -- 1.3 18 14.4 1.3 0.7 -- 2.0
Lung & Bronchus 45 41.9 1.1 0.8 -- 1.4 27 28.1 1.0 0.6 -- 1.4 18 14.1 1.3 0.8 -- 2.0
Peritoneum 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 10 9.3 1.1 0.5 -- 2.0 4 5.1 NC NC -- NC 6 4.2 1.4 0.5 -- 3.1
Pulmonary 3 3.7 NC NC -- NC 0 1.8 NC NC -- NC 3 1.9 NC NC -- NC
COPD 33 21.2 1.6 * 1.1 -- 2.2 16 12.2 1.3 0.8 -- 2.1 17 8.9 1.9 * 1.1 -- 3.1
Pneumoconioses 0 0.3 NC NC -- NC 0 0.3 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 6 4.3 1.4 0.5 -- 3.0 4 2.4 NC NC -- NC 2 1.9 NC NC -- NC
CT 3164
Digestive 22 19.7 1.1 0.7 -- 1.7 13 12.7 1.0 0.5 -- 1.8 9 7.6 1.2 0.5 -- 2.2
Respiratory 46 36.5 1.3 0.9 -- 1.7 26 26.7 1.0 0.6 -- 1.4 20 11.5 1.7 * 1.1 -- 2.7
Lung & Bronchus 42 35.2 1.2 0.9 -- 1.6 22 25.5 0.9 0.5 -- 1.3 20 11.2 1.8 * 1.1 -- 2.8
Peritoneum 1 0.3 NC NC -- NC 1 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 7 7.9 0.9 0.4 -- 1.8 3 4.8 NC NC -- NC 4 3.3 NC NC -- NC
Pulmonary 0 3.2 NC NC -- NC 0 1.7 NC NC -- NC 0 1.5 NC NC -- NC
COPD 13 17.6 0.7 0.4 -- 1.3 6 11.9 0.5 0.2 -- 1.1 7 6.6 1.1 0.4 -- 2.2
Pneumoconioses 0 0.3 NC NC -- NC 0 0.3 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 5 3.7 1.4 0.4 -- 3.2 3 2.3 NC NC -- NC 2 1.5 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 2B
Asbestos-Related Mortality
Billerica, MA
1979-1998
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3165
Digestive 47 33.9 1.4 1.0 -- 1.8 28 16.6 1.7 * 1.1 -- 2.4 19 16.8 1.1 0.7 -- 1.8
Respiratory 72 54.3 1.3 1.0 -- 1.7 39 33.1 1.2 0.8 -- 1.6 33 19.6 1.7 * 1.2 -- 2.4
Lung & Bronchus 66 52.4 1.3 1.0 -- 1.6 35 31.8 1.1 0.8 -- 1.5 31 19.1 1.6 * 1.1 -- 2.3
Peritoneum 1 0.4 NC NC -- NC 0 0.2 NC NC -- NC 1 0.2 NC NC -- NC
Without specification 13 12.9 1.0 0.5 -- 1.7 8 6.1 1.3 0.6 -- 2.6 5 6.7 0.8 0.2 -- 1.7
Pulmonary 3 5.2 NC NC -- NC 1 2.1 NC NC -- NC 2 3.0 NC NC -- NC
COPD 41 33.7 1.2 0.9 -- 1.7 27 17.4 1.6 1.0 -- 2.3 14 15.3 0.9 0.5 -- 1.5
Pneumoconioses 0 0.5 NC NC -- NC 0 0.5 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 8 6.6 1.2 0.5 -- 2.4 2 3.1 NC NC -- NC 6 3.4 1.8 0.7 -- 3.9
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 2C
Asbestos-Related Mortality
Billerica, MA
1979-1998
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All
Census Tracts Obs Exp SIR Obs Exp SIR Obs Exp SIR
Digestive 588 584.6 1.0 0.9 -- 1.1 286 274.3 1.0 0.9 -- 1.2 302 299.0 1.0 0.9 -- 1.1
Respiratory 483 554.9 0.9 0.8 -- 1.0 274 312.6 0.9 0.8 -- 1.0 209 223.6 0.9 0.8 -- 1.1
Lung & Bronchus 434 507.7 0.9 * 0.8 -- 0.9 240 278.4 0.9 0.8 -- 1.0 194 213.0 0.9 0.8 -- 1.1
Peritoneum 7 13.5 0.5 0.2 -- 1.1 5 7.7 0.7 0.2 -- 1.5 2 5.3 NC NC -- NC
Mesothelioma 3 8.3 NC NC -- NC 3 5.8 NC NC -- NC 0 1.9 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 3
Asbestos-Related Cancer Incidence
Cambridge, MA
1986-1995
Total Males Females
 73
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
CT 3521
Digestive 19 15.8 1.2 0.7 -- 1.9 8 8.5 0.9 0.4 -- 1.9 11 7.2 1.5 0.8 -- 2.7
Respiratory 21 16.4 1.3 0.8 -- 2.0 14 10.2 1.4 0.8 -- 2.3 7 6.1 1.1 0.5 -- 2.4
Lung & Bronchus 18 15.0 1.2 0.7 -- 1.9 12 9.1 1.3 0.7 -- 2.3 6 5.8 1.0 0.4 -- 2.2
Peritoneum 2 0.4 NC NC -- NC 0 0.2 NC NC -- NC 2 0.1 NC NC -- NC
Mesothelioma 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
CT 3522
Digestive 31 22.5 1.4 0.9 -- 2.0 13 10.8 1.2 0.6 -- 2.1 18 11.3 1.6 0.9 -- 2.5
Respiratory 21 21.5 1.0 0.6 -- 1.5 12 12.2 1.0 0.5 -- 1.7 9 8.7 1.0 0.5 -- 2.0
Lung & Bronchus 19 19.8 1.0 0.6 -- 1.5 12 11.0 1.1 0.6 -- 1.9 7 8.3 0.9 0.3 -- 1.7
Peritoneum 0 0.5 NC NC -- NC 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
CT 3523
Digestive 9 13.5 0.7 0.3 -- 1.3 4 6.4 NC NC -- NC 5 6.8 0.7 0.2 -- 1.7
Respiratory 11 13.8 0.8 0.4 -- 1.4 5 7.5 0.7 0.2 -- 1.6 6 5.7 1.1 0.4 -- 2.3
Lung & Bronchus 9 12.6 0.7 0.3 -- 1.4 4 6.7 NC NC -- NC 5 5.4 0.9 0.3 -- 2.2
Peritoneum 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Mesothelioma 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
CT 3524
Digestive 3 7.2 NC NC -- NC 2 3.0 NC NC -- NC 1 3.8 NC NC -- NC
Respiratory 5 7.7 0.7 0.2 -- 1.5 4 3.6 NC NC -- NC 1 3.4 NC NC -- NC
Lung & Bronchus 4 7.0 NC NC -- NC 3 3.2 NC NC -- NC 1 3.2 NC NC -- NC
Peritoneum 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Mesothelioma 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 3A
Asbestos-Related Cancer Incidence
Cambridge, MA
1986-1995
Total Males Females
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
CT 3525
Digestive 17 14.3 1.2 0.7 -- 1.9 10 7.9 1.3 0.6 -- 2.3 7 6.5 1.1 0.4 -- 2.2
Respiratory 16 14.2 1.1 0.6 -- 1.8 10 8.9 1.1 0.5 -- 2.1 6 5.4 1.1 . 0.4 -- 2.4
Lung & Bronchus 14 13.0 1.1 0.6 -- 1.8 8 7.9 1.0 0.4 -- 2.0 6 5.1 1.2 0.4 -- 2.6
Peritoneum 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Mesothelioma 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
CT 3526
Digestive 16 15.8 1.0 0.6 -- 1.6 8 7.8 1.0 0.4 -- 2.0 8 7.8 1.0 0.4 -- 2.0
Respiratory 17 16.3 1.0 0.6 -- 1.7 9 9.4 1.0 0.4 -- 1.8 8 6.4 1.3 0.5 -- 2.5
Lung & Bronchus 15 14.9 1.0 0.6 -- 1.7 8 8.4 1.0 0.4 -- 1.9 7 6.1 1.2 0.5 -- 2.4
Peritoneum 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
CT 3527
Digestive 13 17.8 0.7 0.4 -- 1.3 7 8.7 0.8 0.3 -- 1.7 6 8.7 0.7 0.3 -- 1.5
Respiratory 7 18.3 0.4 * 0.2 -- 0.8 5 10.0 0.5 0.2 -- 1.2 2 7.6 NC NC -- NC
Lung & Bronchus 6 16.8 0.4 * 0.1 -- 0.8 4 9.0 NC NC -- NC 2 7.2 NC NC -- NC
Peritoneum 1 0.4 NC NC -- NC 1 0.2 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 1 0.3 NC NC -- NC 1 0.2 NC NC -- NC 0 0.1 NC NC -- NC
CT 3528
Digestive 12 13.1 0.9 0.5 -- 1.6 6 7.1 0.8 0.3 -- 1.8 6 5.9 1.0 0.4 -- 2.2
Respiratory 17 13.8 1.2 0.7 -- 2.0 10 8.5 1.2 0.6 -- 2.2 7 5.3 1.3 0.5 -- 2.8
Lung & Bronchus 16 12.6 1.3 0.7 -- 2.1 9 7.6 1.2 0.5 -- 2.3 7 5.0 1.4 0.6 -- 2.9
Peritoneum 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Mesothelioma 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE 3B
Asbestos-Related Cancer Incidence
Cambridge, MA
1986-1995
Total Males Females
95% CI 95% CI 95% CI
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
CT 3529
Digestive 19 18.8 1.0 0.6 -- 1.6 4 8.6 NC NC -- NC 15 9.9 1.5 0.8 -- 2.5
Respiratory 23 16.6 1.4 0.9 -- 2.1 10 9.6 1.0 0.5 -- 1.9 13 6.5 2.0 * 1.1 -- 3.4
Lung & Bronchus 21 15.2 1.4 0.9 -- 2.1 8 8.5 0.9 0.4 -- 1.9 13 6.2 2.1 * 1.1 -- 3.6
Peritoneum 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
CT 3530
Digestive 20 26.3 0.8 0.5 -- 1.2 8 12.8 0.6 0.3 -- 1.2 12 13.3 0.9 0.5 -- 1.6
Respiratory 42 23.5 1.8 * 1.3 -- 2.4 33 14.5 2.3 * 1.6 -- 3.2 9 8.8 1.0 0.5 -- 1.9
Lung & Bronchus 36 21.6 1.7 * 1.2 -- 2.3 28 12.9 2.2 * 1.4 -- 3.1 8 8.4 1.0 0.4 -- 1.9
Peritoneum 0 0.6 NC NC -- NC 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 0 0.4 NC NC -- NC 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC
CT 3531
Digestive 6 14.0 0.4 * 0.2 -- 0.9 4 6.9 NC NC -- NC 2 6.8 NC NC -- NC
Respiratory 12 14.2 0.9 0.4 -- 1.5 9 8.0 1.1 0.5 -- 2.1 3 5.7 NC NC -- NC
Lung & Bronchus 11 12.8 0.9 0.4 -- 1.5 8 7.0 1.1 0.5 -- 2.3 3 5.4 NC NC -- NC
Peritoneum 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
CT 3532
Digestive 15 19.0 0.8 0.4 -- 1.3 7 9.3 0.8 0.3 -- 1.6 8 9.5 0.8 0.4 -- 1.7
Respiratory 17 18.2 0.9 0.5 -- 1.5 8 10.8 0.7 0.3 -- 1.5 9 7.0 1.3 0.6 -- 2.4
Lung & Bronchus 15 16.7 0.9 0.5 -- 1.5 7 9.6 0.7 0.3 -- 1.5 8 6.7 1.2 0.5 -- 2.4
Peritoneum 0 0.4 NC NC -- NC 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 3C
Asbestos-Related Cancer Incidence
Cambridge, MA 
Total Males Females
1986-1995
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
CT 3533
Digestive 17 18.9 0.9 0.5 -- 1.4 6 9.5 0.6 0.2 -- 1.4 11 9.1 1.2 0.6 -- 2.2
Respiratory 15 18.9 0.8 0.4 -- 1.3 9 10.9 0.8 0.4 -- 1.6 6 7.5 0.8 0.3 -- 1.7
Lung & Bronchus 12 17.3 0.7 0.4 -- 1.2 8 9.7 0.8 0.4 -- 1.6 4 7.2 NC NC -- NC
Peritoneum 0 0.5 NC NC -- NC 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
CT 3534
Digestive 8 10.6 0.8 0.3 -- 1.5 6 5.3 1.1 0.4 -- 2.5 2 5.2 NC NC -- NC
Respiratory 10 10.7 0.9 0.5 -- 1.7 7 6.1 1.2 0.5 -- 2.4 3 4.3 NC NC -- NC
Lung & Bronchus 9 9.7 0.9 0.4 -- 1.8 7 5.4 1.3 0.5 -- 2.7 2 4.1 NC NC -- NC
Peritoneum 1 0.3 NC NC -- NC 1 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Mesothelioma 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
CT 3535
Digestive 19 13.8 1.4 0.8 -- 2.2 7 6.5 1.1 0.4 -- 2.2 12 7.0 1.7 0.9 -- 3.0
Respiratory 5 14.1 0.4 * 0.1 -- 0.8 2 7.6 NC NC -- NC 3 5.8 NC NC -- NC
Lung & Bronchus 5 12.9 0.4 * 0.1 -- 0.9 2 6.8 NC NC -- NC 3 5.5 NC NC -- NC
Peritoneum 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Mesothelioma 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
CT 3536
Digestive 15 15.8 1.0 0.5 -- 1.6 6 7.4 0.8 0.3 -- 1.8 9 8.2 1.1 0.5 -- 2.1
Respiratory 8 14.7 0.6 0.2 -- 1.1 4 8.3 NC NC -- NC 4 5.9 NC NC -- NC
Lung & Bronchus 7 13.3 0.5 0.2 -- 1.1 4 7.3 NC NC -- NC 3 5.6 NC NC -- NC
Peritoneum 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE 3D
Asbestos-Related Cancer Incidence
Cambridge, MA
1986-1995
Total Males Females
95% CI 95% CI 95% CI
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
CT 3537
Digestive 23 25.4 0.9 0.6 -- 1.4 11 11.5 1.0 0.5 -- 1.7 12 13.5 0.9 0.5 -- 1.6
Respiratory 13 22.5 0.6 0.3 -- 1.0 7 12.8 0.6 0.2 -- 1.1 6 9.0 0.7 0.2 -- 1.5
Lung & Bronchus 13 20.6 0.6 0.3 -- 1.1 7 11.4 0.6 0.3 -- 1.3 6 8.6 0.7 0.3 -- 1.5
Peritoneum 0 0.6 NC NC -- NC 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
CT 3538
Digestive 25 22.3 1.1 0.7 -- 1.7 13 9.9 1.3 0.7 -- 2.3 12 12.0 1.0 0.5 -- 1.8
Respiratory 16 19.4 0.8 0.5 -- 1.3 8 10.9 0.7 0.3 -- 1.5 8 7.8 1.0 0.4 -- 2.0
Lung & Bronchus 16 17.7 0.9 0.5 -- 1.5 8 9.6 0.8 0.4 -- 1.6 8 7.4 1.1 0.5 -- 2.1
Peritoneum 0 0.5 NC NC -- NC 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
CT 3539
Digestive 8 9.6 0.8 0.4 -- 1.6 6 4.2 1.4 0.5 -- 3.1 2 5.1 NC NC -- NC
Respiratory 4 8.7 NC NC -- NC 2 4.4 NC NC -- NC 2 3.8 NC NC -- NC
Lung & Bronchus 3 7.8 NC NC -- NC 1 3.8 NC NC -- NC 2 3.6 NC NC -- NC
Peritoneum 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Mesothelioma 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
CT 3540
Digestive 16 21.9 0.7 0.4 -- 1.2 8 9.9 0.8 0.4 -- 1.6 8 11.4 0.7 0.3 -- 1.4
Respiratory 9 21.1 0.4 * 0.2 -- 0.8 4 11.4 NC NC -- NC 5 8.7 0.6 0.2 -- 1.3
Lung & Bronchus 9 19.2 0.5 * 0.2 -- 0.9 4 10.1 NC NC -- NC 5 8.3 0.6 0.2 -- 1.4
Peritoneum 0 0.5 NC NC -- NC 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE 3E
Asbestos-Related Cancer Incidence
Cambridge, MA
1986-1995
Total Males Females
95% CI 95% CI 95% CI
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
CT 3541
Digestive 26 25.2 1.0 0.7 -- 1.5 10 12.5 0.8 0.4 -- 1.5 16 12.4 1.3 0.7 -- 2.1
Respiratory 19 24.4 0.8 0.5 -- 1.2 6 14.4 0.4 * 0.2 -- 0.9 13 9.6 1.4 0.7 -- 2.3
Lung & Bronchus 16 22.4 0.7 0.4 -- 1.2 4 12.9 NC NC -- NC 12 9.2 1.3 0.7 -- 2.3
Peritoneum 0 0.6 NC NC -- NC 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 0 0.4 NC NC -- NC 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC
CT 3542
Digestive 33 33.0 1.0 0.7 -- 1.4 17 16.4 1.0 0.6 -- 1.7 16 16.5 1.0 0.6 -- 1.6
Respiratory 16 30.4 0.5 * 0.3 -- 0.9 10 18.5 0.5 0.3 -- 1.0 6 11.7 0.5 0.2 -- 1.1
Lung & Bronchus 15 27.9 0.5 * 0.3 -- 0.9 9 16.5 0.5 0.3 -- 1.0 6 11.2 0.5 0.2 -- 1.2
Peritoneum 1 0.7 NC NC -- NC 1 0.4 NC NC -- NC 0 0.3 NC NC -- NC
Mesothelioma 0 0.5 NC NC -- NC 0 0.4 NC NC -- NC 0 0.1 NC NC -- NC
CT 3543
Digestive 45 38.0 1.2 0.9 -- 1.6 21 15.5 1.4 0.8 -- 2.1 24 21.2 1.1 0.7 -- 1.7
Respiratory 28 33.1 0.9 0.6 -- 1.2 13 16.9 0.8 0.4 -- 1.3 15 14.1 1.1 0.6 -- 1.8
Lung & Bronchus 26 30.5 0.9 0.6 -- 1.3 12 15.2 0.8 0.4 -- 1.4 14 13.5 1.0 0.6 -- 1.7
Peritoneum 0 0.8 NC NC -- NC 0 0.4 NC NC -- NC 0 0.3 NC NC -- NC
Mesothelioma 0 0.5 NC NC -- NC 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC
CT 3544
Digestive 13 12.4 1.1 0.6 -- 1.8 4 5.8 0.7 0.2 -- 1.8 9 6.3 1.4 0.7 -- 2.7
Respiratory 11 11.9 0.9 0.5 -- 1.7 4 6.8 NC NC -- NC 7 4.7 1.5 0.6 -- 3.1
Lung & Bronchus 11 10.9 1.0 0.5 -- 1.8 4 6.1 NC NC -- NC 7 4.5 1.6 0.6 -- 3.2
Peritoneum 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Mesothelioma 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE 3F
Asbestos-Related Cancer Incidence
Cambridge, MA
1986-1995
Total Males Females
95% CI 95% CI 95% CI
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
CT 3545
Digestive 11 14.4 0.8 0.4 -- 1.4 9 7.1 1.3 0.6 -- 2.4 2 7.1 NC NC -- NC
Respiratory 9 14.0 0.6 0.3 -- 1.2 6 8.1 0.7 0.3 -- 1.6 3 5.6 NC NC -- NC
Lung & Bronchus 9 12.8 0.7 0.3 -- 1.3 6 7.2 0.8 0.3 -- 1.8 3 5.3 NC NC -- NC
Peritoneum 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Mesothelioma 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
CT 3546
Digestive 39 32.4 1.2 0.9 -- 1.7 24 14.4 1.7 * 1.1 -- 2.5 15 17.1 0.9 0.5 -- 1.5
Respiratory 25 30.4 0.8 0.5 -- 1.2 10 16.1 0.6 0.3 -- 1.1 15 12.8 1.2 0.7 -- 1.9
Lung & Bronchus 23 27.9 0.8 0.5 -- 1.2 8 14.4 0.6 0.2 -- 1.1 15 12.2 1.2 0.7 -- 2.0
Peritoneum 1 0.7 NC NC -- NC 1 0.4 NC NC -- NC 0 0.3 NC NC -- NC
Mesothelioma 1 0.5 NC NC -- NC 1 0.3 NC NC -- NC 0 0.1 NC NC -- NC
CT 3547
Digestive 19 15.5 1.2 0.7 -- 1.9 10 6.9 1.5 0.7 -- 2.7 9 8.2 1.1 0.5 -- 2.1
Respiratory 12 14.7 0.8 0.4 -- 1.4 6 8.0 0.8 0.3 -- 1.6 6 6.0 1.0 0.4 -- 2.2
Lung & Bronchus 12 13.5 0.9 0.5 -- 1.6 6 7.1 0.9 0.3 -- 1.8 6 5.8 1.0 0.4 -- 2.3
Peritoneum 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Mesothelioma 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
CT 3548
Digestive 15 13.5 1.1 0.6 -- 1.8 6 5.9 1.0 0.4 -- 2.2 9 7.2 1.3 0.6 -- 2.4
Respiratory 17 12.9 1.3 0.8 -- 2.1 11 6.9 1.6 0.8 -- 2.8 6 5.3 1.1 0.4 -- 2.5
Lung & Bronchus 15 11.8 1.3 0.7 -- 2.1 9 6.2 1.5 0.7 -- 2.8 6 5.1 1.2 0.4 -- 2.6
Peritoneum 1 0.3 NC NC -- NC 1 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Mesothelioma 1 0.2 NC NC -- NC 1 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE 3G
Asbestos-Related Cancer Incidence
Cambridge, MA
1986-1995
Total Males Females
95% CI 95% CI 95% CI
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
CT 3549
Digestive 40 29.8 1.3 1.0 -- 1.8 25 15.1 1.7 * 1.1 -- 2.5 15 14.3 1.1 0.6 -- 1.7
Respiratory 32 30.0 1.1 0.7 -- 1.5 21 17.4 1.2 0.8 -- 1.8 11 12.0 0.9 0.5 -- 1.6
Lung & Bronchus 28 27.4 1.0 0.7 -- 1.5 18 15.5 1.2 0.7 -- 1.8 10 11.4 0.9 0.4 -- 1.6
Peritoneum 0 0.7 NC NC -- NC 0 0.4 NC NC -- NC 0 0.3 NC NC -- NC
Mesothelioma 0 0.4 NC NC -- NC 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC
CT 3550
Digestive 36 34.2 1.1 0.7 -- 1.5 17 13.0 1.3 0.8 -- 2.1 19 19.8 1.0 0.6 -- 1.5
Respiratory 22 28.4 0.8 0.5 -- 1.2 13 13.9 0.9 0.5 -- 1.6 9 12.3 0.7 0.3 -- 1.4
Lung & Bronchus 18 26.2 0.7 0.4 -- 1.1 10 12.5 0.8 0.4 -- 1.5 8 11.8 0.7 0.3 -- 1.3
Peritoneum 0 0.7 NC NC -- NC 0 0.3 NC NC -- NC 0 0.3 NC NC -- NC
Mesothelioma 0 0.5 NC NC -- NC 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE 3H
Asbestos-Related Cancer Incidence
Cambridge, MA
1986-1995
Total Males Females
95% CI 95% CI 95% CI
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All
Census Tracts Obs Exp SMR Obs Exp SMR Obs Exp SMR
Digestive 696 552.4 1.3 * 1.2 -- 1.4 339 260.7 1.3 * 1.2 -- 1.5 357 280.1 1.3 * 1.2 -- 1.4
Respiratory 905 870.3 1.0 1.0 -- 1.1 542 518.9 1.0 1.0 -- 1.1 363 318.5 1.1 1.0 -- 1.3
Lung & Bronchus 865 840.3 1.0 1.0 -- 1.1 507 497.6 1.0 0.9 -- 1.1 358 311.3 1.2 1.0 -- 1.3
Peritoneum 11 6.7 1.6 0.8 -- 2.9 6 3.5 1.7 0.6 -- 3.8 5 3.1 1.6 0.5 -- 3.8
Without specification 247 209.6 1.2 1.0 -- 1.3 129 95.3 1.4 * 1.1 -- 1.6 116 110.8 1.0 0.9 -- 1.3
Pulmonary 80 84.3 1.0 0.8 -- 1.2 37 33.7 1.1 0.8 -- 1.5 43 49.8 0.9 0.6 -- 1.2
COPD 473 567.6 0.8 * 0.8 -- 0.9 243 285.4 0.9 0.8 -- 1.0 230 259.0 0.9 0.8 -- 1.0
Pneumoconioses 2 8.8 NC NC -- NC 2 7.4 NC NC -- NC 0 0.2 NC NC -- NC
Asbestosis 1 1.6 NC NC -- NC 1 1.3 NC NC -- NC 0 0.1 NC NC -- NC
Other respiratory 112 108.4 1.0 0.9 -- 1.2 64 49.5 1.3 1.0 -- 1.7 48 56.4 0.9 0.6 -- 1.1
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 4
Asbestos-Related Mortality
Cambridge, MA
1979-1998
Total Males Females
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3521
Digestive 24 14.3 1.7 * 1.1 -- 2.5 13 7.9 1.7 0.9 -- 2.8 11 6.4 1.7 0.9 -- 3.1
Respiratory 24 25.3 1.0 0.6 -- 1.4 15 16.8 0.9 0.5 -- 1.5 9 8.5 1.1 0.5 -- 2.0
Lung & Bronchus 24 24.5 1.0 0.6 -- 1.5 15 16.1 0.9 0.5 -- 1.5 9 8.3 1.1 0.5 -- 2.1
Peritoneum 1 0.2 NC NC -- NC 0 0.1 NC NC -- NC 1 0.1 NC NC -- NC
Without specification 7 5.5 1.3 0.5 -- 2.6 3 2.9 NC NC -- NC 4 2.6 NC NC -- NC
Pulmonary 6 2.1 2.9 * 1.1 -- 6.2 2 1.0 NC NC -- NC 4 1.1 NC NC -- NC
COPD 15 14.3 1.1 0.6 -- 1.7 8 8.1 1.0 0.4 -- 2.0 7 6.1 1.2 0.5 -- 2.4
Pneumoconioses 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 0 2.6 NC NC -- NC 0 1.4 NC NC -- NC 0 1.2 NC NC -- NC
CT 3522
Digestive 24 21.1 1.1 0.7 -- 1.7 15 10.3 1.5 0.8 -- 2.4 9 10.5 0.9 0.4 -- 1.6
Respiratory 47 34.0 1.4 1.0 -- 1.8 32 20.5 1.6 * 1.1 -- 2.2 15 12.4 1.2 0.7 -- 2.0
Lung & Bronchus 45 32.9 1.4 1.0 -- 1.8 30 19.7 1.5 1.0 -- 2.2 15 12.1 1.2 0.7 -- 2.1
Peritoneum 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 15 7.9 1.9 * 1.1 -- 3.1 10 3.7 2.7 * 1.3 -- 5.0 5 4.1 1.2 0.4 -- 2.8
Pulmonary 4 3.0 NC NC -- NC 2 1.2 NC NC -- NC 2 1.7 NC NC -- NC
COPD 31 22.9 1.4 0.9 -- 1.9 13 12.2 1.1 0.6 -- 1.8 18 10.1 1.8 * 1.1 -- 2.8
Pneumoconioses 0 0.4 NC NC -- NC 0 0.3 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 4 4.0 NC NC -- NC 2 1.9 NC NC -- NC 2 2.0 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 4A
Asbestos-Related Mortality
Cambridge, MA
1979-1998
Total Males Females
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3523
Digestive 14 12.4 1.1 0.6 -- 1.9 7 6.0 1.2 0.5 -- 2.4 7 6.0 1.2 0.5 -- 2.4
Respiratory 19 21.4 0.9 0.5 -- 1.4 13 12.4 1.1 0.6 -- 1.8 6 7.9 0.8 0.3 -- 1.7
Lung & Bronchus 18 20.7 0.9 0.5 -- 1.4 12 11.9 1.0 0.5 -- 1.8 6 7.8 0.8 0.3 -- 1.7
Peritoneum 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 9 4.8 1.9 0.9 -- 3.6 8 2.2 3.6 * 1.6 -- 7.2 1 2.5 0.4 0.0 -- 2.3
Pulmonary 1 1.8 NC NC -- NC 1 0.8 NC NC -- NC 0 1.1 NC NC -- NC
COPD 11 12.6 0.9 0.4 -- 1.6 6 6.3 1.0 0.4 -- 2.1 5 5.8 0.9 0.3 -- 2.0
Pneumoconioses 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 1 2.3 NC NC -- NC 1 1.1 NC NC -- NC 0 1.1 NC NC -- NC
CT 3524
Digestive 11 6.4 1.7 0.9 -- 3.1 8 2.7 2.9 * 1.3 -- 5.8 3 3.3 NC NC -- NC
Respiratory 13 11.7 1.1 0.6 -- 1.9 9 5.9 1.5 0.7 -- 2.9 4 4.7 NC NC -- NC
Lung & Bronchus 13 11.3 1.2 0.6 -- 2.0 9 5.6 1.6 0.7 -- 3.0 4 4.6 0.9 0.2 -- 2.2
Peritoneum 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Without specification 3 2.6 NC NC -- NC 1 1.0 NC NC -- NC 2 1.4 NC NC -- NC
Pulmonary 0 1.1 NC NC -- NC 0 0.4 NC NC -- NC 0 0.6 NC NC -- NC
COPD 7 6.1 1.2 0.5 -- 2.4 4 2.5 NC NC -- NC 3 24.3 NC NC -- NC
Pneumoconioses 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 1 1.3 NC NC -- NC 1 0.5 NC NC -- NC 0 5.3 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 4B
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3525
Digestive 25 13.4 1.9 * 1.2 -- 2.8 13 7.7 1.7 0.9 -- 2.9 12 5.8 2.1 * 1.1 -- 3.6
Respiratory 39 22.1 1.8 * 1.3 -- 2.4 29 14.8 2.0 * 1.3 -- 2.8 10 7.5 1.3 0.6 -- 2.5
Lung & Bronchus 35 21.3 1.6 * 1.1 -- 2.3 26 14.2 1.8 * 1.2 -- 2.7 9 7.3 1.2 0.6 -- 2.3
Peritoneum 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 8 5.1 1.6 0.7 -- 3.1 3 2.8 NC NC -- NC 5 2.4 2.1 0.7 -- 4.9
Pulmonary 2 2.1 NC NC -- NC 0 1.0 NC NC -- NC 2 1.1 NC NC -- NC
COPD 18 13.3 1.4 0.8 -- 2.1 8 8.4 1.0 0.4 -- 1.9 10 5.4 1.8 0.9 -- 3.4
Pneumoconioses 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 3 2.6 NC NC -- NC 3 1.5 NC NC -- NC 0 1.2 NC NC -- NC
CT 3526
Digestive 16 14.4 1.1 0.6 -- 1.8 9 7.1 1.3 0.6 -- 2.4 7 7.0 1.0 0.4 -- 2.1
Respiratory 27 25.2 1.1 0.7 -- 1.6 16 15.5 1.0 0.6 -- 1.7 11 9.0 1.2 0.6 -- 2.2
Lung & Bronchus 26 24.3 1.1 0.7 -- 1.6 15 14.8 1.0 0.6 -- 1.7 11 8.8 1.3 0.6 -- 2.2
Peritoneum 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 9 5.6 1.6 0.7 -- 3.1 7 2.6 2.6 * 1.1 -- 5.4 2 2.9 NC NC -- NC
Pulmonary 1 2.2 NC NC -- NC 0 0.9 NC NC -- NC 1 1.2 NC NC -- NC
COPD 9 14.4 0.6 0.3 -- 1.2 4 7.2 NC NC -- NC 5 6.5 0.8 0.3 -- 1.8
Pneumoconioses 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 4 2.7 NC NC -- NC 3 1.3 NC NC -- NC 1 1.4 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 4C
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3527
Digestive 16 16.2 1.0 0.6 -- 1.6 9 8.2 1.1 0.5 -- 2.1 7 7.7 0.9 0.4 -- 1.9
Respiratory 25 28.4 0.9 0.6 -- 1.3 19 16.7 1.1 0.7 -- 1.8 6 10.5 0.6 0.2 -- 1.2
Lung & Bronchus 25 27.4 0.9 0.6 -- 1.4 19 16.0 1.2 0.7 -- 1.9 6 10.3 0.6 0.2 -- 1.3
Peritoneum 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 8 6.2 1.3 0.6 -- 2.5 5 3.0 1.7 0.5 -- 3.9 3 3.2 NC NC -- NC
Pulmonary 3 2.3 NC NC -- NC 2 1.0 NC NC -- NC 1 1.3 NC NC -- NC
COPD 10 16.6 0.6 0.3 -- 1.1 7 9.0 0.8 0.3 -- 1.6 3 7.3 NC NC -- NC
Pneumoconioses 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 4 3.0 NC NC -- NC 2 1.5 NC NC -- NC 2 1.4 NC NC -- NC
CT 3528
Digestive 24 11.7 2.1 * 1.3 -- 3.1 17 6.6 2.6 * 1.5 -- 4.2 7 5.1 1.4 0.6 -- 2.8
Respiratory 34 21.3 1.6 * 1.1 -- 2.2 21 14.0 1.5 0.9 -- 2.3 13 7.2 1.8 1.0 -- 3.1
Lung & Bronchus 31 20.6 1.5 1.0 -- 2.1 18 13.4 1.3 0.8 -- 2.1 13 7.1 1.8 1.0 -- 3.1
Peritoneum 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 7 4.6 1.5 0.6 -- 3.2 3 2.4 NC NC -- NC 4 2.1 NC NC -- NC
Pulmonary 2 1.8 NC NC -- NC 0 0.8 NC NC -- NC 2 0.9 NC NC -- NC
COPD 19 11.6 1.6 1.0 -- 2.6 11 6.8 1.6 0.8 -- 2.9 8 4.8 1.7 0.7 -- 3.3
Pneumoconioses 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 3 2.1 NC NC -- NC 2 1.2 NC NC -- NC 1 1.0 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 4D
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3529
Digestive 30 18.4 1.6 * 1.1 -- 2.3 14 8.3 1.7 0.9 -- 2.8 16 9.7 1.7 0.9 -- 2.7
Respiratory 34 26.4 1.3 0.9 -- 1.8 19 16.0 1.2 0.7 -- 1.9 15 9.5 1.6 0.9 -- 2.6
Lung & Bronchus 30 25.5 1.2 0.8 -- 1.7 16 15.3 1.1 0.6 -- 1.7 14 9.3 1.5 0.8 -- 2.5
Peritoneum 3 0.2 NC NC -- NC 2 0.1 NC NC -- NC 1 0.1 NC NC -- NC
Without specification 14 6.8 2.1 * 1.1 -- 3.4 6 3.0 2.0 0.7 -- 4.4 8 3.7 2.1 0.9 -- 4.2
Pulmonary 0 2.8 NC NC -- NC 0 1.1 NC NC -- NC 0 1.7 NC NC -- NC
COPD 20 19.0 1.1 0.6 -- 1.6 12 9.1 1.3 0.7 -- 2.3 8 8.8 0.9 0.4 -- 1.8
Pneumoconioses 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 5 3.7 1.3 0.4 -- 3.1 3 1.6 NC NC -- NC 2 2.0 NC NC -- NC
CT 3530
Digestive 40 25.4 1.6 * 1.1 -- 2.2 20 12.2 1.6 1.0 -- 2.5 20 13.0 1.5 0.9 -- 2.4
Respiratory 64 37.4 1.7 * 1.3 -- 2.2 51 24.1 2.1 * 1.6 -- 2.8 13 12.9 1.0 0.5 -- 1.7
Lung & Bronchus 62 36.1 1.7 * 1.3 -- 2.2 49 23.2 2.1 * 1.6 -- 2.8 13 12.6 1.0 0.6 -- 1.8
Peritoneum 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 10 9.5 1.1 0.5 -- 1.9 7 4.4 1.6 0.6 -- 3.3 3 5.0 NC NC -- NC
Pulmonary 7 3.9 1.8 0.7 -- 3.7 5 1.6 3.2 1.0 -- 7.5 2 2.3 NC NC -- NC
COPD 30 26.5 1.1 0.8 -- 1.6 15 13.5 1.1 0.6 -- 1.8 15 11.9 1.3 0.7 -- 2.1
Pneumoconioses 0 0.4 NC NC -- NC 0 0.4 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 6 3.3 1.8 0.7 -- 3.9 4 2.3 NC NC -- NC 2 2.7 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 4E
Asbestos-Related Mortality
Cambridge, MA
1979-1998
 87
Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3531
Digestive 6 12.8 0.5 0.2 -- 1.0 5 6.3 0.8 0.3 -- 1.8 1 6.1 NC NC -- NC
Respiratory 17 21.6 0.8 0.5 -- 1.3 13 12.9 1.0 0.5 -- 1.7 4 7.8 NC NC -- NC
Lung & Bronchus 15 20.8 0.7 0.4 -- 1.2 11 12.3 0.9 0.5 -- 1.6 4 7.6 NC NC NC
Peritoneum 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 6 6.8 0.9 0.3 -- 1.9 4 2.5 NC NC -- NC 3 2.5 NC NC -- NC
Pulmonary 2 2.3 NC NC -- NC 0 1.0 NC NC -- NC 2 1.3 NC NC -- NC
COPD 10 12.7 0.8 0.4 -- 1.5 6 6.4 1.0 0.4 -- 2.1 4 5.8 NC NC -- NC
Pneumoconioses 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 2 2.8 NC NC -- NC 1 1.4 NC NC -- NC 1 1.3 NC NC -- NC
CT 3532
Digestive 24 17.7 1.4 0.9 -- 2.0 9 8.7 1.0 0.5 -- 2.0 15 8.8 1.7 1.0 -- 2.8
Respiratory 31 28.5 1.1 0.7 -- 1.5 18 17.8 1.0 0.6 -- 1.6 13 10.0 1.3 0.7 -- 2.2
Lung & Bronchus 30 27.6 1.1 0.7 -- 1.6 17 17.1 1.0 0.6 -- 1.6 13 9.8 1.3 0.7 -- 2.3
Peritoneum 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 5 6.8 0.7 0.2 -- 1.7 3 3.2 NC NC -- NC 3 3.5 NC NC -- NC
Pulmonary 6 2.7 2.2 0.8 -- 4.9 3 1.1 NC NC -- NC 3 1.6 NC NC -- NC
COPD 16 18.5 0.9 0.5 -- 1.4 7 9.3 0.8 0.3 -- 1.6 9 8.3 1.1 0.5 -- 2.1
Pneumoconioses 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 5 3.4 1.5 0.5 -- 3.4 1 1.6 NC NC -- NC 4 1.8 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 4F
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3533
Digestive 37 17.3 2.1 * 1.5 -- 3.0 17 8.9 1.9 * 1.1 -- 3.1 20 8.1 2.5 * 1.5 -- 3.8
Respiratory 34 29.3 1.2 0.8 -- 1.6 22 18.0 1.2 0.8 -- 1.9 12 10.5 1.1 0.6 -- 2.0
Lung & Bronchus 31 28.3 1.1 0.8 -- 1.6 20 17.2 1.2 0.7 -- 1.8 11 10.3 1.1 0.5 -- 1.9
Peritoneum 1 0.2 NC NC -- NC 0 0.1 NC NC -- NC 1 0.1 NC NC -- NC
Without specification 13 6.7 2.0 1.0 -- 3.3 2 3.3 NC NC -- NC 11 3.3 3.3 * 1.6 -- 5.9
Pulmonary 1 2.7 NC NC -- NC 0 1.2 NC NC -- NC 1 1.5 NC NC -- NC
COPD 22 17.0 1.3 0.8 -- 2.0 10 9.2 1.1 0.5 -- 2.0 12 7.5 1.6 0.8 -- 2.8
Pneumoconioses 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 3 3.3 NC NC -- NC 2 1.7 NC NC -- NC 1 1.6 NC NC -- NC
CT 3534
Digestive 11 9.7 1.1 0.6 -- 2.0 4 5.0 NC NC -- NC 7 4.6 1.5 0.6 -- 3.2
Respiratory 13 16.5 0.8 0.4 -- 1.4 8 10.0 0.8 0.3 -- 1.6 5 6.0 0.8 0.3 -- 2.0
Lung & Bronchus 13 15.9 0.8 0.4 -- 1.4 8 9.6 0.8 0.4 -- 1.6 5 5.8 0.9 0.3 -- 2.0
Peritoneum 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 4 3.8 NC NC -- NC 2 1.8 NC NC -- NC 2 1.9 NC NC -- NC
Pulmonary 2 1.5 NC NC -- NC 1 0.7 NC NC -- NC 1 0.9 NC NC -- NC
COPD 6 9.5 0.6 0.2 -- 1.4 3 5.1 NC NC -- NC 3 4.2 NC NC -- NC
Pneumoconioses 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 3 1.9 NC NC -- NC 2 1.0 NC NC -- NC 1 0.9 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 4G
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3535
Digestive 16 12.6 1.3 0.7 -- 2.1 8 6.0 1.3 0.6 -- 2.6 8 6.2 1.3 0.6 -- 2.5
Respiratory 18 21.8 0.8 0.5 -- 1.3 10 12.5 0.8 0.4 -- 1.5 8 8.1 1.0 0.4 -- 2.0
Lung & Bronchus 17 21.0 0.8 0.5 -- 1.3 9 12.0 0.8 0.3 -- 1.4 8 7.9 1.0 0.4 -- 2.0
Peritoneum 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 5 4.9 1.0 0.3 -- 2.4 2 2.2 NC NC -- NC 3 2.5 NC NC -- NC
Pulmonary 1 1.9 NC NC -- NC 1 0.8 NC NC -- NC 0 1.1 NC NC -- NC
COPD 15 12.5 1.2 0.7 -- 2.0 8 6.1 1.3 0.6 -- 2.6 7 5.8 1.2 0.5 -- 2.5
Pneumoconioses 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 1 2.4 NC NC -- NC 1 1.1 NC NC -- NC 0 1.2 NC NC -- NC
CT 3536
Digestive 9 14.9 0.6 0.3 -- 1.2 3 6.9 NC NC -- NC 6 7.7 0.8 0.3 -- 1.7
Respiratory 8 22.8 0.4 * 0.2 -- 0.7 4 13.5 NC NC -- NC 4 8.4 NC NC -- NC
Lung & Bronchus 8 22.0 0.4 * 0.2 -- 0.7 4 12.9 NC NC -- NC 4 8.2 NC NC -- NC
Peritoneum 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 6 5.8 1.0 0.4 -- 2.3 6 2.6 2.3 0.9 -- 5.1 0 3.1 NC NC -- NC
Pulmonary 2 2.5 NC NC -- NC 1 1.0 NC NC -- NC 1 1.5 NC NC -- NC
COPD 4 14.7 NC NC -- NC 3 7.1 NC NC -- NC 1 10.4 NC NC -- NC
Pneumoconioses 0 0.22 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 3 3.1 NC NC -- NC 2 1.4 NC NC -- NC 1 1.6 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 4H
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3537
Digestive 21 24.7 0.9 0.5 -- 1.3 9 11.0 0.8 0.4 -- 1.6 12 13.1 0.9 0.5 -- 1.6
Respiratory 26 35.7 0.7 0.5 -- 1.1 12 21.2 0.6 0.3 -- 1.0 14 13.1 1.1 0.6 -- 1.8
Lung & Bronchus 26 34.5 0.8 0.5 -- 1.1 12 20.4 0.6 0.3 -- 1.0 14 12.8 1.1 0.6 -- 1.8
Peritoneum 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 6 9.2 0.6 0.2 -- 1.4 4 4.0 NC NC -- NC 2 5.1 NC NC -- NC
Pulmonary 4 3.9 NC NC -- NC 3 1.5 NC NC -- NC 1 2.4 NC NC -- NC
COPD 18 26.0 0.7 0.4 -- 1.1 9 12.5 0.7 0.3 -- 1.4 9 12.1 0.7 0.3 -- 1.4
Pneumoconioses 0 0.4 NC NC -- NC 0 0.3 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 5 5.1 1.0 0.3 -- 2.3 2 2.2 NC NC -- NC 3 2.8 NC NC -- NC
CT 3538
Digestive 31 21.9 1.4 1.0 -- 2.0 14 9.5 1.5 0.8 -- 2.5 17 12.0 1.4 0.8 -- 2.3
Respiratory 37 30.7 1.2 0.9 -- 1.7 21 18.0 1.2 0.7 -- 1.8 16 11.4 1.4 0.8 -- 2.3
Lung & Bronchus 35 29.6 1.2 0.8 -- 1.7 19 17.2 1.1 0.7 -- 1.7 16 11.1 1.4 0.8 -- 2.3
Peritoneum 1 0.3 NC NC -- NC 0 0.1 NC NC -- NC 1 0.1 NC NC -- NC
Without specification 11 8.2 1.3 0.7 -- 2.4 6 3.5 1.7 0.6 -- 3.8 5 4.6 1.1 0.4 -- 2.5
Pulmonary 2 3.6 NC NC -- NC 0 1.3 NC NC -- NC 2 2.2 NC NC -- NC
COPD 16 21.7 0.7 0.4 -- 1.2 8 9.9 0.8 0.3 -- 1.6 8 10.4 0.8 0.3 -- 1.5
Pneumoconioses 0 0.3 NC NC -- NC 0 0.3 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 3 4.6 NC NC -- NC 2 1.9 NC NC -- NC 1 2.6 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 4I
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3539
Digestive 8 9.1 0.9 0.4 -- 1.7 4 4.0 NC NC -- NC 4 4.8 NC NC -- NC
Respiratory 6 13.4 0.5 0.2 -- 1.0 4 7.1 NC NC -- NC 2 5.3 NC NC -- NC
Lung & Bronchus 6 12.9 0.5 0.2 -- 1.0 4 6.8 NC NC -- NC 2 5.2 NC NC -- NC
Peritoneum 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 3 3.6 NC NC -- NC 1 1.6 NC NC -- NC 2 1.9 NC NC -- NC
Pulmonary 0 1.7 NC NC -- NC 0 0.7 NC NC -- NC 0 1.0 NC NC -- NC
COPD 1 9.5 NC NC -- NC 1 4.6 NC NC -- NC 0 4.5 NC NC -- NC
Pneumoconioses 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 0 2.1 NC NC -- NC 0 1.0 NC NC -- NC 0 1.1 NC NC -- NC
CT 3540
Digestive 20 20.4 1.0 0.6 -- 1.5 5 9.3 0.5 0.2 -- 1.3 15 10.5 1.4 0.8 -- 2.4
Respiratory 15 32.8 0.5 * 0.3 -- 0.8 3 18.8 NC NC -- NC 12 12.3 1.0 0.5 -- 1.7
Lung & Bronchus 15 31.7 0.5 * 0.3 -- 0.8 3 18.1 NC NC -- NC 12 12.0 1.0 0.5 -- 1.8
Peritoneum 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 8 7.9 1.0 0.4 -- 2.0 3 3.5 NC NC -- NC 5 4.2 1.2 0.4 -- 2.8
Pulmonary 2 3.2 NC NC -- NC 2 1.2 NC NC -- NC 0 2.0 NC NC -- NC
COPD 12 20.3 0.6 0.3 -- 1.0 5 9.6 0.5 0.2 -- 1.2 7 9.6 0.7 0.3 -- 1.5
Pneumoconioses 0 0.3 NC NC -- NC 0 0.3 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 5 4.0 1.3 0.4 -- 2.9 3 1.7 NC NC -- NC 2 2.1 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 4J
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3541
Digestive 32 23.6 1.4 0.9 -- 1.9 14 12.0 1.2 0.6 -- 2.0 18 11.4 1.6 0.9 -- 2.5
Respiratory 24 38.2 0.6 * 0.4 -- 0.9 12 24.0 0.5 * 0.3 -- 0.9 12 13.6 0.9 0.5 -- 1.5
Lung & Bronchus 24 36.9 0.7 0.4 -- 1.0 12 23.0 0.5 * 0.3 -- 0.9 12 13.3 0.9 0.5 -- 1.6
Peritoneum 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 7 9.0 0.8 0.3 -- 1.6 0 4.3 NC NC -- NC 7 4.6 1.5 0.6 -- 3.2
Pulmonary 2 3.5 NC NC -- NC 1 1.5 NC NC -- NC 1 2.0 NC NC -- NC
COPD 10 23.9 0.4 * 0.2 -- 0.8 2 13.1 NC NC -- NC 8 10.5 0.8 0.3 -- 1.5
Pneumoconioses 0 0.4 NC NC -- NC 0 0.3 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 3 4.4 NC NC -- NC 1 2.2 NC NC -- NC 2 2.2 NC NC -- NC
CT 3542
Digestive 20 31.8 0.6 0.4 -- 1.0 5 15.8 0.3 * 0.1 -- 0.7 15 15.9 0.9 0.5 -- 1.6
Respiratory 31 48.2 0.6 * 0.4 -- 0.9 21 31.0 0.7 0.4 -- 1.0 10 16.9 0.6 0.3 -- 1.1
Lung & Bronchus 30 46.6 0.6 * 0.4 -- 0.9 20 29.8 0.7 0.4 -- 1.0 10 16.5 0.6 0.3 -- 1.1
Peritoneum 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC
Without specification 7 11.9 0.6 0.2 -- 1.2 6 5.7 1.1 0.4 -- 2.3 1 6.2 NC NC -- NC
Pulmonary 3 4.7 NC NC -- NC 0 1.9 NC NC -- NC 3 2.7 NC NC -- NC
COPD 16 33.2 0.5 * 0.3 -- 0.8 6 18.2 0.3 * 0.1 -- 0.7 10 14.5 0.7 0.3 -- 1.3
Pneumoconioses 0 0.5 NC NC -- NC 0 0.5 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 5 6.2 0.8 0.3 -- 1.9 3 2.9 NC NC -- NC 2 3.2 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 4K
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3543
Digestive 48 37.5 1.3 0.9 -- 1.7 19 15.4 1.2 0.7 -- 1.9 29 20.8 1.4 0.9 -- 2.0
Respiratory 58 53.2 1.1 0.8 -- 1.4 30 28.6 1.1 0.7 -- 1.5 28 20.7 1.4 0.9 -- 2.0
Lung & Bronchus 57 51.4 1.1 0.8 -- 1.4 29 27.4 1.1 0.7 -- 1.5 28 20.3 1.4 0.9 -- 2.0
Peritoneum 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC
Without specification 10 13.7 0.7 0.3 -- 1.3 5 5.5 0.9 0.3 -- 2.1 5 7.9 0.6 0.2 -- 1.5
Pulmonary 4 5.5 NC NC -- NC 1 1.9 NC NC -- NC 3 3.5 NC NC -- NC
COPD 23 40.4 0.6 * 0.4 -- 0.9 9 18.6 0.5 * 0.2 -- 0.9 14 19.4 0.7 0.4 -- 1.2
Pneumoconioses 0 0.6 NC NC -- NC 0 0.5 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 9 7.5 1.2 0.5 -- 2.3 4 3.0 NC NC -- NC 5 4.2 1.2 0.4 -- 2.8
CT 3544
Digestive 20 11.6 1.7 * 1.1 -- 2.7 7 5.5 1.3 0.5 -- 2.7 13 5.9 2.2 * 1.2 -- 3.8
Respiratory 25 18.6 1.3 0.9 -- 2.0 11 11.2 1.0 0.5 -- 1.8 14 6.7 2.1 * 1.1 -- 3.5
Lung & Bronchus 25 18.0 1.4 0.9 -- 2.1 11 10.8 1.0 0.5 -- 1.8 14 6.6 2.1 * 1.2 -- 3.6
Peritoneum 1 0.1 NC NC -- NC 1 NC NC NC -- NC 0 0.1 NC NC -- NC
Without specification 4 4.4 NC NC -- NC 2 2.0 NC NC -- NC 2 2.4 NC NC -- NC
Pulmonary 1 1.8 NC NC -- NC 1 0.7 NC NC -- NC 0 1.1 NC NC -- NC
COPD 11 11.9 0.9 0.5 -- 1.7 6 5.8 1.0 0.4 -- 2.2 5 5.5 0.9 0.3 -- 2.1
Pneumoconioses 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 3 2.2 NC NC -- NC 2 1.0 NC NC -- NC 1 1.2 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3545
Digestive 11 13.4 0.8 0.4 -- 1.5 5 6.7 0.8 0.2 -- 1.7 6 6.5 0.9 0.3 -- 2.0
Respiratory 14 21.8 0.6 0.4 -- 1.1 7 13.4 0.5 0.2 -- 1.1 7 7.9 0.9 0.4 -- 1.8
Lung & Bronchus 14 21.1 0.7 0.4 -- 1.1 7 12.8 0.6 0.2 -- 1.1 7 7.7 0.9 0.4 -- 1.9
Peritoneum 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 3 5.2 NC NC -- NC 1 2.5 NC NC -- NC 2 2.6 NC NC -- NC
Pulmonary 0 2.1 NC NC -- NC 0 0.9 NC NC -- NC 0 1.1 NC NC -- NC
COPD 5 13.1 0.4 * 0.1 -- 0.9 3 7.0 NC NC -- NC 2 5.9 NC NC -- NC
Pneumoconioses 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 2 2.6 NC NC -- NC 1 1.2 NC NC -- NC 1 1.3 NC NC -- NC
CT 3546
Digestive 43 30.7 1.4 1.0 -- 1.9 25 13.8 1.8 * 1.2 -- 2.7 18 16.0 1.1 0.7 -- 1.8
Respiratory 50 47.9 1.0 0.8 -- 1.4 25 27.0 0.9 0.6 -- 1.4 25 18.3 1.4 0.9 -- 2.0
Lung & Bronchus 47 46.3 1.0 0.8 -- 1.4 23 25.9 0.9 0.6 -- 1.3 24 17.8 1.4 0.9 -- 2.0
Peritoneum 2 0.4 NC NC -- NC 1 0.2 NC NC -- NC 1 0.2 NC NC -- NC
Without specification 14 11.6 1.2 0.7 -- 2.0 10 5.0 2.0 1.0 -- 3.7 4 6.3 NC NC -- NC
Pulmonary 7 4.6 1.5 0.6 -- 3.2 2 1.7 NC NC -- NC 5 2.8 1.8 0.6 -- 4.2
COPD 21 31.9 0.7 0.4 -- 1.0 10 15.7 0.6 0.3 -- 1.2 11 14.8 0.7 0.4 -- 1.3
Pneumoconioses 0 0.5 NC NC -- NC 0 0.4 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 11 6.0 1.9 0.9 -- 3.3 7 2.6 2.7 * 1.1 -- 5.5 4 3.2 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 4M
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3547
Digestive 20 14.5 1.4 0.8 -- 2.1 7 6.4 1.1 0.4 -- 2.3 13 7.6 1.7 0.9 -- 2.9
Respiratory 24 23.1 1.0 0.7 -- 1.5 12 13.2 0.9 0.5 -- 1.6 12 8.6 1.4 0.7 -- 2.4
Lung & Bronchus 24 22.3 1.1 0.7 -- 1.6 12 12.6 1.0 0.5 -- 1.7 12 8.4 1.4 0.7 -- 2.5
Peritoneum 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 4 5.5 NC NC -- NC 0 2.4 NC NC -- NC 4 3.0 NC NC -- NC
Pulmonary 4 2.2 NC NC -- NC 2 0.8 NC NC -- NC 2 1.3 NC NC -- NC
COPD 20 15.1 1.3 0.8 -- 2.1 10 6.9 1.5 0.7 -- 2.7 10 7.1 1.4 0.7 -- 2.6
Pneumoconioses 1 0.2 NC NC -- NC 1 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 1 0.0 NC NC -- NC 1 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 2 2.8 NC NC -- NC 2 1.2 NC NC -- NC 0 1.5 NC NC -- NC
CT 3548
Digestive 20 12.7 1.6 1.0 -- 2.4 10 5.5 1.8 0.9 -- 3.4 10 6.8 1.5 0.7 -- 2.7
Respiratory 33 20.2 1.6 * 1.1 -- 2.3 23 11.4 2.0 * 1.3 -- 3.0 10 7.6 1.3 0.6 -- 2.4
Lung & Bronchus 30 19.5 1.5 1.0 -- 2.2 20 11.0 1.8 * 1.1 -- 2.8 10 7.4 1.4 0.7 -- 2.5
Peritoneum 2 0.2 NC NC -- NC 2 0.1 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 10 4.8 2.1 1.0 -- 3.8 5 2.0 2.5 0.8 -- 5.8 5 2.7 1.9 0.6 -- 4.4
Pulmonary 2 1.9 NC NC -- NC 2 0.7 NC NC -- NC 0 1.2 NC NC -- NC
COPD 13 13.0 1.0 0.5 -- 1.7 8 5.7 1.4 0.6 -- 2.8 5 6.2 0.8 0.3 -- 1.9
Pneumoconioses 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 4 2.5 NC NC -- NC 2 1.0 NC NC -- NC 2 1.4 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 4N
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 3549
Digestive 47 24.4 1.7 * 1.3 -- 2.3 25 14.3 1.8 * 1.1 -- 2.6 22 12.9 1.7 * 1.1 -- 2.6
Respiratory 54 46.5 1.2 0.9 -- 1.5 29 28.9 1.0 0.7 -- 1.4 25 16.7 1.5 1.0 -- 2.2
Lung & Bronchus 54 44.9 1.2 0.9 -- 1.6 29 27.7 1.1 0.7 -- 1.5 25 16.3 1.5 1.0 -- 2.3
Peritoneum 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC
Without specification 12 10.6 1.1 0.6 -- 2.0 5 5.2 1.0 0.3 -- 2.2 7 5.3 1.3 0.5 -- 2.7
Pulmonary 3 4.1 NC NC -- NC 2 1.8 NC NC -- NC 1 2.3 NC NC -- NC
COPD 26 27.5 1.0 0.6 -- 1.4 18 15.4 1.2 0.7 -- 1.8 8 11.9 0.7 0.3 -- 1.3
Pneumoconioses 0 0.4 NC NC -- NC 0 0.4 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 7 5.2 1.3 0.5 -- 2.8 3 2.7 NC NC -- NC 4 2.5 NC NC -- NC
CT 3550
Digestive 23 34.5 0.7 0.4 -- 1.0 15 13.1 1.2 0.6 -- 1.9 8 20.0 0.4 * 0.2 -- 0.8
Respiratory 54 46.2 1.2 0.9 -- 1.5 28 23.7 1.2 0.8 -- 1.7 26 18.4 1.4 0.9 -- 2.1
Lung & Bronchus 50 44.6 1.1 0.8 -- 1.5 25 22.7 1.1 0.7 -- 1.6 25 18.0 1.4 0.9 -- 2.1
Peritoneum 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC
Without specification 16 12.5 1.3 0.7 -- 2.1 8 4.6 1.7 0.8 -- 3.4 8 7.5 1.1 0.5 -- 2.1
Pulmonary 6 5.1 1.2 0.4 -- 2.6 3 1.6 NC NC -- NC 3 3.3 NC NC -- NC
COPD 34 37.6 0.9 0.6 -- 1.3 20 16.2 1.2 0.8 -- 1.9 14 18.5 0.8 0.4 -- 1.3
Pneumoconioses 1 0.6 NC NC -- NC 1 0.4 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 4 7.1 NC NC -- NC 2 2.6 NC NC -- NC 2 4.1 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE 4O
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All
Census Tracts Obs Exp SIR Obs Exp SIR Obs Exp SIR
Digestive 110 116.7 0.9 0.8 -- 1.1 68 61.6 1.1 0.9 -- 1.4 42 54.7 0.8 0.6 -- 1.0
Respiratory 99 117.2 0.8 0.7 -- 1.0 57 72.2 0.8 0.6 -- 1.0 42 44.4 1.0 0.7 -- 1.3
Lung & Bronchus 91 107.4 0.9 0.7 -- 1.0 51 64.5 0.8 0.6 -- 1.0 40 42.3 1.0 0.7 -- 1.3
Peritoneum 0 2.7 NC NC -- NC 0 1.7 NC NC -- NC 0 1.0 NC NC -- NC
Mesothelioma 1 1.7 NC NC -- NC 1 1.3 NC NC -- NC 0 0.4 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 5
Asbestos-Related Cancer Incidence
Easthampton, MA
1986-1995
Total Males Females
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
CT 8223
Digestive 51 52.4 1.0 0.7 -- 1.3 30 26.6 1.1 0.8 -- 1.6 21 25.3 0.8 0.5 -- 1.3
Respiratory 42 51.8 0.8 0.6 -- 1.1 25 31.0 0.8 0.5 -- 1.2 17 20.0 0.9 0.5 -- 1.4
Lung & Bronchus 39 47.6 0.8 0.6 -- 1.1 22 27.8 0.8 0.5 -- 1.2 17 19.1 0.9 0.5 -- 1.4
Peritoneum 0 1.2 NC NC -- NC 0 0.7 NC NC -- NC 0 0.4 NC NC -- NC
Mesothelioma 0 0.8 NC NC -- NC 0 0.6 NC NC -- NC 0 0.2 NC NC -- NC
CT 8224
Digestive 57 64.3 0.9 0.7 -- 1.2 37 35.1 1.1 0.7 -- 1.5 20 29.4 0.7 0.4 -- 1.1
Respiratory 57 65.4 0.9 0.7 -- 1.1 32 41.2 0.8 0.5 -- 1.1 25 24.4 1.0 0.7 -- 1.5
Lung & Bronchus 52 59.8 0.9 0.7 -- 1.1 29 36.7 0.8 0.5 -- 1.1 23 23.2 1.0 0.6 -- 1.5
Peritoneum 0 1.6 NC NC -- NC 0 1.0 NC NC -- NC 0 0.6 NC NC -- NC
Mesothelioma 1 1.0 NC NC -- NC 1 0.8 NC NC -- NC 0 0.2 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 5A
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All
Census Tracts Obs Exp SMR Obs Exp SMR Obs Exp SMR
Digestive 117 107.5 1.1 0.9 -- 1.3 76 57.8 1.3 1.0 -- 1.7 41 49.5 0.8 0.6 -- 1.1
Respiratory 187 182.6 1.0 0.9 -- 1.2 115 119.8 1.0 0.8 -- 1.2 72 62.3 1.2 0.9 -- 1.5
Lung & Bronchus 179 176.4 1.0 0.9 -- 1.2 109 115.0 1.0 0.8 -- 1.1 70 60.9 1.2 0.9 -- 1.5
Peritoneum 0 1.4 NC NC -- NC 0 0.8 NC NC -- NC 0 0.6 NC NC -- NC
Without specification 39 41.1 0.9 0.7 -- 1.3 19 21.1 0.9 0.5 -- 1.4 20 20.0 1.0 0.6 -- 1.5
Pulmonary 15 15.8 1.0 0.5 -- 1.6 7 7.2 1.0 0.4 -- 2.0 8 8.6 0.9 0.4 -- 1.8
COPD 111 110.8 1.0 0.8 -- 1.2 62 63.0 1.0 0.8 -- 1.3 49 46.9 1.0 0.8 -- 1.4
Pneumoconioses 1 1.7 NC NC -- NC 1 1.7 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 1 0.3 NC NC -- NC 1 0.3 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 31 20.1 1.6 * 1.1 -- 2.2 25 10.5 2.4 * 1.6 -- 3.5 6 9.5 0.6 0.2 -- 1.4
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 6
Asbestos-Related Mortality
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Total Males Females
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 8223
Digestive 60 48.6 1.2 0.9 -- 1.6 42 25.1 1.7 * 1.2 -- 2.3 18 23.1 0.8 0.5 -- 1.2
Respiratory 88 81.2 1.1 0.9 -- 1.3 51 51.8 1.0 0.7 -- 1.3 37 28.3 1.3 0.9 -- 1.8
Lung & Bronchus 83 78.5 1.1 0.8 -- 1.3 47 49.7 0.9 0.7 -- 1.3 36 27.7 1.3 0.9 -- 1.8
Peritoneum 0 0.6 NC NC -- NC 0 0.3 NC NC -- NC 0 0.3 NC NC -- NC
Without specification 20 18.4 1.1 0.7 -- 1.7 7 9.1 0.8 0.3 -- 1.6 13 9.2 1.4 0.8 -- 2.4
Pulmonary 9 6.9 1.3 0.6 -- 2.5 6 3.0 2.0 0.7 -- 4.3 3 3.9 NC NC -- NC
COPD 41 51.9 0.8 0.6 -- 1.1 27 28.5 1.0 0.6 -- 1.4 14 22.4 0.6 0.3 -- 1.1
Pneumoconioses 1 0.8 NC NC -- NC 1 0.8 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 1 0.2 NC NC -- NC 1 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 15 9.0 1.7 0.9 -- 2.7 11 4.5 2.4 * 1.2 -- 4.4 4 4.4 NC NC -- NC
CT 8224
Digestive 56 58.9 1.0 0.7 -- 1.2 33 32.8 1.0 0.7 -- 1.4 23 26.4 0.9 0.6 -- 1.3
Respiratory 99 101.3 1.0 0.8 -- 1.2 64 68.0 0.9 0.7 -- 1.2 35 34.1 1.0 0.7 -- 1.4
Lung & Bronchus 96 97.8 1.0 0.8 -- 1.2 62 65.2 1.0 0.7 -- 1.2 34 33.3 1.0 0.7 -- 1.4
Peritoneum 0 0.8 NC NC -- NC 0 0.4 NC NC -- NC 0 0.3 NC NC -- NC
Without specification 19 22.7 0.8 0.5 -- 1.3 12 12.0 1.0 0.5 -- 1.7 7 10.8 0.7 0.3 -- 1.3
Pulmonary 6 8.8 0.7 0.3 -- 1.5 1 4.1 NC NC -- NC 5 4.7 1.1 0.3 -- 2.5
COPD 70 58.9 1.2 0.9 -- 1.5 35 34.5 1.0 0.7 -- 1.4 35 24.5 1.4 1.0 -- 2.0
Pneumoconioses 0 0.9 NC NC -- NC 0 0.9 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 16 11.0 1.5 0.8 -- 2.4 14 5.9 2.4 * 1.3 -- 4.0 2 5.1 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 6A
Asbestos-Related Mortality
Easthampton, MA
1979-1998
Total Males Females
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Asbestos-Related Health Outcomes:  Incidence Data 
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Asbestos Related Health Outcomes
Incidence Data ICD-O2
ICD-O1 (82-90 
Data)
Excluding 
Types
Maligant neoplasms of the digestive organs
C150:C218, 
C260:C269
150.0-154.8,159-
159.9 M-9590:9989
Maligant neoplasms of the respiratory system and 
intrathoracic organs C320:C399 161-165.9 M-9590:9989
Maligant neoplasms of the lung and bronchus C340:C349 162-162.9 M-9590:9989
Maligant neoplasms of peritoneum, retroperitoneum and 
pleura (inlcudes mesothelioma) C480:C488, C384
158-158.9, 160-
163.9 M-9590:9989
Maligant neoplasms of mesothelioma  M9050:9053 M9050-M9053
Asbestos- Related Health Outcomes: Incidence Data
WHO. International Classification of Diseases for Oncology, Revision 2. World Health Organization.                    
Geneva: Switzerland, 1990.
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Asbestos-Related Health Outcomes:  Mortality Data 
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Other diseases of the respiratory system
Asbestos- related health outcomes: Mortality Data
199
415-417
490-496
Asbestos Related Health Outcomes
Mortality Data ICD-9 Groupings
Maligant neoplasms without specification of site
Disease of pulmonary circulation
Chronic obstructive pulmonary disease
Maligant neoplasms of the digestive organs
Maligant neoplasms of the respiratory system and intrathoracic organs
Maligant neoplasmsof the lung and bronchus
150-154, 159
161-165
162.2-162.9
500-505Pneumoconioses and other lung diseases due to external agents
Maligant neoplasms of peritoneum, retroperitoneum and pleura (inlcudes 
mesothelioma)
WHO. International Classification of Diseases, Injuries and Causes of Death, Revision 9. 
World Health Organization. Geneva: Switzerland, 1978.
158,163
501
510-519
Asbestosis
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Appendix C 
 
A third statistic called a standardized rate ratio (SRR) was also computed in this Health Statistics 
Review.  As stated earlier, comparisons of SIRs or SMRs between communities or census tracts 
are not possible because of differences in the age and gender distributions of the communities.  
Comparing the cancer or mortality experience of communities can be achieved, however, by 
using a common population distribution (a reference population) to calculate an SRR.   
 
An SRR is the ratio of the number of expected deaths (or cancer cases) in the reference 
population, based on the cancer or mortality rates in the community, to the number of observed 
deaths (or cancer cases) in the reference population.  The expected number of deaths or cancer 
cases is the weighted sum of the community’s rates, where the weights used are the stratum-
specific (i.e., age, gender) population distribution of the reference population (i.e., from the 
National Center for Health Statistics and SEER).  Because each SRR is weighted by the 
population distribution of a particular reference population, SRRs may be validly compared 
across communities. 
 
An SRR of exactly one indicates that a community’s mortality (or incidence) is equal to that of 
the reference population, based on the cancer or mortality rates of the community. An SRR 
greater than one indicates that a community’s mortality (or incidence) is higher than that of the 
reference population while an SRR less than one indicates that a community’s mortality (or 
incidence) is lower than that of the reference population. 
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All
Census Tracts SRR SRR SRR
Digestive 1.1 0.9 -- 1.2 1.2 1.0 -- 1.5 0.9 0.7 -- 1.2
Respiratory 1.4 * 1.2 -- 1.6 1.3 * 1.1 -- 1.5 1.7 * 1.4 -- 2.0
Lung & Bronchus 1.4 * 1.2 -- 1.6 1.2 1.0 -- 1.5 1.6 * 1.4 -- 2.0
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of cases < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.1
Asbestos-Related Cancer Incidence
Billerica, MA
1986-1995
Total Males Females
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Census Tract
SRR SRR SRR
CT 3161
Digestive 1.0 0.8 -- 1.4 1.2 0.8 -- 1.9 1.0 0.7 -- 1.5
Respiratory 1.5 * 1.2 -- 1.8 1.3 0.9 -- 1.8 2.0 * 1.5 -- 2.8
Lung & Bronchus 1.5 * 1.2 -- 1.8 1.3 0.9 -- 1.9 2.1 * 1.5 -- 2.8
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3162
Digestive 1.0 0.8 -- 1.4 1.1 0.7 -- 1.6 1.0 0.6 -- 1.6
Respiratory 1.5 * 1.1 -- 2.0 1.5 * 1.1 -- 2.2 1.4 0.9 -- 2.2
Lung & Bronchus 1.4 1.0 -- 1.9 1.4 1.0 -- 2.1 1.2 0.8 -- 2.0
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3163
Digestive 1.0 0.7 -- 1.5 2.6 * 1.6 -- 4.1 0.5 0.2 -- 1.1
Respiratory 1.3 0.9 -- 1.8 1.1 0.7 -- 1.9 1.5 0.9 -- 2.4
Lung & Bronchus 1.3 0.9 -- 1.8 1.2 0.7 -- 2.0 1.5 0.9 -- 2.4
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3164
Digestive 1.1 0.7 -- 1.8 1.0 0.5 -- 1.7 1.2 0.6 -- 2.5
Respiratory 1.2 0.8 -- 1.8 0.9 0.5 -- 1.6 1.7 1.0 -- 2.9
Lung & Bronchus 1.1 0.7 -- 1.7 0.8 0.5 -- 1.6 1.5 0.9 -- 2.6
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3165
Digestive 0.9 0.6 -- 1.3 1.3 0.8 -- 2.0 0.6 0.3 -- 1.1
Respiratory 1.4 1.0 -- 1.8 1.4 1.0 -- 2.1 1.4 0.9 -- 2.2
Lung & Bronchus 1.4 1.0 -- 1.9 1.5 1.0 -- 2.2 1.5 0.9 -- 2.3
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of cases < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not calculated
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
Total Males Females
TABLE C.1A 
Asbestos-Related Cancer Incidence
Billerica, MA
1986-1995
 113
All
Census Tracts SRR SRR SRR
Digestive 1.2 1.0 -- 1.4 1.3 1.0 -- 1.5 1.1 0.9 -- 1.4
Respiratory 1.3 * 1.1 -- 1.4 1.2 1.0 -- 1.4 1.5 * 1.2 -- 1.7
Lung & Bronchus 1.3 * 1.1 -- 1.4 1.2 1.0 -- 1.3 1.5 * 1.2 -- 1.8
Peritoneum 3.0 * 1.4 -- 6.3 4.3 * 1.9 -- 9.8 NC NC -- NC
Without specification 1.0 0.8 -- 1.3 1.0 0.7 -- 1.5 1.0 0.7 -- 1.5
Pulmonary 0.6 0.4 -- 1.1 0.4 * 0.2 -- 0.9 0.8 0.4 -- 1.5
COPD 1.2 * 1.1 -- 1.4 1.3 * 1.1 -- 1.6 1.2 1.0 -- 1.5
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.3 0.9 -- 1.8 1.6 1.0 -- 2.4 1.1 0.7 -- 1.8
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.2
Asbestos-Related Mortality
Billerica, MA
1979-1998
Total Males Females
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Census Tract
SRR SRR SRR
CT 3161
Digestive 0.9 0.7 -- 1.3 1.2 0.8 -- 1.9 0.9 0.6 -- 1.3
Respiratory 1.2 1.0 -- 1.5 1.3 1.0 -- 1.7 1.4 1.0 -- 1.9
Lung & Bronchus 1.3 1.0 -- 1.5 1.3 1.0 -- 1.7 1.4 1.0 -- 1.9
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 0.9 0.6 -- 1.5 0.6 0.2 -- 1.7 1.4 0.8 -- 2.4
Pulmonary 0.5 0.2 -- 1.2 NC NC -- NC NC NC -- NC
COPD 1.0 0.8 -- 1.4 1.4 0.9 -- 2.2 1.1 0.7 -- 1.7
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.6 0.9 -- 2.7 3.0 * 1.6 -- 5.8 NC NC -- NC
CT 3162
Digestive 1.4 0.9 -- 1.9 1.2 0.7 -- 2.0 1.5 0.9 -- 2.5
Respiratory 1.4 * 1.1 -- 1.8 1.5 1.0 -- 2.0 1.3 0.9 -- 1.9
Lung & Bronchus 1.4 * 1.1 -- 1.9 1.5 * 1.1 -- 2.1 1.3 0.8 -- 1.9
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.0 0.6 -- 1.7 1.5 0.8 -- 2.8 NC NC -- NC
Pulmonary 1.1 0.5 -- 2.5 NC NC -- NC NC NC -- NC
COPD 1.7 * 1.2 -- 2.3 1.7 * 1.1 -- 2.5 1.6 1.0 -- 2.6
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
CT 3163
Digestive 1.1 0.8 -- 1.7 1.2 0.7 -- 2.1 1.1 0.6 -- 2.2
Respiratory 1.1 0.8 1.6 1.0 0.7 -- 1.6 1.3 0.8 -- 2.1
Lung & Bronchus 1.2 0.9 -- 1.6 1.1 0.7 -- 1.7 1.3 0.8 -- 2.2
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.1 0.5 -- 2.2 NC NC -- NC 1.1 0.5 -- 2.6
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 1.6 * 1.1 -- 2.3 1.5 0.9 -- 2.6 1.8 * 1.1 -- 3.2
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.3 0.6 -- 2.9 NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.2A
Asbestos-Related Mortality
Billerica, MA
1979-1998
Total Males Females
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Census Tract
SRR SRR SRR
CT 3164
Digestive 1.2 0.8 -- 1.8 1.1 0.6 -- 2.0 1.3 0.6 -- 2.7
Respiratory 1.2 0.9 -- 1.7 1.0 0.6 -- 1.5 1.6 1.0 -- 2.7
Lung & Bronchus 1.1 0.8 -- 1.6 0.8 0.5 -- 1.3 1.7 1.0 -- 2.7
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.2 0.5 -- 2.7 NC NC -- NC NC NC -- NC
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 0.6 0.3 -- 1.1 0.5 0.2 -- 1.1 0.7 0.3 -- 1.7
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.7 0.7 -- 4.5 NC NC -- NC NC NC -- NC
CT 3165
Digestive 1.4 1.0 -- 1.8 1.8 * 1.2 -- 2.6 1.1 0.7 -- 1.7
Respiratory 1.3 * 1.1 -- 1.7 1.2 0.9 -- 1.7 1.6 * 1.2 -- 2.3
Lung & Bronchus 1.3 1.0 -- 1.6 1.2 0.8 -- 1.6 1.6 * 1.1 -- 2.3
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.1 0.6 -- 1.9 1.5 0.7 -- 3.0 0.8 0.3 -- 1.9
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 1.2 0.9 -- 1.7 1.6 * 1.1 -- 2.4 0.9 0.5 -- 1.5
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.4 0.7 -- 2.8 NC NC -- NC 2.3 * 1.1 -- 5.2
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE C.2B
Asbestos-Related Mortality
Billerica, MA
1979-1998
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All
Census Tracts SRR SRR SRR
Digestive 1.0 0.9 -- 1.1 1.1 0.9 -- 1.2 1.0 0.9 -- 1.1
Respiratory 0.9 0.8 -- 1.0 0.9 0.8 -- 1.0 1.0 0.8 -- 1.1
Lung & Bronchus 0.9 0.8 -- 1.0 0.9 0.8 -- 1.0 0.9 0.8 -- 1.1
Peritoneum 0.5 0.2 -- 1.0 0.6 0.2 -- 1.5 NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of cases < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.3
Asbestos-Related Cancer Incidence
Cambridge, MA
1986-1995
Total Males Females
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Census Tract
SRR SRR SRR
CT 3521
Digestive 1.2 0.7 -- 1.9 0.9 0.4 -- 1.7 1.7 0.9 -- 3.1
Respiratory 1.3 0.9 -- 2.1 1.3 0.8 -- 2.3 1.4 0.7 -- 3.0
Lung & Bronchus 1.3 0.8 -- 2.0 1.3 0.7 -- 2.3 1.2 0.5 -- 2.7
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3522
Digestive 1.5 1.0 -- 2.2 1.4 0.8 -- 2.7 1.6 1.0 -- 2.5
Respiratory 1.3 0.8 -- 2.1 1.5 0.8 -- 3.0 0.9 0.5 -- 1.7
Lung & Bronchus 1.3 0.8 -- 2.2 1.7 0.9 -- 3.3 0.7 0.3 -- 1.5
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3523
Digestive 0.6 0.3 -- 1.2 NC NC -- NC 0.7 0.3 -- 1.7
Respiratory 0.9 0.5 -- 1.6 0.9 0.3 -- 2.3 1.1 0.5 -- 2.4
Lung & Bronchus 0.7 0.4 -- 1.4 NC NC -- NC 0.9 0.4 -- 2.2
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3524
Digestive NC NC -- NC NC NC -- NC NC NC -- NC
Respiratory 0.5 0.2 -- 1.4 NC NC -- NC NC NC -- NC
Lung & Bronchus NC NC -- NC NC NC -- NC NC NC -- NC
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3525
Digestive 1.2 0.8 -- 2.0 1.2 0.7 -- 2.3 1.3 0.6 -- 2.7
Respiratory 1.1 0.7 -- 1.8 1.1 0.6 -- 2.1 1.0 0.4 -- 2.2
Lung & Bronchus 1.1 0.6 -- 1.8 1.0 0.5 -- 2.1 1.0 0.5 -- 2.3
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of cases < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.3A
Asbestos-Related Cancer Incidence
Cambridge, MA
1986-1995
Total Males Females
 118
Census Tract
SRR SRR SRR
CT 3526
Digestive 1.0 0.6 -- 1.6 1.0 0.5 -- 2.1 1.0 0.5 -- 2.0
Respiratory 1.1 0.7 -- 1.7 0.9 0.5 -- 1.7 1.2 0.6 -- 2.5
Lung & Bronchus 1.0 0.6 -- 1.7 0.9 0.5 -- 1.8 1.1 0.5 -- 2.4
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3527
Digestive 0.9 0.5 -- 1.5 1.0 0.5 -- 2.2 0.8 0.3 -- 1.8
Respiratory 0.4 * 0.2 -- 0.8 0.5 0.2 -- 1.1 NC NC -- NC
Lung & Bronchus 0.3 * 0.2 -- 0.8 NC NC -- NC NC NC -- NC
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3528
Digestive 1.0 0.5 -- 2.0 0.7 0.3 -- 1.5 1.3 0.5 -- 3.5
Respiratory 1.4 0.8 -- 2.3 1.1 0.6 -- 2.0 1.9 0.8 -- 4.5
Lung & Bronchus 1.4 0.8 -- 2.5 1.1 0.6 -- 2.1 2.0 0.8 -- 4.7
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3529
Digestive 1.0 0.6 -- 1.6 NC NC -- NC 1.6 0.9 -- 2.7
Respiratory 1.5 1.0 -- 2.3 1.7 0.8 -- 3.6 2.5 * 1.4 -- 4.3
Lung & Bronchus 1.5 1.0 -- 2.3 1.6 0.7 -- 3.8 2.6 * 1.5 -- 4.5
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3530
Digestive 0.8 0.5 -- 1.2 0.7 0.4 -- 1.4 0.9 0.5 -- 1.6
Respiratory 1.9 * 1.4 -- 2.6 2.4 * 1.7 -- 3.3 1.2 0.6 -- 2.4
Lung & Bronchus 1.8 * 1.3 -- 2.5 2.3 * 1.6 -- 3.3 1.2 0.6 -- 2.4
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of cases < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE C.3B
Asbestos-Related Cancer Incidence
Cambridge, MA
1986-1995
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Census Tract
SRR SRR SRR
CT 3531
Digestive 0.4 * 0.2 -- 0.9 NC NC -- NC NC NC -- NC
Respiratory 0.9 0.5 -- 1.5 1.1 0.6 -- 2.1 NC NC -- NC
Lung & Bronchus 0.9 0.5 -- 1.6 1.0 0.5 -- 2.1 NC NC -- NC
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3532
Digestive 0.8 0.5 -- 1.4 0.7 0.3 -- 1.4 1.0 0.5 -- 2.0
Respiratory 1.0 0.6 -- 1.5 0.9 0.4 -- 1.8 1.2 0.6 -- 2.4
Lung & Bronchus 0.9 0.5 -- 1.5 0.8 0.4 -- 1.7 1.1 0.5 -- 2.2
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3533
Digestive 0.9 0.6 -- 1.5 0.6 0.3 -- 1.4 1.3 0.7 -- 2.4
Respiratory 0.8 0.5 -- 1.3 0.8 0.4 -- 1.5 0.8 0.3 -- 1.7
Lung & Bronchus 0.7 0.4 -- 1.2 0.7 0.4 -- 1.5 NC NC -- NC
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3534
Digestive 0.7 0.4 -- 1.5 1.0 0.4 -- 2.2 NC NC -- NC
Respiratory 0.9 0.5 -- 1.6 1.0 0.5 -- 2.3 NC NC -- NC
Lung & Bronchus 0.9 0.4 -- 1.7 1.2 0.5 -- 2.5 NC NC -- NC
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3535
Digestive 1.4 0.9 -- 2.2 1.1 0.5 -- 2.3 1.7 1.0 -- 3.0
Respiratory 0.4 * 0.1 -- 0.9 NC NC -- NC NC NC -- NC
Lung & Bronchus 0.4 * 0.2 -- 0.9 NC NC -- NC NC NC -- NC
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of cases < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.3C
Asbestos-Related Cancer Incidence
Cambridge, MA 
Total Males Females
1986-1995
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Census Tract
SRR SRR SRR
CT 3536
Digestive 1.0 0.6 -- 1.7 1.0 0.5 -- 2.3 1.1 0.5 -- 2.1
Respiratory 0.5 0.2 -- 1.0 NC NC -- NC NC NC -- NC
Lung & Bronchus 0.5 0.3 -- 1.1 NC NC -- NC NC NC -- NC
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3537
Digestive 1.1 0.7 -- 1.6 1.0 0.5 -- 1.8 1.2 0.7 -- 2.2
Respiratory 0.6 0.3 -- 1.0 0.5 0.2 -- 1.1 0.8 0.3 -- 1.8
Lung & Bronchus 0.6 0.4 -- 1.1 0.6 0.3 -- 1.2 0.8 0.3 -- 1.9
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3538
Digestive 1.3 0.8 -- 2.0 1.6 0.9 -- 2.8 1.1 0.6 -- 2.0
Respiratory 1.0 0.6 -- 1.6 0.8 0.4 -- 1.7 1.3 0.6 -- 2.7
Lung & Bronchus 1.1 0.6 -- 1.7 0.9 0.4 -- 1.9 1.4 0.7 -- 2.8
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3539
Digestive 1.0 0.5 -- 2.1 1.6 0.7 -- 3.8 NC NC -- NC
Respiratory NC NC -- NC NC NC -- NC NC NC -- NC
Lung & Bronchus NC NC -- NC NC NC -- NC NC NC -- NC
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3540
Digestive 0.8 0.5 -- 1.2 0.8 0.4 -- 1.6 0.8 0.4 -- 1.6
Respiratory 0.4 * 0.2 -- 0.8 NC NC -- NC 0.6 0.3 -- 1.5
Lung & Bronchus 0.4 * 0.2 -- 0.9 NC NC -- NC 0.6 0.3 -- 1.6
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of cases < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE C.3D
Asbestos-Related Cancer Incidence
Cambridge, MA
1986-1995
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Census Tract
SRR SRR SRR
CT 3541
Digestive 1.1 0.7 -- 1.6 0.8 0.4 -- 1.5 1.4 0.9 -- 2.3
Respiratory 0.8 0.5 -- 1.3 0.4 0.2 -- 1.0 1.4 0.8 -- 2.4
Lung & Bronchus 0.7 0.5 -- 1.2 NC NC -- NC 1.4 0.8 -- 2.4
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3542
Digestive 1.0 0.7 -- 1.5 1.1 0.7 -- 1.9 1.0 0.6 -- 1.6
Respiratory 0.5 * 0.3 -- 0.8 0.5 0.3 -- 1.0 0.5 0.2 -- 1.0
Lung & Bronchus 0.5 * 0.3 -- 0.9 0.5 0.3 -- 1.1 0.5 0.2 -- 1.1
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3543
Digestive 1.2 0.8 -- 1.6 1.3 0.8 -- 2.0 1.2 0.8 -- 1.9
Respiratory 1.0 0.7 -- 1.5 0.9 0.5 -- 1.6 1.4 0.8 -- 2.4
Lung & Bronchus 1.0 0.7 -- 1.5 0.9 0.5 -- 1.7 1.3 0.8 -- 2.3
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3544
Digestive 1.1 0.6 -- 1.9 0.8 0.3 -- 2.0 1.5 0.7 -- 2.8
Respiratory 1.0 0.5 -- 1.7 NC NC -- NC 1.8 0.8 -- 3.7
Lung & Bronchus 1.0 0.6 -- 1.9 NC NC -- NC 1.9 0.9 -- 3.9
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3545
Digestive 0.8 0.4 -- 1.4 1.7 0.8 -- 3.6 NC NC -- NC
Respiratory 0.6 0.3 -- 1.2 0.7 0.3 -- 1.5 NC NC -- NC
Lung & Bronchus 0.7 0.4 -- 1.3 0.8 0.3 -- 1.7 NC NC -- NC
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of cases < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE C.3E
Asbestos-Related Cancer Incidence
Cambridge, MA
1986-1995
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Census Tract
SRR SRR SRR
CT 3546
Digestive 1.3 0.9 -- 1.7 1.7 * 1.2 -- 2.6 0.9 0.5 -- 1.5
Respiratory 0.8 0.6 -- 1.2 0.6 0.3 -- 1.2 1.1 0.7 -- 1.9
Lung & Bronchus 0.8 0.6 -- 1.3 0.6 0.3 -- 1.2 1.2 0.7 -- 2.0
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3547
Digestive 1.2 0.8 -- 2.0 1.4 0.8 2.6 1.0 0.5 -- 1.9
Respiratory 0.8 0.5 -- 1.4 0.8 0.4 -- 1.9 0.9 0.4 -- 2.2
Lung & Bronchus 0.9 0.5 -- 1.6 0.9 0.4 -- 2.1 1.0 0.4 -- 2.3
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3548
Digestive 1.1 0.7 -- 1.9 1.0 0.5 -- 2.3 1.3 0.6 -- 2.5
Respiratory 1.4 0.9 -- 2.3 1.5 0.8 -- 2.7 1.4 0.6 -- 3.2
Lung & Bronchus 1.4 0.8 -- 2.3 1.3 0.7 -- 2.6 1.5 0.7 -- 3.3
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3549
Digestive 1.6 * 1.2 -- 2.2 1.6 * 1.1 2.4 1.1 0.7 -- 1.9
Respiratory 1.1 0.8 -- 1.5 1.2 0.8 -- 1.9 0.9 0.5 -- 1.6
Lung & Bronchus 1.0 0.7 -- 1.5 1.2 0.7 -- 1.9 0.8 0.5 -- 1.6
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 3550
Digestive 1.3 0.9 -- 1.9 1.4 0.8 -- 2.3 1.3 0.8 -- 2.2
Respiratory 0.8 0.5 -- 1.3 1.0 0.6 -- 1.8 0.7 0.3 -- 1.5
Lung & Bronchus 0.7 0.4 -- 1.2 0.8 0.4 -- 1.6 0.7 0.3 -- 1.5
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of cases < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE C.3F
Asbestos-Related Cancer Incidence
Cambridge, MA
1986-1995
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All
Census Tracts SRR SRR SRR
Digestive 1.3 * 1.2 -- 1.4 1.3 * 1.2 -- 1.5 1.3 * 1.1 -- 1.4
Respiratory 1.0 1.0 -- 1.1 1.1 1.0 -- 1.1 1.1 1.0 -- 1.3
Lung & Bronchus 1.0 1.0 -- 1.1 1.0 0.9 -- 1.1 1.2 1.0 -- 1.3
Peritoneum 1.7 0.9 -- 3.0 1.8 0.8 -- 4.0 1.7 0.7 -- 4.0
Without specification 1.2 * 1.1 -- 1.4 1.4 * 1.1 -- 1.6 1.1 0.9 -- 1.3
Pulmonary 1.0 0.8 -- 1.2 1.1 0.8 -- 1.5 0.9 0.7 -- 1.2
COPD 0.8 * 0.8 -- 0.9 0.9 0.8 -- 1.0 0.9 0.8 -- 1.0
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.0 0.8 -- 1.2 1.3 1.0 -- 1.7 0.8 0.6 -- 1.1
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public 
95% CI 95% CI 95% CI
TABLE C.4
Asbestos-Related Mortality
Cambridge, MA
1979-1998
Totals Males Females
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Census Tract
SRR SRR SRR
CT 3521
Digestive 1.7 * 1.1 -- 2.5 1.6 0.9 -- 2.8 1.8 1.0 -- 3.4
Respiratory 1.0 0.6 -- 1.5 1.0 0.6 -- 1.6 1.1 0.6 -- 2.2
Lung & Bronchus 1.0 0.7 -- 1.5 1.0 0.6 -- 1.7 1.1 0.6 -- 2.2
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.4 0.6 -- 2.9 NC NC -- NC NC NC -- NC
Pulmonary 2.8 * 1.2 -- 6.4 NC NC -- NC NC NC -- NC
COPD 1.3 0.8 -- 2.2 1.5 0.7 -- 3.0 1.4 0.7 -- 3.0
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
CT 3522
Digestive 1.2 0.8 -- 1.9 1.6 0.9 -- 2.6 0.9 0.5 -- 1.8
Respiratory 1.5 * 1.1 -- 2.0 1.7 * 1.1 -- 2.5 1.3 0.7 -- 2.3
Lung & Bronchus 1.5 * 1.1 -- 2.0 1.7 * 1.1 -- 2.5 1.3 0.7 -- 2.3
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.7 1.0 -- 2.9 2.6 * 1.4 -- 5.0 1.1 0.5 -- 2.7
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 1.4 1.0 -- 1.9 1.0 0.6 -- 1.8 1.8 * 1.1 -- 2.8
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
CT 3523
Digestive 1.2 0.7 -- 2.0 1.1 0.5 -- 2.3 1.3 0.6 -- 2.8
Respiratory 0.9 0.6 -- 1.4 1.2 0.6 -- 2.2 0.7 0.3 -- 1.6
Lung & Bronchus 0.9 0.5 -- 1.4 1.1 0.6 -- 2.1 0.7 0.3 -- 1.6
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 2.2 * 1.1 -- 4.3 3.7 * 1.8 -- 7.6 0.3 0.0 -- 2.2
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 1.0 0.5 -- 1.8 1.1 0.4 -- 2.5 1.1 0.5 -- 2.8
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.4A
Asbestos-Related Mortality
Cambridge, MA
1979-1998
Total Males Females
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Census Tract
SRR SRR SRR
CT 3524
Digestive 2.2 * 1.1 -- 4.3 5.9 * 2.6 -- 13.6 NC NC -- NC
Respiratory 1.1 0.7 -- 2.0 1.7 0.9 -- 3.4 NC NC -- NC
Lung & Bronchus 1.2 0.7 -- 2.0 1.8 0.9 -- 3.6 0.9 0.3 -- 2.5
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification NC NC -- NC NC NC -- NC NC NC -- NC
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 1.1 0.5 -- 2.3 NC NC -- NC NC NC -- NC
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
CT 3525
Digestive 1.8 * 1.2 -- 2.7 1.6 0.9 -- 2.8 1.9 * 1.1 -- 3.4
Respiratory 1.7 * 1.3 -- 2.4 1.8 * 1.3 -- 2.7 1.4 0.7 -- 2.7
Lung & Bronchus 1.6 * 1.1 -- 2.2 1.7 * 1.1 -- 2.5 1.2 0.6 -- 2.5
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.6 0.8 -- 3.2 NC NC -- NC 2.0 0.8 -- 4.9
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 1.4 0.8 -- 2.2 1.0 0.5 -- 2.0 2.1 * 1.1 -- 3.9
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
CT 3526
Digestive 1.2 0.7 -- 2.0 1.2 0.6 -- 2.3 1.1 0.5 -- 2.2
Respiratory 1.1 0.7 -- 1.6 1.0 0.6 -- 1.6 1.3 0.7 -- 2.3
Lung & Bronchus 1.1 0.7 -- 1.6 1.0 0.6 -- 1.6 1.3 0.7 -- 2.3
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.5 0.8 -- 2.9 2.2 1.0 -- 4.6 NC NC -- NC
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 0.7 0.3 -- 1.3 NC NC -- NC 0.8 0.3 -- 1.9
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE C.4B
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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Census Tract
SRR SRR SRR
CT 3527
Digestive 1.0 0.6 -- 1.7 1.2 0.6 -- 2.3 1.0 0.5 2.2
Respiratory 0.9 0.6 -- 1.3 1.2 0.8 -- 2.0 0.6 0.3 1.3
Lung & Bronchus 0.9 0.6 -- 1.3 1.3 0.8 -- 2.0 0.6 0.3 1.3
Peritoneum NC NC -- NC NC NC -- NC NC NC NC
Without specification 1.3 0.6 -- 2.7 1.9 0.8 -- 4.5 NC NC NC
Pulmonary NC NC -- NC NC NC -- NC NC NC NC
COPD 0.6 0.3 -- 1.2 0.9 0.4 -- 1.8 NC NC NC
Pneumoconioses NC NC -- NC NC NC -- NC NC NC NC
Asbestosis NC NC -- NC NC NC -- NC NC NC NC
Other respiratory NC NC -- NC NC NC -- NC NC NC NC
CT 3528
Digestive 2.0 * 1.3 -- 3.1 2.7 * 1.6 -- 4.6 1.1 0.5 -- 2.3
Respiratory 2.0 * 1.4 -- 3.0 2.1 * 1.3 -- 3.5 2.1 * 1.1 -- 3.9
Lung & Bronchus 2.0 * 1.3 -- 3.0 2.0 * 1.2 -- 3.4 2.1 * 1.1 -- 4.0
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.4 0.6 -- 2.9 NC NC -- NC NC NC -- NC
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 2.0 * 1.1 -- 3.4 2.1 * 1.1 -- 4.3 1.8 0.8 -- 4.1
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
CT 3529
Digestive 1.7 * 1.2 -- 2.5 2.3 * 1.2 -- 4.6 1.7 1.0 -- 3.0
Respiratory 1.4 1.0 -- 2.0 1.5 0.9 -- 2.7 2.0 * 1.2 -- 3.4
Lung & Bronchus 1.3 0.9 -- 1.8 1.4 0.8 -- 2.6 1.9 * 1.1 -- 3.2
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 2.5 * 1.4 -- 4.3 2.2 1.0 -- 4.8 2.7 * 1.3 -- 5.6
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 1.1 0.7 -- 1.7 1.5 0.7 -- 3.1 1.0 0.5 -- 2.0
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.1 0.4 -- 2.8 NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE C.4C
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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Census Tract
SRR SRR SRR
CT 3530
Digestive 1.4 1.0 -- 2.0 1.7 * 1.1 -- 2.6 1.3 0.8 -- 2.0
Respiratory 1.8 * 1.4 -- 2.3 2.2 * 1.6 -- 2.9 1.1 0.6 2.0
Lung & Bronchus 1.8 * 1.4 -- 2.3 2.2 * 1.6 -- 2.9 1.1 0.6 -- 2.0
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.1 0.6 -- 2.2 1.7 0.8 -- 3.6 NC NC -- NC
Pulmonary 2.1 1.0 -- 4.5 3.0 * 1.2 -- 7.6 NC NC -- NC
COPD 1.2 0.8 -- 1.8 1.1 0.7 -- 1.9 1.3 0.8 -- 2.3
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 2.4 * 1.1 -- 5.5 NC NC -- NC NC NC -- NC
CT 3531
Digestive 0.5 0.2 -- 1.2 0.9 0.4 -- 2.2 NC NC -- NC
Respiratory 0.8 0.5 -- 1.3 1.2 0.7 -- 2.0 NC NC -- NC
Lung & Bronchus 0.8 0.5 -- 1.3 1.1 0.6 -- 2.0 NC NC NC
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.0 0.4 -- 2.2 NC NC -- NC NC NC -- NC
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 0.8 0.5 -- 1.6 1.1 0.5 -- 2.6 NC NC -- NC
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
CT 3532
Digestive 1.3 0.9 -- 2.0 1.1 0.5 -- 2.3 1.7 1.0 -- 2.8
Respiratory 1.1 0.8 -- 1.5 1.1 0.7 -- 1.8 1.1 0.6 -- 1.9
Lung & Bronchus 1.1 0.7 -- 1.5 1.1 0.7 -- 1.8 1.1 0.6 -- 2.0
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 0.9 0.4 -- 2.0 NC NC -- NC NC NC -- NC
Pulmonary 2.4 1.0 -- 5.3 NC NC -- NC NC NC -- NC
COPD 0.8 0.5 -- 1.4 0.9 0.4 -- 2.1 1.0 0.5 -- 2.0
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.7 0.7 -- 4.0 NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE C.4D
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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Census Tract
SRR SRR SRR
CT 3533
Digestive 2.2 * 1.6 -- 3.0 2.0 * 1.2 -- 3.2 2.6 * 1.7 -- 4.0
Respiratory 1.2 0.8 -- 1.6 1.3 0.8 -- 1.9 1.1 0.6 -- 1.9
Lung & Bronchus 1.1 0.8 -- 1.6 1.2 0.8 -- 1.9 1.0 0.6 -- 1.9
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.9 * 1.1 -- 3.3 NC NC -- NC 3.2 * 1.7 -- 5.8
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 1.2 0.8 -- 1.9 1.1 0.6 -- 2.0 1.5 0.8 -- 2.6
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
CT 3534
Digestive 1.2 0.7 -- 2.2 NC NC -- NC 1.7 0.8 -- 3.6
Respiratory 0.8 0.4 -- 1.4 0.7 0.4 -- 1.5 0.9 0.4 -- 2.2
Lung & Bronchus 0.8 0.5 -- 1.4 0.8 0.4 -- 1.6 0.9 0.4 -- 2.3
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification NC NC -- NC NC NC -- NC NC NC -- NC
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 0.6 0.3 -- 1.4 NC NC -- NC NC NC -- NC
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
CT 3535
Digestive 1.3 0.8 -- 2.2 1.4 0.7 -- 2.9 1.4 0.7 -- 2.8
Respiratory 0.8 0.5 -- 1.3 0.8 0.4 -- 1.5 0.9 0.5 -- 1.9
Lung & Bronchus 0.8 0.5 -- 1.3 0.8 0.4 1.5 1.0 0.5 -- 1.9
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.0 0.4 -- 2.4 NC NC -- NC NC NC -- NC
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 1.2 0.7 -- 2.0 1.3 0.6 -- 2.7 1.3 0.6 -- 2.7
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE C.4E
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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Census Tract
SRR SRR SRR
CT 3536
Digestive 0.6 0.3 -- 1.2 NC NC -- NC 0.8 0.4 -- 1.8
Respiratory 0.3 * 0.2 -- 0.7 NC NC -- NC NC NC -- NC
Lung & Bronchus 0.3 * 0.2 -- 0.7 NC NC -- NC NC NC -- NC
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 0.8 0.4 -- 2.0 2.1 0.9 -- 4.8 NC NC -- NC
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD NC NC -- NC NC NC -- NC NC NC -- NC
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
CT 3537
Digestive 0.9 0.6 -- 1.4 0.8 0.4 -- 1.5 1.1 0.6 -- 2.1
Respiratory 0.7 0.5 -- 1.1 0.6 0.3 -- 1.0 1.1 0.6 -- 2.0
Lung & Bronchus 0.8 0.5 -- 1.1 0.6 0.3 -- 1.1 1.1 0.6 -- 2.0
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 0.9 0.4 -- 2.0 NC NC -- NC NC NC -- NC
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 0.8 0.5 -- 1.3 0.8 0.4 -- 1.6 0.9 0.4 -- 1.7
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 0.9 0.4 -- 2.4 NC NC -- NC NC NC -- NC
CT 3538
Digestive 1.7 * 1.2 -- 2.6 1.6 0.9 -- 2.9 1.9 * 1.1 -- 3.2
Respiratory 1.4 1.0 -- 1.9 1.4 0.9 -- 2.2 1.4 0.8 -- 2.5
Lung & Bronchus 1.3 0.9 -- 1.9 1.3 0.8 -- 2.1 1.5 0.9 -- 2.5
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.6 0.9 -- 3.0 2.0 0.8 -- 4.7 1.2 0.5 -- 3.1
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 0.6 0.3 -- 1.1 0.7 0.3 -- 1.4 0.6 0.3 -- 1.5
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE C.4F
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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Census Tract
SRR SRR SRR
CT 3539
Digestive 1.1 0.5 -- 2.3 NC NC -- NC NC NC -- NC
Respiratory 0.4 0.2 -- 1.0 NC NC -- NC NC NC -- NC
Lung & Bronchus 0.5 0.2 -- 1.0 NC NC -- NC NC NC -- NC
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification NC NC -- NC NC NC -- NC NC NC -- NC
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD NC NC -- NC NC NC -- NC NC NC -- NC
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
CT 3540
Digestive 1.0 0.6 -- 1.6 0.6 0.3 -- 1.5 1.5 * 2.5 -- 5.0
Respiratory 0.4 * 0.3 -- 0.7 NC NC -- NC 1.0 0.5 -- 1.7
Lung & Bronchus 0.5 * 0.3 -- 0.8 NC NC -- NC 1.0 0.6 -- 1.8
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.0 0.5 -- 2.0 NC NC -- NC 1.3 0.5 -- 3.1
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 0.6 0.3 -- 1.0 0.6 0.2 -- 1.3 0.7 0.3 -- 1.5
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.2 0.5 -- 2.9 NC NC -- NC NC NC -- NC
CT 3541
Digestive 1.3 0.9 -- 1.9 1.2 0.7 -- 2.0 1.5 1.0 -- 2.4
Respiratory 0.6 * 0.4 -- 0.9 0.5 * 0.3 -- 0.9 0.9 0.5 -- 1.5
Lung & Bronchus 0.6 0.4 -- 1.0 0.5 * 0.3 -- 0.9 0.9 0.5 -- 1.5
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 0.9 0.4 -- 1.9 NC NC -- NC 1.7 0.8 3.7
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 0.4 * 0.2 -- 0.7 NC NC -- NC 0.7 0.4 -- 1.4
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE C.4G
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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Census Tract
SRR SRR SRR
CT 3542
Digestive 0.6 0.4 -- 1.0 0.3 * 0.1 -- 0.8 1.0 0.6 -- 1.7
Respiratory 0.6 * 0.4 -- 0.9 0.7 0.4 -- 1.0 0.6 0.3 -- 1.1
Lung & Bronchus 0.6 * 0.4 -- 0.9 0.6 0.4 -- 1.0 0.6 0.3 -- 1.1
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 0.6 0.3 -- 1.3 1.0 0.5 -- 2.3 NC NC -- NC
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 0.5 * 0.3 -- 0.8 0.4 * 0.2 -- 0.8 0.7 0.4 -- 1.4
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 0.7 0.3 -- 1.7 NC NC -- NC NC NC -- NC
CT 3543
Digestive 1.4 1.0 -- 1.9 1.4 0.9 -- 2.2 1.5 1.0 -- 2.3
Respiratory 1.3 1.0 -- 1.6 1.0 0.7 -- 1.5 1.8 * 1.2 -- 2.7
Lung & Bronchus 1.3 1.0 -- 1.7 1.0 0.7 -- 1.5 1.9 * 1.3 -- 2.8
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 0.6 0.3 -- 1.2 0.8 0.3 -- 2.1 0.7 0.2 -- 1.8
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 0.6 0.4 -- 1.0 0.5 0.3 -- 1.1 0.9 0.5 -- 1.5
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.1 0.6 -- 2.3 NC NC -- NC 1.2 0.5 -- 3.2
CT 3544
Digestive 1.7 * 1.1 -- 2.6 1.4 0.7 -- 3.0 2.1 * 1.2 -- 3.6
Respiratory 1.4 1.0 -- 2.1 1.0 0.5 -- 1.8 2.4 * 1.4 -- 4.0
Lung & Bronchus 1.5 1.0 -- 2.2 1.0 0.6 -- 1.9 2.4 * 1.4 -- 4.1
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification NC NC -- NC NC NC -- NC NC NC -- NC
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 0.9 0.5 -- 1.7 1.4 0.6 -- 3.3 1.1 0.4 -- 2.6
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE C.4H
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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Census Tract
SRR SRR SRR
CT 3545
Digestive 0.8 0.4 -- 1.4 0.7 0.3 -- 1.7 0.8 0.4 -- 1.9
Respiratory 0.7 0.4 -- 1.2 0.6 0.3 -- 1.2 1.0 0.5 -- 2.1
Lung & Bronchus 0.7 0.4 -- 1.2 0.6 0.3 -- 1.2 1.0 0.5 -- 2.1
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification NC NC -- NC NC NC -- NC NC NC -- NC
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 0.4 0.2 -- 1.0 NC NC -- NC NC NC -- NC
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
CT 3546
Digestive 1.4 * 1.1 -- 2.0 1.9 * 1.3 -- 2.8 1.1 0.7 -- 1.8
Respiratory 1.0 0.8 -- 1.4 1.0 0.6 -- 1.4 1.4 0.9 -- 2.0
Lung & Bronchus 1.0 0.8 -- 1.3 0.9 0.6 -- 1.4 1.3 0.9 -- 2.0
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.3 0.8 -- 2.3 2.1 * 1.1 -- 4.1 NC NC -- NC
Pulmonary 1.6 0.8 -- 3.4 NC NC -- NC 1.9 0.8 -- 4.6
COPD 0.7 0.4 -- 1.1 0.6 0.3 -- 1.2 0.9 0.5 -- 1.7
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.6 0.9 -- 2.9 2.4 * 1.1 -- 5.2 NC NC -- NC
CT 3547
Digestive 1.4 0.9 -- 2.2 1.1 0.5 -- 2.3 1.7 1.0 -- 3.0
Respiratory 1.0 0.7 -- 1.5 1.0 0.5 -- 1.7 1.3 0.7 -- 2.4
Lung & Bronchus 1.1 0.7 -- 1.6 1.0 0.6 -- 1.8 1.3 0.7 -- 2.4
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification NC NC -- NC NC NC -- NC NC NC -- NC
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 1.3 0.8 -- 2.0 1.5 0.8 -- 2.8 1.3 0.7 -- 2.4
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE C.4I
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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Census Tract
SRR SRR SRR
CT 3548
Digestive 1.6 * 1.1 -- 2.6 2.0 * 1.1 -- 3.9 1.7 0.9 -- 3.1
Respiratory 1.6 * 1.2 -- 2.3 2.0 * 1.3 -- 3.1 1.6 0.8 -- 3.0
Lung & Bronchus 1.6 * 1.1 -- 2.3 1.9 * 1.2 -- 2.9 1.6 0.9 -- 3.1
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 2.2 * 1.1 -- 4.1 2.5 1.0 -- 6.2 2.0 0.8 -- 5.1
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 1.0 0.6 -- 1.7 1.2 0.6 -- 2.4 0.8 0.3 -- 1.8
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
CT 3549
Digestive 1.8 * 1.3 -- 2.3 1.8 * 1.2 -- 2.6 1.8 * 1.2 -- 2.8
Respiratory 1.2 0.9 -- 1.5 1.0 0.7 -- 1.5 1.5 1.0 -- 2.3
Lung & Bronchus 1.2 0.9 -- 1.6 1.1 0.7 -- 1.5 1.6 1.1 -- 2.3
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.2 0.7 -- 2.0 1.1 0.5 -- 2.7 1.3 0.6 -- 2.7
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 1.0 0.7 -- 1.4 1.2 0.8 -- 1.9 0.7 0.3 -- 1.4
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.4 0.6 -- 2.9 NC NC -- NC NC NC -- NC
CT 3550
Digestive 0.9 0.6 -- 1.5 1.3 0.8 -- 2.3 0.7 0.3 -- 1.5
Respiratory 1.3 0.9 -- 1.7 1.3 0.9 -- 2.0 1.6 1.0 -- 2.4
Lung & Bronchus 1.2 0.9 -- 1.7 1.2 0.8 -- 1.9 1.6 1.0 -- 2.4
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.5 0.9 -- 2.5 2.0 0.9 -- 4.3 1.2 0.6 -- 2.4
Pulmonary 1.0 0.4 -- 2.3 NC NC -- NC NC NC -- NC
COPD 1.1 0.8 -- 1.6 1.6 1.0 -- 2.6 0.8 0.5 -- 1.4
Pneumoconiosis NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public
Total Males Females
95% CI 95% CI 95% CI
TABLE C.4J
Asbestos-Related Mortality
Cambridge, MA
1979-1998
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All
Census Tracts SRR SRR SRR
Digestive 1.0 0.8 -- 1.1 1.1 0.9 -- 1.4 0.8 0.6 -- 1.0
Respiratory 0.8 0.7 -- 1.0 0.8 0.6 -- 1.0 1.0 0.7 -- 1.3
Lung & Bronchus 0.9 0.7 -- 1.0 0.8 0.6 -- 1.0 1.0 0.7 -- 1.3
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of cases < 5.
SRR = Standardized Rate Ratio 95% CI95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.5
Asbestos-Related Cancer Incidence
Easthampton, MA
1986-1995
Total Males Females
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Census Tract
SRR SRR SRR
CT 8223
Digestive 1.0 0.7 -- 1.3 1.2 0.8 -- 1.7 0.8 0.5 -- 1.2
Respiratory 0.9 0.6 -- 1.2 0.8 0.5 -- 1.3 1.0 0.6 -- 1.7
Lung & Bronchus 0.9 0.6 -- 1.2 0.8 0.5 -- 1.2 1.1 0.6 -- 1.8
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 8224
Digestive 0.9 0.7 -- 1.2 1.1 0.8 -- 1.5 0.7 0.5 -- 1.1
Respiratory 0.9 0.7 -- 1.1 0.8 0.5 -- 1.1 1.0 0.7 -- 1.5
Lung & Bronchus 0.9 0.7 -- 1.1 0.8 0.5 -- 1.1 1.0 0.7 -- 1.5
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of cases < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.5A
Asbestos-Related Cancer Incidence
Easthampton, MA
1986-1995
Total Males Females
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All
Census Tracts SRR SRR SRR
Digestive 1.1 0.9 -- 1.3 1.4 * 1.1 -- 1.7 0.9 0.6 -- 1.2
Respiratory 1.1 0.9 -- 1.2 1.0 0.8 -- 1.2 1.2 1.0 -- 1.5
Lung & Bronchus 1.1 0.9 -- 1.2 1.0 0.8 -- 1.2 1.2 1.0 -- 1.5
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.0 0.7 -- 1.3 0.9 0.6 -- 1.4 1.0 0.7 -- 1.6
Pulmonary 1.0 0.6 -- 1.7 1.1 0.5 -- 2.4 0.9 0.5 -- 1.9
COPD 1.0 0.8 -- 1.2 1.0 0.8 -- 1.3 1.0 0.8 -- 1.4
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.6 * 1.1 -- 2.2 2.4 * 1.6 -- 3.6 0.7 0.3 -- 1.6
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.6
Asbestos-Related Mortality
Easthampton, MA
1979-1998
Total Males Females
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Census Tract
SRR SRR SRR
CT 8223
Digestive 1.3 1.0 -- 1.7 1.7 * 1.2 -- 2.3 0.9 0.5 -- 1.4
Respiratory 1.2 1.0 -- 1.5 1.0 0.8 -- 1.4 1.6 * 1.1 -- 2.2
Lung & Bronchus 1.2 0.9 -- 1.5 1.0 0.8 -- 1.4 1.6 * 1.1 -- 2.2
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.1 0.7 -- 1.8 0.7 0.3 -- 1.5 1.6 0.9 -- 2.7
Pulmonary 1.3 0.7 -- 2.5 2.2 1.0 -- 5.1 NC NC -- NC
COPD 0.8 0.6 -- 1.1 0.9 0.6 -- 1.3 0.6 0.4 -- 1.1
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.8 1.0 -- 3.1 2.6 * 1.4 -- 4.9 NC NC -- NC
CT 8224
Digestive 1.0 0.8 -- 1.3 1.1 0.8 -- 1.5 0.9 0.6 -- 1.4
Respiratory 1.0 0.8 -- 1.2 0.9 0.7 -- 1.2 1.1 0.8 -- 1.5
Lung & Bronchus 1.0 0.8 -- 1.2 0.9 0.7 -- 1.2 1.1 0.8 -- 1.5
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 0.8 0.5 -- 1.3 1.1 0.6 -- 1.9 0.6 0.3 -- 1.3
Pulmonary 0.7 0.3 -- 1.5 NC NC -- NC 1.0 0.4 -- 2.5
COPD 1.2 1.0 -- 1.5 1.1 0.8 -- 1.5 1.5 1.0 -- 2.0
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.4 0.9 -- 2.4 2.3 * 1.4 -- 4.0 NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.6A
Asbestos-Related Mortality
Easthampton, MA
1979-1998
Total Males Females
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All
Census Tracts SRR SRR SRR
Digestive 1.0 0.9 -- 1.2 1.2 0.9 -- 1.4 0.9 0.7 -- 1.2
Respiratory 0.8 * 0.7 -- 0.9 0.7 * 0.5 -- 0.9 0.9 0.7 -- 1.2
Lung & Bronchus 0.8 * 0.6 -- 0.9 0.7 * 0.5 -- 0.9 0.9 0.7 -- 1.2
Peritoneum 1.7 0.8 -- 3.7 NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of cases < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.7
Asbestos-Related Cancer Incidence
Hingham, MA
1986-1995
Total Males Females
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Census Tract
SRR SRR SRR
CT 5011.01
Digestive 0.9 0.6 -- 1.4 1.1 0.6 -- 1.8 0.8 0.5 -- 1.5
Respiratory 0.7 0.5 -- 1.1 0.8 0.5 -- 1.3 0.7 0.4 -- 1.4
Lung & Bronchus 0.7 0.5 -- 1.1 0.8 0.5 -- 1.4 0.6 0.3 -- 1.3
Peritoneum NC NC -- NC NC NC NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 5011.02
Digestive 1.2 1.0 -- 1.6 1.2 0.9 -- 1.7 1.2 0.9 -- 1.8
Respiratory 1.0 0.8 -- 1.3 0.8 0.5 -- 1.2 1.4 1.0 -- 2.0
Lung & Bronchus 0.9 0.7 -- 1.2 0.7 0.4 -- 1.0 1.3 0.9 -- 2.0
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
CT 5012
Digestive 1.0 0.8 -- 1.2 1.2 0.9 -- 1.6 0.8 0.5 -- 1.2
Respiratory 0.7 * 0.5 -- 0.9 0.6 * 0.4 -- 0.9 0.7 0.4 -- 1.1
Lung & Bronchus 0.7 * 0.5 -- 0.9 0.7 0.4 -- 1.0 0.7 0.4 -- 1.2
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of cases < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.7A
Asbestos-Related Cancer Incidence
Hingham, MA
1986-1995
Total Male Female
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All
Census Tracts SRR SRR SRR
Digestive 1.1 1.0 -- 1.3 1.2 0.9 -- 1.4 1.1 0.9 -- 1.4
Respiratory 0.8 0.7 -- 1.0 0.7 * 0.6 -- 0.9 1.1 0.9 -- 1.3
Lung & Bronchus 0.8 0.7 -- 1.0 0.7 * 0.6 -- 0.9 1.1 0.9 -- 1.4
Peritoneum 6.3 * 3.5 -- 11.5 7.2 * 3.4 -- 15.3 NC NC -- NC
Without specification 1.0 0.8 -- 1.3 0.8 0.6 -- 1.3 1.1 0.8 -- 1.6
Pulmonary 0.4 * 0.2 -- 0.8 0.5 0.2 -- 1.3 NC NC -- NC
COPD 0.9 0.7 -- 1.0 0.8 0.6 -- 1.1 0.9 0.7 -- 1.2
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.0 0.7 -- 1.5 1.5 0.9 -- 2.3 0.6 0.3 -- 1.2
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.8
Asbestos-Related Mortality
Hingham, MA
1979-1998
Total Males Females
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Census Tract
SRR SRR SRR
CT 5011.01
Digestive 1.0 0.7 1.5 1.1 0.6 1.8 1.0 0.5 1.8
Respiratory 0.8 0.6 1.1 0.8 0.5 1.2 1.0 0.6 1.6
Lung & Bronchus 0.9 0.6 1.2 0.8 0.5 1.2 1.0 0.6 1.7
Peritoneum NC NC NC NC NC NC NC NC NC
Without specification 1.2 0.7 2.1 0.9 0.4 2.3 1.5 0.7 3.3
Pulmonary NC NC NC NC NC NC NC NC NC
COPD 0.6 0.4 1.0 0.4 * 0.2 0.8 1.0 0.5 1.8
Pneumoconioses NC NC NC NC NC NC NC NC NC
Asbestosis NC NC NC NC NC NC NC NC NC
Other respiratory 2.3 * 1.3 4.2 2.7 * 1.3 5.6 NC NC NC
CT 5011.02
Digestive 1.3 1.0 1.7 1.3 0.9 1.8 1.4 1.0 2.0
Respiratory 1.0 0.8 1.2 0.8 0.6 1.1 1.3 0.9 1.8
Lung & Bronchus 1.0 0.8 1.2 0.8 0.6 1.1 1.3 0.9 1.8
Peritoneum 8.1 * 3.3 19.4 NC NC NC NC NC NC
Without specification 0.8 0.5 1.4 0.5 0.2 1.3 1.1 0.6 2.1
Pulmonary NC NC NC NC NC NC NC NC NC
COPD 1.1 0.8 1.5 1.1 0.7 1.6 1.2 0.8 1.8
Pneumoconioses NC NC NC NC NC NC NC NC NC
Asbestosis NC NC NC NC NC NC NC NC NC
Other respiratory NC NC NC NC NC NC NC NC NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.8A
Asbestos-Related Mortality
Hingham, MA
1979-1998
Total Males Females
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Census Tract
SRR SRR SRR
CT 5012
Digestive 1.0 0.8 1.2 1.1 0.8 1.6 1.0 0.7 1.4
Respiratory 0.7 * 0.6 0.9 0.6 * 0.4 0.8 1.0 0.7 1.4
Lung & Bronchus 0.7 * 0.6 0.9 0.6 * 0.4 0.8 1.1 0.8 1.5
Peritoneum 6.2 * 2.5 15.1 NC NC NC NC NC NC
Without specification 1.1 0.7 1.6 1.0 0.6 1.8 1.1 0.6 1.9
Pulmonary 0.6 0.3 1.4 NC NC NC NC NC NC
COPD 0.8 0.6 1.0 0.9 0.6 1.3 0.8 0.5 1.2
Pneumoconioses NC NC NC NC NC NC NC NC NC
Asbestosis NC NC NC NC NC NC NC NC NC
Other respiratory 0.9 0.5 1.6 1.5 0.7 3.0 NC NC NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
TABLE C.8B
Asbestos-Related Mortality
Hingham, MA
1979-1998
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All
Census Tracts SRR SRR SRR
Digestive 1.1 0.8 -- 1.5 1.3 0.9 -- 1.8 0.9 0.5 -- 1.6
Respiratory 0.8 0.6 -- 1.1 0.7 0.4 -- 1.1 1.0 0.6 -- 1.6
Lung & Bronchus 0.7 0.5 -- 1.0 0.6 0.4 -- 1.0 0.8 0.5 -- 1.5
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Mesothelioma NC NC -- NC NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of cases < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.9
Asbestos-Related Cancer Incidence
Westminster, MA
1986-1995
Total Males Females
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All
Census Tracts SRR SRR SRR
Digestive 1.0 0.7 -- 1.4 0.9 0.6 -- 1.4 1.1 0.7 -- 1.9
Respiratory 0.9 0.7 -- 1.2 0.8 0.5 -- 1.1 1.0 0.6 -- 1.6
Lung & Bronchus 0.9 0.7 -- 1.2 0.8 0.5 -- 1.2 1.0 0.6 -- 1.6
Peritoneum NC NC -- NC NC NC -- NC NC NC -- NC
Without specification 1.2 0.7 -- 2.0 1.6 0.8 -- 2.9 0.7 0.3 -- 1.7
Pulmonary NC NC -- NC NC NC -- NC NC NC -- NC
COPD 0.9 0.6 -- 1.4 0.8 0.4 -- 1.3 1.1 0.6 -- 2.1
Pneumoconioses NC NC -- NC NC NC -- NC NC NC -- NC
Asbestosis NC NC -- NC NC NC -- NC NC NC -- NC
Other respiratory 1.5 0.7 -- 3.3 NC NC -- NC NC NC -- NC
Note: SRRs and 95% CI are not calculated when observed number of deaths < 5.
SRR = Standardized Rate Ratio 95% CI = 95% Confidence Interval
* = Statistical significance NC = Not Calculated
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE C.10
Asbestos-Related Mortality
Westminster, MA
1979-1998
Total Males Females
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Appendix D 
Cancer Incidence and Mortality Data Review 
Hingham, Massachusetts 
 
As noted in the main text, after an extensive records review, the USEPA concluded that there 
was no evidence of an industrial facility in Hingham that accepted or processed vermiculite ore 
(W. Toland, USEPA, personal communication, 2005).  The USEPA record review included 
Hingham business registration records and building permits dating back to the 1930s; 
Massachusetts Secretary of State, Corporate Registration Division records; and personal visits to 
the Hingham Fire and Police Departments as well as the Hingham Public Library and Senior 
Citizens Center.  Because this health statistics review began before it was confirmed that no 
asbestos facility existed in Hingham, we conducted a health statistics review for Hingham and 
have included the results here.   
 
Cancer Incidence in the Town of Hingham (Table D.1) 
 
Over the 10 year period of 1986 - 1995, the incidence of the five types of cancer evaluated 
occurred about as expected, with a few exceptions.  Cancers of the lung/bronchus occurred 
statistically significantly less often than expected in the town of Hingham overall.  In addition, 
the incidence of peritoneum, retroperitoneum and pleura cancers was slightly higher than 
expected (6 diagnoses observed vs. 3.5 diagnoses expected); the elevation, however, was not 
statistically significant.  Townwide, three cases of mesothelioma were reported while 
approximately two cases were expected.  More Hingham residents were diagnosed with digestive 
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system cancers than was expected (160 diagnoses observed vs. 151.6 diagnoses expected) but the 
elevation was not statistically significant.  (See Table D.1 for a summary of results). 
 
Cancer Incidence in Hingham Census Tracts (Table D.2) 
 
The town of Hingham is geographically subdivided into three census tracts (CTs 5011.01, 
5011.02 and CT 5012).  CTs 5011.01 and 5011.02 are located in the northern portion of the town 
with CT 5011.01 bordering the towns of Hull and Cohasset.  CT 5011.02 borders the town of 
Weymouth.  CT 5012 is the largest of the three census tracts and encompasses the southern half 
of the town of Hingham.  The location and boundaries of Hingham’s census tracts are illustrated 
in Figure D.1.   
 
Review of incidence rates for the CTs within Hingham showed that most of the cancer types 
investigated occurred at approximately equal to or less than expected rates.  In CT 5012, which 
includes the southern half of Hingham, lung and bronchus cancer occurred statistically 
significantly less often than expected.  In a few instances, the number of observed cancers was 
greater than the number expected but the elevations were not statistically significant.  In CT 
5011.02, four diagnoses of peritoneum cancers were observed while approximately one 
diagnosis was expected.  Cancer incidence data for Hingham’s census tracts are summarized in 
Table D.2. 
 
Cancer Incidence Risk Factor Information 
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Tobacco Use  
 
A review of tobacco use among individuals diagnosed with lung and bronchus cancer in 
Hingham indicated that 80% were current or former smokers at the time of their diagnosis.  The 
remaining 7% were non-smokers while smoking history was unknown for 13% of those with 
respiratory system cancers.  Of those individuals with a known smoking status, 92% reported to 
be current or former smokers at the time of their diagnosis. 
 
Of the six individuals diagnosed with cancers of the peritoneum, retroperitoneum and pleura, 
three were current or former smokers while three reportedly had never smoked at the time of 
their diagnosis.  The three individuals diagnosed in Hingham with mesothelioma were current or 
former smokers at the time of their diagnosis. 
 
Occupational History Review 
 
Occupational history information for the six individuals diagnosed with cancers of the 
peritoneum, retroperitoneum and pleura indicated that one individual reported at the time of their 
diagnosis occupational exposure to asbestos.  The other five individuals reported either job titles 
not typically related to asbestos exposure or limited information regarding their occupational 
history.  One of the three individuals diagnosed with mesothelioma reported an occupation with 
an increased risk of asbestos exposure. 
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Review of occupational information for females diagnosed with cancers of the respiratory system 
in CT 5011.02, where more diagnoses were observed than expected, revealed that one woman 
reported at the time of her diagnosis a positive occupational exposure to asbestos while the 
remaining 27 women reported job titles not associated with an increased risk of asbestos 
exposure. 
 
Mortality in the Town of Hingham (Table D.3) 
 
Over the 20-year time period 1979-1998, townwide mortality was statistically significantly 
elevated, compared to national rates, for cancers of the peritoneum, retroperitoneum, and pleura 
(including mesothelioma) (11 deaths observed vs. 1.7 deaths expected). These types of cancer 
occurred more often than expected among both males and females in Hingham.  Cause of death 
for seven of the 11 individuals was reported as mesothelioma.  Deaths due to lung and bronchus 
cancer occurred statistically significantly less often than expected (186 deaths observed vs. 229.5 
deaths expected). This was mainly due to a statistically significant decrease in reported deaths 
from lung and bronchus cancer among males (101 deaths observed vs. 149.7 deaths expected).  
During this 20-year time period, diseases of the pulmonary circulation also occurred statistically 
significantly less often then expected townwide (9 deaths observed vs. 20.6 deaths expected). 
 
Mortality in Hingham Census Tracts (Tables D.4 and D.5) 
 
For most causes of death, mortality rates in Hingham’s three CTs were about as expected, with a 
few exceptions.  During the 20-year period, deaths due to cancers of the peritoneum, 
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retroperitoneum and pleura (including mesothelioma) occurred statistically significantly more 
often then expected in CT 5011.02 (5 deaths observed vs. 0.6 deaths expected) and in CT 5012 
(5 deaths observed vs. 0.8 deaths expected).  In CT 5011.01, there was one death reported from 
cancers of the peritoneum, retroperitoneum and pleura and two deaths from asbestosis, while less 
than one death from each type was expected. 
 
During 1979-1998, deaths due to COPD occurred statistically significant less often than expected 
among males in CT 5011.01(6 deaths observed vs. 16.0 deaths expected). 
 
In CT 5011.02, deaths due to digestive organ cancers occurred statistically significantly more 
often than expected (63 deaths observed vs. 47.5 deaths expected).   
 
During 1979-1998, deaths due to lung and bronchus cancer occurred statistically significantly 
less often than expected in CT 5012, due to a decrease among males in this census tract.  Among 
males, there were 34 less deaths than expected (37 deaths observed vs. 70.8 deaths expected).  
 
Mortality Risk Factor Information 
 
Occupational History Review 
 
A review of occupational information on the death certificates of the 565 individuals of Hingham 
who died of one of the causes of death evaluated revealed that 7% (40 of 565) had job titles with 
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an increased risk of exposure to asbestos.  The remaining 93% (525 of 565) had job titles not 
thought to be associated with occupational exposure to asbestos.  
 
Between 1979-1998, the townwide mortality rate for peritoneum cancers (including 
mesothelioma) was statistically significantly elevated.  This elevation occurred mainly in two 
CTs:  5011.02 and 5012.  Of the 11 individuals diagnosed with peritoneum cancers in Hingham, 
seven of the 11 deaths were reportedly due to mesothelioma. The death certificates of two 
individuals, both of whom died of mesothelioma, indicated possible occupational exposure to 
asbestos.  Shipbuilding in southeastern Massachusetts was one of the primary industries during 
the period around World War II.  Asbestos was used in the shipbuilding process to insulate 
boilers, steam pipes, and hot water pipes. 
 
Of the two individuals who died of asbestosis in Hingham, one death certificate did not indicate 
possible occupational exposure to asbestos while the second death certificate identified the 
individual as a laborer, and therefore work with asbestos cannot be ruled out. 
 
Mortality from cancers of the digestive organs occurred statistically significantly more often than 
expected in CT 5011.02.   Sixty-three deaths were reported due to digestive system cancers 
among males and females in this census tract while approximately 48 deaths were expected.  
Occupational history information reported on death certificates for these individuals indicated 
that the majority (76%; 48 of 63) had job titles not typically associated with exposure to 
asbestos.  However, three males in this census tract reportedly had possible occupational 
exposures to asbestos.  Death certificates for the remaining 19% of the individuals who died of 
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digestive organ cancers in this census tract did not indicate a potential for occupational exposure 
to asbestos. 
 
Hingham Geographic Distribution 
 
In addition to determining incidence and mortality rates, a qualitative evaluation of the point 
pattern of selected diseases and causes of death was conducted.  Place of residence at the time of 
diagnosis or death was mapped to assess any possible geographic concentration of disease. 
 
Place of residence at diagnosis for the six individuals diagnosed with peritoneum cancers (two of 
whom were also diagnosed with mesothelioma) and the other Hingham resident diagnosed with 
mesothelioma were mapped.  Four of these individuals lived in CT 5011.02, one lived in 
5011.01, and one lived in 5012.  None of the addresses appeared to be concentrated in any one 
area or neighborhood. 
 
Between 1979-1998, the mortality rate for cancers of the peritoneum, retroperitoneum, pleura 
(including mesothelioma) was statistically significantly elevated in Hingham and two of its 
census tracts (CT 5011.02 and 5012).  A review of the geographic distribution of residence at 
death for the 11 individuals who died of these causes revealed no apparent concentration of 
deaths in any particular neighborhood of Hingham.   
 
Although the two individuals who died of asbestosis in Hingham both were residents of CT 
5011.01 at the time of their death, they did not live in close proximity to one another. 
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Conclusions 
 
• Over the 10-year period of 1986-1995, the incidence of the five types of cancer evaluated 
occurred about as expected in Hingham, with a few exceptions.  The incidence of 
peritoneum cancers was slightly higher than expected (6 diagnoses observed vs. 3.5 
diagnoses expected) but the elevation was not statistically significant.  Cancer of the lung 
and bronchus occurred significantly less often than expected townwide. 
• Review of incidence rates for the CTs within Hingham showed that most of the cancer 
types investigated occurred at approximately equal to or less than expected rates.  In CT 
5011.02, however, more diagnoses from peritoneum cancers occurred than were 
expected.  It is possible that smoking and occupational exposure to asbestos may have 
played a role in the incidence of this type of cancer in Hingham.   
• The pattern of mortality rates for the selected causes of death was very similar to the 
pattern of incidence rates in Hingham.  Over the 20-year time period 1979-1998, 
townwide mortality was statistically significantly elevated for peritoneum cancers 
(including mesothelioma).  Eleven deaths were reported (seven due to mesothelioma) 
while approximately two deaths were expected.  Ten of the eleven deaths occurred in two 
of Hingham’s three CTs.  The death certificates of two of the 11 individuals, both of 
whom died of mesothelioma, indicated a possible occupational exposure to asbestos.  (No 
smoking history information is available through death certificates.)  Shipbuilding in 
southeastern Massachusetts was one of the primary industries during the period around 
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World War II.  Asbestos was used in the shipbuilding process to insulate boilers, steam 
pipes, and hot water pipes.   
• The mortality rate for lung and bronchus cancer was significantly lower than expected 
townwide, as was the incidence rate for this type of cancer. 
• Review of the geographic distribution of the residences of those in Hingham who died of 
selected causes of death (lung and bronchus cancer, peritoneum cancers, and asbestosis) 
did not reveal any apparent spatial patterns at the neighborhood or census tract level that 
could not be attributed to such factors as higher population density.   
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All
Census Tracts Obs Exp SIR Obs Exp SIR Obs Exp SIR
Digestive 160 151.6 1.1 1.0 -- 1.2 92 79.5 1.2 0.9 -- 1.4 68 71.7 1.0 0.7 -- 1.2
Respiratory 120 152.9 0.8 * 0.7 -- 0.9 67 94.4 0.7 * 0.6 -- 0.9 53 57.8 0.9 0.7 -- 1.2
Lung & Bronchus 107 139.7 0.8 * 0.6 -- 0.9 58 84.1 0.7 * 0.5 -- 0.9 49 55.0 0.9 0.7 -- 1.2
Peritoneum 6 3.5 1.7 0.6 -- 3.7 4 2.2 NC NC -- NC 2 1.3 NC NC -- NC
Mesothelioma 3 2.2 NC NC -- NC 2 1.7 NC NC -- NC 1 0.5 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE D.1
Asbestos-Related Cancer Incidence
Hingham, MA
1986-1995
Total Males Females
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Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
CT 5011.01
Digestive 26 29.1 0.9 0.6 -- 1.3 15 15.6 1.0 0.5 -- 1.6 11 13.4 0.8 0.4 -- 1.5
Respiratory 22 29.5 0.8 0.5 -- 1.1 14 18.4 0.8 0.4 -- 1.3 8 11.1 0.7 0.3 -- 1.4
Lung & Bronchus 20 27.0 0.7 0.5 -- 1.2 13 16.4 0.8 0.4 -- 1.4 7 10.6 0.7 0.3 -- 1.4
Peritoneum 0 0.7 NC NC -- NC 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC
Mesothelioma 1 0.4 NC NC -- NC 1 0.3 NC NC -- NC 0 0.1 NC NC -- NC
CT 5011.02
Digestive 63 51.7 1.2 0.9 -- 1.6 33 26.5 1.2 0.9 -- 1.8 30 24.7 1.2 0.8 -- 1.7
Respiratory 53 52.2 1.0 0.8 -- 1.3 25 31.3 0.8 0.5 -- 1.2 28 20.3 1.4 0.9 -- 2.0
Lung & Bronchus 45 47.8 0.9 0.7 -- 1.3 19 27.9 0.7 0.4 -- 1.1 26 19.3 1.4 0.9 -- 2.0
Peritoneum 4 1.2 NC NC -- NC 3 0.7 NC NC -- NC 1 0.5 NC NC -- NC
Mesothelioma 2 0.8 NC NC -- NC 1 0.6 NC NC -- NC 1 0.2 NC NC -- NC
CT 5012
Digestive 71 70.9 1.0 0.8 -- 1.3 44 37.4 1.2 0.9 -- 1.6 27 33.6 0.8 0.5 -- 1.2
Respiratory 45 71.2 0.6 * 0.5 -- 0.9 28 44.8 0.6 * 0.4 -- 0.9 17 26.4 0.6 0.4 -- 1.0
Lung & Bronchus 42 65.0 0.7 * 0.5 -- 0.9 26 39.8 0.7 * 0.4 -- 1.0 16 25.1 0.6 0.4 -- 1.0
Peritoneum 2 1.6 NC NC -- NC 1 1.0 NC NC -- NC 1 0.6 NC NC -- NC
Mesothelioma 0 1.0 NC NC -- NC 0 0.8 NC NC -- NC 0 0.2 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE D.2
Asbestos-Related Cancer Incidence
Hingham, MA
1986-1995
Total Males Females
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All
Census Tracts Obs Exp SMR Obs Exp SMR Obs Exp SMR
Digestive 155 140.5 1.1 0.9 -- 1.3 82 74.6 1.1 0.9 -- 1.4 73 65.6 1.1 0.9 -- 1.4
Respiratory 194 237.7 0.8 * 0.7 -- 0.9 109 156.1 0.7 * 0.6 -- 0.8 85 81.2 1.1 0.8 -- 1.3
Lung & Bronchus 186 229.5 0.8 * 0.7 -- 0.9 101 149.7 0.7 * 0.6 -- 0.8 85 79.4 1.1 0.9 -- 1.3
Peritoneum 11 1.7 6.3 * 3.2 -- 11.3 7 1.0 7.1 * 2.8 -- 14.6 4 0.8 NC NC -- NC
Without specification 53 53.9 1.0 0.7 -- 1.3 23 27.3 0.8 0.5 -- 1.3 30 26.5 1.1 0.8 -- 1.6
Pulmonary 9 20.6 0.4 * 0.2 -- 0.8 5 9.1 0.6 0.2 -- 1.3 4 11.4 NC NC -- NC
COPD 118 139.3 0.9 0.7 -- 1.0 62 77.1 0.8 0.6 -- 1.0 56 60.0 0.9 0.7 -- 1.2
Pneumoconioses 3 2.1 NC NC -- NC 2 2.0 NC NC -- NC 1 0.1 NC NC -- NC
Asbestosis 2 0.4 NC NC -- NC 1 0.4 NC NC -- NC 1 0.0 NC NC -- NC
Other respiratory 26 26.0 1.0 0.7 -- 1.5 18 13.1 1.4 0.8 -- 2.2 8 12.7 0.6 0.3 -- 1.2
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source:  Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE D.3
Asbestos-Related Mortality
Hingham, MA
1979-1998
Total Males Females
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 5011.01
Digestive 26 26.8 1.0 0.6 -- 1.4 15 14.8 1.0 0.6 -- 1.7 11 12.1 0.9 0.5 -- 1.6
Respiratory 36 45.9 0.8 0.6 -- 1.1 25 30.5 0.8 0.5 -- 1.2 14 15.6 0.9 0.5 -- 1.5
Lung & Bronchus 38 44.3 0.9 0.6 -- 1.2 24 29.3 0.8 0.5 -- 1.2 14 15.2 0.9 0.5 -- 1.5
Peritoneum 1 0.3 NC NC -- NC 1 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Without specification 12 10.3 1.2 0.6 -- 2.0 5 5.4 0.9 0.3 -- 2.2 7 4.9 1.4 0.6 -- 2.9
Pulmonary 0 3.9 NC NC -- NC 0 1.8 NC NC -- NC 0 2.1 NC NC -- NC
COPD 17 27.2 0.6 0.4 -- 1.0 6 16.0 0.4 * 0.1 -- 0.8 11 11.3 1.0 0.5 -- 1.7
Pneumoconioses 2 0.4 NC NC -- NC 1 0.4 NC NC -- NC 1 0.0 NC NC -- NC
Asbestosis 2 0.1 NC NC -- NC 1 0.1 NC NC -- NC 1 0.0 NC NC -- NC
Other respiratory 11 4.9 2.3 * 1.1 -- 4.0 7 2.6 2.7 * 1.1 -- 5.5 4 2.3 NC NC -- NC
CT 5011.02
Digestive 63 47.5 1.3 * 1.0 -- 1.7 32 24.9 1.3 0.9 -- 1.8 31 22.3 1.4 0.9 -- 2.0
Respiratory 76 81.2 0.9 0.7 -- 1.2 41 51.8 0.8 0.6 -- 1.1 35 28.4 1.2 0.9 -- 1.7
Lung & Bronchus 74 78.4 0.9 0.7 -- 1.2 39 49.7 0.8 0.6 -- 1.1 35 27.7 1.3 0.9 -- 1.8
Peritoneum 5 0.6 8.4 * 2.7 -- 19.6 3 0.3 NC NC -- NC 2 0.3 NC NC -- NC
Without specification 15 18.3 0.8 0.5 -- 1.4 5 9.1 0.5 0.2 -- 1.3 10 9.0 1.1 0.5 -- 2.0
Pulmonary 3 7.0 NC NC -- NC 2 3.1 NC NC -- NC 1 3.9 NC NC -- NC
COPD 52 47.6 1.1 0.8 -- 1.4 28 26.1 1.1 0.7 -- 1.5 24 20.6 1.2 0.7 -- 1.7
Pneumoconioses 0 0.7 NC NC -- NC 0 0.7 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 4 8.8 NC NC -- NC 3 4.4 NC NC -- NC 1 4.3 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source:  Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE D.4
Asbestos-Related Mortality
Hingham, MA
1979-1998
Total Males Females
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Census Tract
Obs Exp SMR Obs Exp SMR Obs Exp SMR
CT 5012
Digestive 65 66.2 1.0 0.8 -- 1.3 35 34.9 1.0 0.7 -- 1.4 30 31.3 1.0 0.6 -- 1.4
Respiratory 78 110.6 0.7 * 0.6 -- 0.9 42 73.9 0.6 * 0.4 -- 0.8 36 37.3 1.0 0.7 -- 1.3
Lung & Bronchus 73 106.8 0.7 * 0.5 -- 0.9 37 70.8 0.5 * 0.4 -- 0.7 36 36.5 1.0 0.7 -- 1.4
Peritoneum 5 0.8 6.2 * 2.0 -- 14.4 3 0.5 NC NC -- NC 2 0.4 NC NC -- NC
Without specification 26 25.4 1.0 0.7 -- 1.5 13 12.9 1.0 0.5 -- 1.7 13 12.5 1.0 0.6 -- 1.8
Pulmonary 6 9.8 0.6 0.2 -- 1.3 3 4.3 NC NC -- NC 3 5.5 NC NC -- NC
COPD 49 64.5 0.8 0.6 -- 1.0 28 35.0 0.8 0.5 -- 1.2 21 28.0 0.8 0.5 -- 1.1
Pneumoconioses 1 1.0 NC NC -- NC 1 0.9 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 11 12.3 0.9 0.4 -- 1.6 8 6.1 1.3 0.6 -- 2.6 3 6.2 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source:  Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE D.5
Asbestos-Related Mortality
Hingham, MA
1979-1998
Total Males Females
95% CI 95% CI 95% CI
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APPENDIX E 
 
Cancer Incidence and Mortality Data Review - Westminster 
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Appendix E 
Cancer Incidence and Mortality Data Review 
Westminster, MA 
 
As noted in the main text, the USEPA concluded that there was no evidence that the Advance 
Coating Company in eastern Westminster ever accepted or processed vermiculite ore (D. 
McIntyre, USEPA, personal communication, 2005) (see Figure E.1).  Although on the USEPA 
original list of facilities that may have received vermiculite ore from the Libby, Montana, mine, 
the agency’s investigation found no evidence that this was true.  Because this health statistics 
review began before it was concluded that vermiculite ore had not been shipped to the 
Westminster facility, we conducted a health statistics review for Westminster and have included 
the results here. 
 
Asbestos-Related Cancer Incidence in the Town of Westminster (Table E.1) 
 
During 1986-1995, the three sentinel cancer types occurred in Westminster at rates either 
approximately equal to or less than expected rates:  peritoneum cancers (2 diagnoses observed 
vs. 1.0 expected), mesothelioma (one diagnosis observed vs. 0.6 diagnoses expected), and lung 
and bronchus cancer (27 diagnoses observed vs. 37.1 diagnoses expected).  These data are 
presented in Table E.1. 
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As seen in Table E.1, the incidence of cancers of the digestive organs was greater than expected 
due to an increase among males; however, the elevation was not statistically significant (28 
diagnoses observed versus 22.1 diagnoses expected). 
 
Review of Cancer Incidence Risk Factor Information 
 
Tobacco History 
 
A review of tobacco use for the two individuals with cancers of the peritoneum, retroperitoneum 
and pleura revealed that one individual was a current smoker at the time of their diagnosis while 
the other individual had never smoked.  Of the 27 individuals who were diagnosed with lung and 
bronchus cancer, 78% (21 of 27) were current or former smokers at the time of their diagnosis, 
19% (5 of 27) had an unknown smoking status, and 3% (1 of 27) never smoked.  Thus, 95% (21 
of 22) of individuals with a known smoking history and who were diagnosed with lung and 
bronchus cancer reported being current or former smokers. 
 
Occupational History Review 
 
A review of occupational information reported to the MCR for the 77 individuals in Westminster 
diagnosed with one of the asbestos-related cancers during 1986-1995 showed that seven 
individuals had possible exposure to asbestos. The remaining 91% (70 of 77) reported either job 
titles not typically related to asbestos exposure or limited or no information regarding their 
occupational history. 
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Of the two individuals with peritoneum cancers, one reported being a housewife while the 
second person reported being retired at the time of their diagnoses.  
 
Asbestos-Related Mortality in the Town of Westminster (Table E.2) 
 
Over the 20-year time period 1979-1998, townwide mortality for the sentinel causes of death was 
about as or lower than would be expected.  There was one reported death from asbestosis in 
Westminster while no deaths were expected.  There was one reported death from cancer of the 
peritoneum, retroperitoneum and pleura (which was a mesothelioma) while approximately one 
death was expected.  The mortality rate for lung and bronchus cancer was lower than expected in 
Westminster (48 observed vs. 60.5 expected). 
 
The mortality rates for the following additional causes of death were at or near expected rates:  
digestive organ cancers, site-unspecified neoplasms, diseases of pulmonary circulation, COPD, 
pneumoconiosis, and other diseases of the respiratory system.  In some instances the number of 
observed deaths exceeded the expected number, based on national rates, but no statistically 
significant differences between the number of observed and expected deaths were found. 
 
Review of Mortality Risk Factor Information 
 
Occupational History 
 
A review of occupational information on the death certificates of the 141 individuals in 
Westminster who died of one of the asbestos-related diseases during the 20-year time period of 
1979-1998 revealed eight individuals (6%) had job titles associated with possible exposure to 
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asbestos. Eighty-one percent (114 of 141) of the individuals had job titles not associated with an 
increased risk of exposure to asbestos.  The remaining 13% (19 of 141) were housewives or had 
never worked.  
 
Geographic Distribution 
 
In addition to determining incidence and mortality rates for asbestos-related diseases, a 
qualitative evaluation of the point pattern of sentinel cancer diagnoses and deaths in Westminster 
was conducted.  Place of residence at the time of diagnosis or death was mapped to assess any 
possible geographic concentration of disease.   
 
In general, review of the geographic distribution of sentinel health outcomes did not reveal any 
apparent spatial patterns at the neighborhood level that could not be attributed to such factors as 
areas of higher population density.  The residences of the two peritoneum cancer cases were in 
different neighborhoods.  The distribution of residences for those Westminster residents with 
lung and bronchus cancer was fairly spread out across the town, consistent with population 
density.  The one individual who died of asbestosis was a fireman; it is possible that he faced an 
increased risk of asbestos exposure through his occupation. 
 
Conclusions 
 
• For Westminster, the three sentinel cancer types occurred at rates approximately equal to 
or less than expected rates:  peritoneum cancers (2 diagnoses observed vs. 1.0 expected), 
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mesothelioma (one diagnosis observed vs. 0.6 diagnoses expected), and lung and 
bronchus cancer (27 diagnoses observed vs. 37.1 diagnoses expected).   
• Over the 20-year time period 1979-1998, townwide mortality for the sentinel causes of 
death was about as expected or less than expected. 
• Review of the geographic distribution of sentinel health outcomes did not reveal any 
apparent spatial patterns at the neighborhood (or census tract) level that could not be 
attributed to such factors as areas of higher population density.   
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All
Census Tracts Obs Exp SIR Obs Exp SIR Obs Exp SIR
Digestive 41 38.9 1.1 0.8 -- 1.4 28 22.1 1.3 0.8 -- 1.8 13 17.0 0.8 0.4 -- 1.3
Respiratory 34 40.6 0.8 0.6 -- 1.2 18 26.1 0.7 0.4 -- 1.1 16 15.0 1.1 0.6 -- 1.7
Lung & Bronchus 27 37.1 0.7 0.5 -- 1.1 14 23.2 0.6 0.3 -- 1.0 13 14.2 0.9 0.5 -- 1.6
Peritoneum 2 1.0 NC NC -- NC 0 0.6 NC NC -- NC 2 0.3 NC NC -- NC
Mesothelioma 1 0.6 NC NC -- NC 0 0.5 NC NC -- NC 1 0.1 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE E.1
Asbestos-Related Cancer Incidence
Westminster, MA
1986-1995
Total Males Females
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All
Census Tracts Obs Exp SMR Obs Exp SMR Obs Exp SMR
Digestive 36 34.9 1.0 0.7 -- 1.4 18 20.5 0.9 0.5 -- 1.4 18 14.8 1.2 0.7 -- 1.9
Respiratory 50 62.6 0.8 0.6 -- 1.1 30 43.1 0.7 0.5 -- 1.0 20 20.7 1.0 0.6 -- 1.5
Lung & Bronchus 48 60.5 0.8 0.6 -- 1.1 29 41.3 0.7 0.5 -- 1.0 19 20.2 0.9 0.6 -- 1.5
Peritoneum 1 0.5 NC NC -- NC 0 0.3 NC NC -- NC 1 0.2 NC NC -- NC
Without specification 16 13.6 1.2 0.7 -- 1.9 11 7.6 1.5 0.7 -- 2.6 5 6.2 0.8 0.3 -- 1.9
Pulmonary 4 5.2 NC NC -- NC 2 2.6 NC NC -- NC 2 2.6 NC NC -- NC
COPD 25 34.7 0.7 0.5 -- 1.1 14 21.5 0.7 0.4 -- 1.1 11 13.9 0.8 0.4 -- 1.4
Pneumoconioses 1 0.5 NC NC -- NC 1 0.6 NC NC -- NC 0 0.0 NC NC -- NC
Asbestosis 1 0.1 NC NC -- NC 1 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Other respiratory 8 6.4 1.3 0.5 -- 2.5 4 3.7 NC NC -- NC 4 2.8 NC NC -- NC
Note: SMRs are calculated based on the exact number of expected deaths.
Expected number of deaths presented are rounded to the nearest tenth.
SMRs and 95% CI are not calculated when observed number of deaths < 5.
Obs = Observed number of deaths 95% CI = 95% Confidence Interval
Exp = Expected number of deaths NC = Not calculated
SMR = Standardized Mortality Ratio * = Statistical significance
Data Source: Registry of Vital Records and Statistics, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE E.2
Asbestos-Related Mortality
Westminster, MA
1979-1998
Total Males Females
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